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MicroRNAs (miRNAs), small-sized ~22 nucleotide noncoding RNA (ncRNA) regulate diverse 
biological processes, mainly developmental timing and tumorigenesis. Still little is known about 
miRNAs as potential regulators of membrane trafficking that are crucial for growth and homeostasis. 
Therefore the aim of this study was to systematically identify miRNAs that regulate protein 
trafficking and to investigate the mechanism of their action. 
I carried out high-throughput microscopy-based screen to identify miRNAs playing a role in ER to 
PM trafficking of secretory cargo tsO45-G. 875 miRNAs were down-regulated by Anti-miR 
inhibitors. 93 miRNAs facilitated and 41 miRNAs inhibited tsO45-G secretion under these conditions. 
Down-regulation of endogenously expressed miR-30b facilitated tsO45-G secretion, whereas over-
expression of miR-30b inhibited tsO45-G traffic and induced fragmentation of the Golgi complex. 
Therefore, miR-30b was chosen for further study particularly because it is known to be tumor 
suppressor. No experimental data of miR-30b targets playing a role in membrane trafficking are 
available. To identify functionally relevant targets of miR-30b, I used prediction programs, 
TargetScan, PicTar and miRanda. Out of 444 overlapping targets, 18 core trafficking regulators were 
selected for RNAi-based ts-O45-G assay. 10 of them recapitulated the inhibition phenotype of over-
expressed miR-30b. 3 genes (AP3S1, Golgin-97 and SCAMP1) were validated as targets of miR-30b 
by luciferase assay, qRT-PCR, Western Blot and mutagenesis. I also showed that combinatorial 
knockdown of AP3S1, Golgin-97 and SCAMP1 by siRNA inhibits tsO45-G transport to the same 
degree as that of over-expressed miR-30b. Simultaneous down-regulation of all three genes was 
needed to rescue the facilitation effect of tsO45-G trafficking induced by Anti-miR-30b. Similar to 
tsO45-G, transport of yet another basolateral cargo transferrin was inhibited when miR-30b was over-
expressed. Interestingly, AP3S1, Golgin-97 and SCAMP1 are known to play a role in between TGN 
and PM. Indeed, I showed all three genes inhibited tsO45-G transport from trans-Golgi network 
(TGN) to PM albeit they do not belong to the same protein complex. Our findings suggest that miR-
30b regulates TGN or RE to PM trafficking by targeting multiple regulators in concert. 
In addition, I tested whether one type of long noncoding RNA (lncRNA), namely pseudogenes could 
act as regulators of membrane trafficking. Here, we reported for the first time that 15 out of 68 RAB 
GTPases have retroposed transcripts.  3 out of 15 retroposed transcripts (RAB42, RAB5c and 
RAB28) were shown to be expressed in HeLa cells; and showed varying expression across different 
cell types. Retroposed transcript of RAB42, named RAB42p inhibited transport of tsO45-G when 
down-regulated. RAB42p was predicted to have full length ORF showing 92% identical on amino 
acid level. This branch of my project opens a new research field to investigate whether RAB42p 
carries out its potential regulatory function of membrane trafficking as a new protein or exerts its 




MicroRNAs (miRNAs), etwa 22 Nukleotide umfassende nicht-kodierende RNA (ncRNA) regulieren 
verschiedene biologische Prozesse. Trotz der wachsenden Liste von miRNA – regulierten Prozessen 
ist bisher wenig bekannt über miRNAs als Regulatoren des Membrantransports, der für Wachstum 
und Homeostaseessentiell ist. Systematische Untersuchungen von Membrantransport-regulierenden 
miRNAserlangt wachsende Bedeutsamkeit.Das Ziel dieser Arbeit war es, miRNAs und ihre 
biologisch relevanten Zielgene, die den Protein-Transport regulieren, zu identifizieren. 
Hierfür habe ich einen Mikroskop-basierter Hochdurchsatz- Screen des anterograden Transports  von 
sekretorischen Transportproteinen tsO45-G durch Runterregulierung von 875 miRNAs mit Anti-miR 
Inhibitoren durchgeführt.Von den getesteten 875 miRNAs begünstigten  93 die tsO45-G Sekretion, 41 
hemmten sie. Die Runterregulierung von miR-30b begünstigt die Sekretion von tsO45-G, während 
eine Überexpression von miR-30b den tsO45-G Transport hemmt und den Golgi 
Komplexfragmentiert.Daher wurde miR-30b für die weitere Untersuchungen ausgewählt. 
Experimentelle Daten zu miR-30b Zielgenen, die eine Rolle im Membrantransport spielen, sind nicht 
verfügbar.Um funktionell relevante Zielgene von miR-30b zu identifizieren, habe ich die Vorhersagen 
der ProgrammeTargetScan, PicTar und miRanda verwendet.Aus 444 übergreifenden Zielgenen 
wurden 18 relevante Membrantransport-Regulatoren für die RNAi basierten tsO45-G Untersuchungen 
ausgewählt.Von diesen haben 10 den unterdrückten Phänotyp des überexprimierten miR-30b im 
Experiment wiederholt.3 Gene (AP3S1, Golgin-97 and SCAMP1) wurden als Zielgene von miR-30b 
durch Luziferase-Assay, qRT-PCR, WesternBlot und Mutagenese validiert.Ich habe desweiteren 
gezeigt, dass der kombinierte Knockdown von AP3S1, Golgin-97 and SCAMP1 durch siRNA den 
tsO45-G Transport in gleichem Maße hemmt, wie die Überexpression von miR-30b.Die 
Runterregulierung von drei Genen behob den begünstigenden Effekt von tsO45-G induziert von Anti-
miR-30b. Ähnlich wie tsO45-G, wurde auch der Transport vonbasolateralenTransferrins vom 
Recycling Endosom(RE) zur Plasma Membran (PM) durch Überexpression von miR-30b gehemmt. 
Interessanterweise zeigten AP3S1, Golgin-97 and SCAMP1 eine wichtige Rolle im Trans-Golgi-
Netzwerk zum PM-Transport, obwohl sie nicht zum selben Protein Komplex gehören. Unsere 
Ergebnisse deuten darauf hin, dass miR-30b den Transport von TGN oder RE zur PM beeinflusst, 
wenn sie diese Regulatoren gleichzeitig angreifen.  
Zusätzlich habe ich getestet, ob ein Typ von langen nicht-kodierenden RNA (lncRNA) Pseudogenen 
als Regulator des Membrantransports agieren kann.Hier haben wir zum ersten Mal belegt, dass 15 von 
68 RAB GTPasen retroposierte Transkripte vorweisen. 3 von 15 retroposierte Transkripte von 
RAB42, RAB5c and RAB28 konnten in Hela Zellen als exprimiert nachgewiesen werdenund zeigten 
unterschiedliche Expression in verschiedenen Zell-Typen. Retroposierte Transkripte von RAB42, 
speziell RAB42p, inhibierten bei Runterregulierung den Transport von tsO45-G. Für RAB42p wurde 
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eine ORF vorhergesagt.Meine Arbeit eröffnet ein neues Forschungsgebiet, um zu erforschen ob 






















1.1 Principles of membrane trafficking in mammalian cells 
Organelles are distinct in morphology and composition which perform specialized functions 
in a eukaryotic cell. These organelles surrounded by membrane separate the contents from the 
rest of cytoplasm. The important organelles are nuclear envelope, ER, Golgi, endosomes, 
mitochondria, lysosomes and PM (Figure 1.1).  
 
      
Figure 1.1 Overview of the biosynthetic and endocytic pathway. Newly synthesized molecules are 
transported from the ER to the Golgi cisternae and from the TGN, the cargo proteins are destined to 
either PM or endosomes. In the endocytic pathway, the cargo proteins are internalized at PM and 
sorted at EE to deliver the proteins either to lysosomes for degradation or RE for recycling back to 
PM (adapted and modified from Scheller, 2013).  
 
Efficient segregation of various metabolic processes is ensured by compartmentalization 
mediated by enzymes, regulatory and structural proteins (Lev, 2010). Each organelle 
performs a specific function critical for the survival, growth and maintenance of homeostasis 
of the cell, for example, nucleus for DNA replication and mitochondria for respiration. 
Organelles work in concert to regulate the transfer of newly synthesized proteins, lipids and 
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carbohydrates important for growth, survival, communication and homeostasis (Tokarev, 
Alfonso & Segev, 2009; Lippincott-Schwartz, Roberts & Hirshberg, 2000). Shuttling of 
newly synthesized proteins and lipids to appropriate destinations as well as regulating the 
turnover of cell surface proteins is the main purpose of secretion and endocytosis-linked 
pathways. The involvement of transport of newly synthesized proteins and lipids from the ER 
to Golgi, further intra-Golgi and from the Golgi to the PM is what comprises of the secretory 
pathway (De Matteis & Luini, 2011). The endocytic pathway includes the transport from the 
PM to endosomes and finally either degradation route from endosomes to lysosomes or 
recycling to PM (Tokarev, Alfonso & Segev, 2009). Specific protein-targeting motifs mediate 
the distribution of proteins among organelles (Kim & Hwang, 2013). Vesicular or tubular 
carriers bud from the donor compartment, selectively package cargo and fuse to the acceptor 
compartment which allows the transport of proteins between two compartments (Mellman & 
Warren, 2000). Briefly, the vesicles coated with coat proteins bud by deformation of donor 
membranes. The recruited coat proteins on the vesicles interact to specific signals of the 
cargo or cargo receptors and enable the cargo incorporation into budding vesicle. This 
mechanism is called molecular sorting, the first step of communication (Pelham, 1999). After 
budding, vesicles are delivered to the destined compartment either by passive diffusion or on 
a motor-mediated cytoskeleton track (Cai, Reinisch & Ferro-Novick, 2007). The final steps 
are tethering and fusion with the target membrane. The vesicles tether to the acceptor 
compartment by SNARE complex facilitated by Rabs (Schimmoller, Simon & Pfeffer, 1998; 
Cai, Reinisch & Ferro-Novick, 2007). The identity and specificity of the compartments are 
maintained through the orchestrated series of vesicle fusion events mediated by SNAREs and 
provide the road map of the membrane trafficking (Malsam & Soellner, 2011).  
1.2 ER exit  
Proteins and lipids are synthesised on the polysomes attached to the membrane of rER 
(Kalies, Gorlich & Rapoport, 1994). The polypeptides are folded and undergo initial post-
translational modifications that allow them to pass through the ER membrane to the Golgi 
complex. These proteins are being separated from ER-resident proteins and packaged into 
vesicles at ER-exit sites (ERES) (Schweizer, Fransen & Matter, 1990). Therefore, the ER is 
known to be the first compartment having rate-determining role that ensures proteins to be 
correctly folded before ER exit. Two distinct ER-export motifs are found in the cytoplasmic 
domain of membrane proteins - i) diphenylalanine (FF) motif of ERFIC-53 and p24 proteins 
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ii) diacidic (DxE) motif of tsO45-G protein flanking YXXϕ signal for basolateral sorting 
(Nishimura & Balch, 1997; Nufer et al., 2001). The ER contains resident enzymes, lectins 
and chaperones which perform the quality control check for the assembly and export of 
protein (Howell et al., 2006). Proteins out of ERES shuttle to and fro the Golgi complex in a 
60-100nm sized intermediates or vesicles containing coat protein complexes such as COPI 
and COPII (Zanetti et al., 2012) (Figure 1.2).  For the efficient recruitment of COPII to sites 
of smooth ER, three soluble protein complexes: Sec23/Sec24, Sec13/Sec31 complexes and 
small GTPase Sar1 perform the budding reaction such as cargo capture, coat assembly, 
scission and subsequent coat release (Dancourt & Barlowe, 2010). Sec23a and Sec24d are 
important for the selection of cargo. Their individual knockdowns do not result in secretion 
defect, whereas double knockdown impairs ER-Golgi trafficking in HeLa cells (Wendeler, 
Paccaud & Hauri, 2007). Mutations in COPII coat proteins lead to diseases in human. Few 
examples include chylomicron retention disease (mutation in SAR1B), cranio-lenticulo-
sutural dysplasia (mutation in Sec23A), CDAII (mutation in Sec23B) (Khoriaty, Vasievich & 
Ginsburg, 2012). 
                  
Figure 1.2 Bidirectional transport between ER and Golgi cisternae. Fully folded secretory 
proteins are exported from the ER into COPII coated vesicles in anterograde direction and fuse with 
ERGIC. The retrograde transport pathway involves COPI coated retrieval of ER resident proteins or 







1.3 Intra-Golgi trafficking  
The Golgi apparatus is a highly dynamic organized organelle that sorts multiple secretory 
proteins in transit. In mammalian cells, a series of flattened membrane-bound cisternae 
ranging from three to eight makes up the Golgi apparatus. The closely aligned stacks are 
positioned around the centrosome forming a ribbon-like perinuclear structure (Wang & 
Seemann, 2011). The primary roles of the Golgi apparatus are glycosylation and sorting. But 
the debate about movement of proteis through the Golgi complex still exists. The well known 
models are vesicular transport and cisternal maturation (Luini, 2011). Regardless of the 
mechanism, the cargo proteins undergo series of covalent modifications as they pass through 
each cisternae. Each cisternae has resident glycosylation enzymes which perform 
modification to the carbohydrate side chain of the cargo proteins. The structural proteins such 
as Golgins and GRASPs along with interactive partners, microtubules and actin cytoskeleton 
assist in Golgi maintenance and intra-Golgi transport (Martinez-Menárguez, 2013). Golgins 
known to be structural matrix components of the Golgi complex play important roles in the 
secretion and maintenance of the complex. A large number of Golgins interacts with RAB, 
ARF and ARL GTPases to recruit cargo proteins on membranes (Figure 1.3). For example, 
p115 tethers COPI coated vesicles on the cis-Golgi marked by GM130 by binding to RAB1 
(Derby & Gleeson, 2007). Depletion of p115 disrupts the Golgi structure and inhibits the 
tsO45-G transport from ER to Golgi (Seemann, Jokitalo & Warren, 2000). Finally, the 
SNARE proteins such as syntaxin 5, syntaxin 10, GOS28 provide the membrane targeting 
and fusion (Cosson et al., 2005). Coats must differentiate between resident and cargo proteins 
of the donor compartment, though little is known about sorting at the ERGIC. Retrograde 
transport from Golgi-ER is mediated by the recognition of a dilysine signal KKXX ER 





                          
Figure 1.3  Locaization of Golgins across the Golgi complex.  Golgins localized mainly in the cis- 
and trans- faces of the Golgi mediates the interaction with membrane associated ARL1 which is 
useful for the maintenance and structural integrity of the Golgi complex (adapted from Goud & 
Gleeson, 2010). 
 
1.3.1 Post-Golgi transport                       
The final Golgi subcompartment is the trans-Golgi network that can be divided into trans 
COPI-positive cisternae and trans-most perforated cisternae with clathrin-coated buds 
(Ladinsky et al., 2002; De Matteis & Luini, 2008; Scahub et al.,2006). Cargo proteins are 
post-translationally modified, sorted, packaged and transported to the final destination such 
as PM, EE, lysosomes or RE. The convergence of secretory and endocytic routes occurs at 
this compartment (Vliet et al., 2003). In polarized epithelial cells, cargo proteins are sorted at 
TGN/RE for their delivery to either basolateral or apical surface depending on the proteins 
(Mostov et al., 2000). Cargoes also exit the TGN into tubular transport carriers, named as 
post-Golgi carriers (PGC; 1-8 µm long) (Valente et al., 2012). In both polarized and non-
polarized cells, basolateral cargo proteins tsO45-G-GFP, E-cadherin and transferrin receptor 
(TfR) were transported in tubular PGCs from TGN to PM via transferrin-positive Rab11-
positive RE as shown by live cell imaging (Hirschberg et al., 1998; Lock & Stow, 2005; Lock 
et al., 2005; Henry & Sheff, 2008). Newly synthesized E-cadherin is transported to the 
basolateral cell surface with highly conserved dileucine motif in cytoplasmic domain and 
functions in cell-cell adhesion and cell polarity (Miranda et al., 2001). Four adaptor 
complexes (AP1, AP2, AP3 and AP4) are involved in transport of cargo proteins in between 
TGN and PM (Nakatsu & Ohno, 2003). For example, AP1 complex form clathrin coated 
vesicles at the TGN for their transport to PM or late endosomes (Ponnambalam & Baldwin, 
2003). AP4 adaptor protein is non-clathrin association with TGN and regulated by ARF1. 
The published data on AP3 and AP4 localized on TGN may imply their significant role in 
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basolateral secretion, whereas AP2 acting on PM play role in secretion and endocytosis cross-
talk. AP3 is recruited by tsO45-G using the tyrosine-based di-acidic motif (YTDIE) in its 
cytoplasmic tail for the efficient transport from TGN to cell surface (Nishimura, Plutner, 
Hahn & Balch, 2002). This is the same sorting signal which recruits COPII for ER – Golgi 
transport. Knockdown of GOLGA1 (known as Golgin-97) or over-expression of the GRIP 
domain of GOLGA4 (known as Golgin-245 or p230) blocks the exit of E-cadherin transport 
from the TGN (Lock et al., 2005). Over-expression of GOLGA4 has no effect on tsO45-G 
transport (Kakinuma et al., 2004). Double knockdowns of ARF1 and ARF4 inhibited the 
transport of tsO45-G from the ER and VTCs (Volpicelli-Daley, Li, Zhang & Kahn, 2005). 
RAB8a and RAB6 participate in vesicle fusion with PM and play role in tsO45-G traffic from 
TGN to PM in MDCK cells (Huber et al., 1993; Grigoriev et al., 2011). Therefore, various 
regulators are involved in cargo trafficking from TGN to PM. The cation-dependent and –
independent mannose 6 phosphate receptors (M6PR) sort acid hydrolases to the lysosome in 
humans. The hydrolase precursors bind to the receptors at the TGN and fuses with 
endosomes (Perez-Victoria et al., 2008). Ligand dissociates in the late endosome at low pH 
followed by movement of free CI-M6PR from TGN to cell surface (Maxfield & McGraw, 
2004) 
1.4 Endocytosis 
Proteins and ligands are endocytosed either by clathrin-dependent or clathrin-independent 
mechanism. Clathrin-mediated endocytosis is well studied that involves adaptor complexes 
and Rab GTPases, whereas investigation on clathrin- and caveolin- independent pathways is 
emerging (Mayor & Pagano, 2007). The endocytic pathway consists of EE, RE, LE and 
lysosomes. Retrograde transport from endosomes to TGN is trafficked by a variety of cargo 
proteins that is a crucial part of the regulatory process to maintain harmony of the cellular 
process (Johannes & Popoff, 2008). Some toxins and virus use the internalization pathway 
for the entry into cells to perform its lethal action. Shiga toxin B (StxB) is endocytosed from 
the PM to ERC and travel to the ER via TGN where the catalytic A subunit are retranslocated 
into cytosol and fulfil their lethal mission (Engedal et al., 2011; Spang, 2013). Similar to Stx, 
the other toxins such as Cholera toxin, exotoxin from Pseudomonas and plant toxin ricin 
follow the similar transport route. Viruses such as HIV-1 infect host cells and its envelope 
protein undergoes retrograde transport (Grove & Marsh, 2011). GOLGA1 and GOLGA4 
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interact with ARL1 thorugh its GRIP domain and transport StxB from TGN (Lu, Tai & 
Hong, 2004; Lieu  et al., 2007).          
The two types of recycling routes exists: ‘slow’ and ‘fast’ where the former one involves the 
transport of cargo proteins from EE to endosomal recycling compartment (ERC) to PM and  
the latter transports  from EE directly to PM (Figure 1.4). Iron-bound transferrin receptor 
(TfR) and low-density lipoprotein (LDLR) are examples of cargo proteins in clathrin-
dependent endocytosis (Grant & Donaldson, 2009). RAB4 and RAB11 are markers of fast 
and slow recycling routes, respectively. Apart from the degradation and recycling routes, 
there is yet another route serving as a junction between endocytic and exocytic pathways 
originating from EE. The retrograde transport from EE to TGN is accompanied by retromer-
mediated tubulation (Maxfield & McGraw, 2004). Sorting of the proteins and lipids initiate at 
EE which serve as the focal point of the endocytic pathway like TGN. Generally, the ligand is 
separated from the receptor in the mild acidic pH ~6.2-6.8 and gets degraded in the late 
endosomes whereas the receptors are recycled back to PM for additional rounds (Gruenberg, 
2001). The exception occurs for Tf which is not released and degraded in the acidic 
environment of sorting endosomes. Two irons (Fe3+) are released from diferric Tf and the 
iron-free Tf bound to its receptor recycles back (Maxfield & McGraw, 2004). LDLR, EGFR, 
TfR, furin, TGN38, M6PR, and LAMP-1 are among those proteins with specific motifs 
present in the cytoplasmic domain to mediate its interaction with AP and its recruitment in 
clathrin coated vesicles (Bonifacino & Traub, 2003). The tetrapeptide YXXФ serves as the 
important sorting signal that binds to the µ subunit of AP1 and AP2 and directs the distinct 
sorting itineraries (Bonifacino & Traub, 2003). The trafficking motif for internalization is a 
conserved tetrameric sequence NPXY is present in the cytoplasmic domain of LDLR, EGFR 
and other insulin receptor families (Kurten, 2003). RAB5a GTPase present on the cytosolic 
face of the plasma membrane and vesicles regulate the fusion of the endosomes that helps in 
the cargo movement and sorting. Early endosomal antigen (EEA1) binds to RAB5a-GTP and 
to regulate the endosomal tethering (Bucci et al., 1995). Knockdown of ARF4 alters 
retrograde transport of TGN38/M6PR (Nakai et al., 2013). Knockdown of RAB10 attenuates 
GLUT4 exocytosis rate to the PM but no effect on transferrin recycling (Sano et al., 2007). 
RAB11 is considered to be recycling marker of recycling endosomes and its depletion retards 
the exocytic process of internalized Tfn (Takahashi et al, 2012). Over-expression of RAB15 
mutants regulates the internalization and recycling of the TfR.  Down-regulation of RAB32 
and RAB38 regulates the biogenesis of melanosomes and causes incorrect transport of 
19 
 
melanin-producing tyrosinase and Tyrp1 from ERC to melanosomes mediated by AP-1 or 
AP-3 (Bultema & Di Petro, 2013). 
                                              
Figure 1.4 Endocytic recycling pathways. Recycling trafficking of cargo proteins (LDLR, TfR, CI-
MPR, TGN38) take different routes from TGN and recycling endosomes to the PM , whereas Furin 
and CI-MPR can move from late endosomes to PM  (adapted and modified from Maxfield & 
McGraw, 2004). 
 
1.5 Vesicular Stomatitis Virus Glycoprotein 
A negative-sense RNA rhabdovirus, Vesicular Stomatitis virus (VSV) contains a single 
species of glycoprotein (G), membrane matrix protein (M), nucleocapsid proteins (N, NS and 
L) and genome RNA. This virus matures by budding through membranes of the host cell 
(Rigaut, Birk & Lenard, 1991; Hunt & Summers, 1976a). Glycoproteins are well studied due 
to its diverse important cellular and structural functions. They are synthesized from ER and 
follow the conventational transport pathway from Golgi to PM by undergoing various 
modifications. G protein is engineered as temperature-sensitive (ts) and precisely defines the 
intracellular location of the export of newly synthesiszed G protein (Mottet, Tuffereau & 
Roux, 1986). The G protein of 511 amino acids is divided into four primary structural parts: 
signal sequence, main body, transmembrane domain and cytoplasmic tail (Figure 1.5). 
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Different steps of glycosylation of G protein start at the two glycosylation sites (residues 179 
and 335) when G protein was either still bound to the ribosome as a nascent polypeptide 
chain or shortly after the biosynthesis is over (Robertson, Etchison & Summers, 1976). The 
signal peptide of 16 amino acids is cleaved cotranslationally after translocation from ER 
lumen (Gallione & Rose, 1983; Gallione & Rose, 1985; Flamand & Pringle, 1971).  
 
NH2                                                                                                                                    COOH 
 
  Signal                                               Phe (W.T)                                Transmembrane Tail 
 Peptide                                                                                                       
 
Figure 1.5 Primary structure of VSV-G protein. cDNA analysis of G protein reveals four structural 
domains with two glycosylation sites (residues 179 and 335). Phe at residue 204 near glycosylation 
site was mutated to Ser. (adapted from Gallione & Rose,1985; Hunt & Summers, 1976a). 
 
The G protein is a transmembrane protein and it must be inserted into the lipid bilayer after 
the protein synthesis. Most of the polypeptide chain faces the ER lumen and about 30 amino 
acids are exposed to the cytoplasmic face of the membrane. The G protein on the cell surface 
is required for successful budding and release of viral particles (Witte & Baltimore, 1977). 
The G protein of VSV has been extensively studied to analyse the export of a membrane 
component by the secretory pathway. Several temperature sensitive G mutants induced by the 
mutagen 5-fluorouracil were isolated from Orsay strain of VSV by complementation group 
assay (Rettenmier, Dumont & Baltimore, 1975; Pringle, Duncan & Stevenson, 1971; Lafay, 
1974). A single amino acid replacement from Phe at residue 204 to Ser near the glycosylation 
site results in temperature-sensitive phenotype (Gallione & Rose, 1985; Hunt & Summers, 
1976b). The mutant tsO45 encoding for a G protein shows normal synthesis and initial 
glycosylation but blocks the normal maturation from rER to sER and remains unglycosylated 
at 39.50C, whereas shift to 320C leads to accumulation of G protein on PM (Bergmann & 
Singer, 1983). The maturation and migration of G protein to the cell surface was normal at 
non-permissive temperature when the nucleocapsid proteins (N) or matrix protein (M) were 
mutated.  Studies have shown that transport carriers or COPII coated vesicles containing 
tsO45-G move from ERES to the Golgi in living cells. Incubation of tsO45-G expressing 
Vero cells at 100C accumulates the folded protein in ERES without further movement to 
ASN 179 ASN 335 
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ERGIC and Golgi (Supek et al., 2002). At 150C, tsO45-G leaves the ER and accumulates in 
ERGIC whereas at 200C tsO45-G is transported to late Golgi compartment (TGN) (Lin et al., 
1999). At 39.50C, tsO45-G is synthesized and glycosylated normally where nascent chain 
acquires intra-chain di-sulfide bonds and associates with two chaperones BiP/GRP78 and 
calnexin. The folding defect in the protein prevents full intra-chain disulfide oxidation and 
calnexin helps in the retention of the unfolded protein as well as failure to trimerize.  At non-
permissive temperature, excess amount of tsO45-G at unfolded state shows movement from 
the ER to ERGIC and Golgi in CHO cells and recycling back to the ER (De Silva, Balch & 
Helenius, 1990). The putative reason is the retrieval from the Golgi by the KDEL receptor 
bound to the KDEL sequence of BiP/GRP78 (Hammond & Helenius, 1994). The key 
component of this assay is a temperature-sensitive glycoprotein mutant of vesicular stomatitis 
virus tsO45-G tagged with fluorescent protein YFP or CFP. This ectopically expressed 
chimeric transmembrane protein remains in misfolded state at 39.50C and therefore 
accumulates in the ER (Zilberstein et al, 1980; Starkuviene & Pepperkok, 2007). The 
synchronized release of protein at permissive temperature of 320C to PM is detected by 
antibody on PM (Figure 1.6). 
                           
Figure 1.6 Detection of fluorescently labelled tsO45-G anterograde transport.  The travel of 
tsO45-G from the ER to the PM is measured by the infection of fluorescently –tagged glycoprotein 
and detection by antibody labelling on the PM (A.Serva). 
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1.6 Challenging the central dogma: Non-coding RNA 
The central dogma of gene encoding for proteins via mRNA intermediate is challenged by 
non-protein-coding RNA (ncRNA) in higher eukaryotes (Szymanski et al., 2003). The 
prokaryotes do contain ncRNA comprising of 0.5% of the total number of genes in E.coli, 
whereas ~97-98% of the transcriptional output of the human genome is ncRNA (Argaman et 
al., 2001; Mattick, 2003; Costa, Leitao & Francisco, 2012). The term ncRNA is defined by 
RNA that does not encode for a protein but serves a wide range of functions such as 
transcriptional regulation, alternative splicing, mRNA stability and translation, and chromatin 
modification and DNA methylation (Gomes, Nolasco & Soares, 2013). There are different 
classes of ncRNAs based on two broader functional annotations: a) housekeeping such as 
transfer RNA(tRNA), ribosomal RNA(rRNA), small nucleolar RNA(snoRNA), small nuclear 
RNA(snRNA) and b) regulatory such as small interfering RNA(siRNA), 
microRNA(miRNA), piwi-interacting RNA(piRNA) (Szymanski & Barciszewski, 2002). 
rRNA and tRNA are used in mRNA translation , snRNA in splicing, whereas snoRNA in 
modification of rRNA (Griffiths-Jones, 2007; Szymanski, et al., 2003). These riboregulators 
are further divided into two categories in terms of length: ‘short’ and ‘long’. The GENCODE 
consortium within the framework of the ENCODE project represents a valuable resource of 
comprehensive analysis of human lncRNA which suggests the growing attention towards 
poorly understood ncRNA (Derrien et al., 2012). 
 
1.7 A novel class of regulators: miRNAs 
MicroRNAs (miRNAs) are a family of small ncRNA of 21-24 nt in length that regulate the 
gene expression of target mRNAs post-transcriptionally. They are highly conserved among 
animals, humans, plants and some viruses. The first microRNA lin-4 was discovered in 
C.elegans in 1993 (Lee &Ambros, 2001) and a decade of extensive research has brought 
about 2000 human miRNAs as currently curated in the miRBase database (miRBase v20). 
miRNA bind to their target mRNAs. For example, Lin-4 binds to lin-14 mRNA and controls 
the appropriate timing of development in C.elegans (Wightman & Ruvkun, 1993).  30-60% 
of the human protein coding genes are being regulated by miRNAs (Filipowicz, Bhattacharya 
& Sonenberg, 2008; Friedman et al., 2009; Selbach et al., 2008). Extraction and detection of 
miRNAs from cell lines, fresh tissues, formalin fixed paraffin embedded tissues, urine, 
plasma, serum and other body fluids are possible with the molecular biology technologies. 
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Extraction of miRNAs is similar to that of mRNA except small modifications to enrich the 
small RNA fraction since miRNAs represent ~0.01% of the total RNA.  
Profiles of miRNAs are found to be stable whereas mRNA profile is highly fragmented and 
less reliable (Pritchard, Cheng & Tewari, 2012; Liu & Xu, 2011). This is the reason why 
miRNAs are used as clinical biomarkers. miRNA has a wide variety of regulatory functions 
such as  development, differentiation, apoptosis, immune responses (Rotllan & Fernandez-
Hernando, 2012; Huang et al., 2011). The deregulation causes various human diseases such 
as cancer, diabetes, nervous system disorders, cardiovascular diseases, asthma, infectious 
diseases, autoimmune diseases and arthritis (Ikonen, 2006; Ha, 2011). Different stages of 
cancer such as developmental lineage and differentiation state of tumours are reflected by 
miRNA expression profiles which suggest the usage of miRNAs as diagnostic markers or 
therapeutic targets.  Alteration of the expression of key miRNAs can separate groups of 
patients into clinically relevant classes. miRNAs being relatively stable, circulating miRNAs 
are detected in serum and plasma and used as clinically useful biomarkers (Liu et al., 2009).  
Approaches for potential therapeutic agents such as antisense oligonucleotides are being 
explored to inhibit miRNA function. Recent advances have illustrated miRNA to be the next 
possible candidate for treating human diseases. Decreased expression of miR-133 by in vivo 
infusion of antagomir resulted in sustained cardiac hypertrophy in heart disease (Care et al., 
2007). Another evidence of miR-140 showed resistance to osteoarthritis in chondocytes when 
over-expressed in mice (Miyaki et al., 2010). miR-122 has already entered the Clinical Trial 
II in order to eradicate the replication of hepatitis C virus from infected human body (Janssen 
et al., 2013). Circulating miRNAs, especially in plasma has been considered to be high 
source of novel biomarkers.  More than half of the human miRNA genes are in genomic 
clusters and located in cancer-associated genomic regions which are deleted or amplified in 
high frequency. Misregulation of miRNAs can function either as tumour suppressors or 
oncogenes. The oncogenic miRNAs are miR-10b, miR-155, miR-21 and miR-17-92 
polycistronic cluster, whereas tumour suppressors are miR-26a, miR-126, miR-335, miR-34 
and let -7 family (Van Rooij, Purcell & Levin, 2012).   
1.7.1 miRNA biogenesis 
The polyadenylated and capped miRNA genes are generally transcribed from miRNA-
encoding genes by RNA polymerase II to produce the primary transcripts (pri-miRNA) of 
~3-4 kilobases in length (Takada & Asahara, 2012). A pri-miRNA usually is made of a 
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hairpin stem of 33 bp, a terminal loop and two flanking regions upstream and downstream of 
the hairpin.  The first endonucleolytic reaction occurs in the nucleus where pri-miRNA is 
cleaved into precursor miRNA (pre-miRNA) by RNase III endonuclease Drosha bound by its 
regulatory subunit DGCR8 (also known as Pasha in D.melanogaster and C.elegans). DGCR8 
binding and Drosha cleavage depend on the stem and the flanking regions. DGCR8 acts as a 
molecular ruler to determine the cleavage site at which two RNase domains of Drosha cleave 
11 bp away from the flanking region of the hairpin stem. ~70nt pre-miRNA is exported from 
the nucleus to the cytoplasm by Exportin-5 along with Ran-GTP which recognizes the 
defined length of stem (double-stranded) and 3’ overhangs. Following the export, pre-
miRNA cleaves into double-stranded mature miRNA by attaching to the multi-protein core 
complex consisting of RNase III Dicer, Tar RNA binding protein (TRBP, double-stranded 
RNA binding protein), protein activator of PKR (PACT) and Argonaute-2 (Ago2). The whole 
complex is collectively named as RISC loading complex. Dicer cuts off the loop of pre-
miRNA leaving behind roughly ~22nt miRNA duplex with an overhang of two nucleotides at 
3’end. In some cases, Ago2 cleaves before Dicer and probably mediates strand dissociation 
and RISC activation. Four members of the Ago protein family, Ago(1-4) play roles in RNA-
mediated gene regulation. The miRNA/miRNA* duplex is separated into functional guide 
strand by helicases which is incorporated into the RISC and guides to target mRNAs. The 
miRNA* strand called passenger strand is eventually degraded. The selection of the guide 
strand by RISC depends on the less thermodynamic stability of the base pair of miRNA 
duplex at 5’end (Figure 1.7). The functional miRNA is capable of silencing target mRNAs by 
cleavage, repression or deadenylation. Ago2 with slicer activity digests the mRNA target 
when miRNA binds to the target with 100% complementarity. When they are not 100% 
complement, mRNA function is suppressed by translational inhibition (Carthew and 
Sontheimer, 2009; Lim et al., 2005; Lindow, 2011; Winter et al., 2009) 
The non-canonical biogenesis pathway exist which is independent of the RNase III enzymes 
Drosha and Dicer. The first major pathway is mirtrons which bypasses Drosha cleavage by 
defining the splice donor and acceptor sites of miRNA/miRNA* pairs and pre-miRNA 
hairpins are generated by splicing machinery and lariat debranching enzyme. They are 
identified in flies, nematodes and mammals. Mirtrons are situated within very short introns 
and exported to the cytoplasm via exportin and further processed by Dicer. Dicer independent 
pathway uses RNase H-like endonuclease Ago2 cleavage of Pre-miR (Yang & Lai, 2011). 
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Figure 1.7 MicroRNA biogenesis pathway.  The maturation of pri-miRNA in the nucleus into pre-
miRNA is exported in the cytoplasm. Further processing leads to the mature miRNA duplex. The 
fuctional strand loaded onto RISC silences target mRNAs (adapted from Winter et al., 2009) 
 
1.7.2 miRNA: mRNA interaction 
miRNA base pairs mostly with 3’UTR of a target mRNA, although few evidences show that 
base-pairing occurs in 5’UTR and CDS (Lytle,Yario & Steitz, 2007). In animals, Watson-
Crick base pairing to the mRNA is mostly imperfect involving the seed sequence at the 
position 2-7 or 2-8 (canonical sites) of 5’end of the mature miRNA sequence in contrast to 
perfect complementary in plants (Ameres & Zamore, 2013). Repression of the targets is 
linked to either decreased translational efficiency, or decreased mRNA levels. There are two 
theories behind the timeline of the action – mRNA destabilization is the predominant reason 
and secondly, translational inhibition is followed by effects of deadenylation and decay. 
Inhibiting the expression of the critical miRNA processing enzymes Dicer and Drosha also 
yields specific derepression of predicted miRNA targets at the mRNA level (Nielsen et al., 
2007). miRNAs regulate the expression of multiple target genes simultaneously that enables 
them to orchestrate cellular signaling pathways. For example, with the activation of p53 
transcription factor miR-34 family (miR-34a/b/c) induces cell death through apoptosis or cell 
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cycle arrest by suppressing multiple targets (Jain & Barton, 2012). There are other features 
which can also be responsible for targeting of miRNAs such as high AU nucleotide content, 
3’UTR compensatory sites and positioning of the seed sequence in 3’UTR (Lee & Shin, 
2012). Number of miRNAs is increasing while only a small number of targets are 
experimentally verified due to low throughput biological validation method. Identification of 
miRNA targets is possible by the following tools: 
a) In silico methods – The online tools include miRanda , PicTar, TargetScan, MicroCosm, 
Diana-microT and PITA. They help in reducing the predicted targets to a manageable number 
for experimental verification. Though this approach is easy and quick, but it gives false 
positives and therefore, it is necessary to verify candidate targets (Zheng et al., 2013; John, 
Sander & Marks, 2006). The tools in general make use of different parameters for the 
identification of mRNA targets for a single miRNA. The first parameter is the location of 
miRNA either in 3’UTR, or 5’UTR, though a list of non-overlapping targets are noticed 
which may be due to the different 3’UTR sequences. Secondly, the type of matches to the 
target sequence which spans 7-8mer miRNA seed sites makes stronger assumption. Apart 
from Watson-Crick base pairing, some prediction tools use another canonical pairing is G-U 
base pairs.  Another two key features in prediction tools are evolutionary conservation across 
several species as well as thermodynamic properties of miRNA: mRNA binding. The free 
energy change occurs via formation of duplex between miRNA and mRNA (Lekprasert, 
Mayhew & Ohler, 2011). Additional features include AU content and relative target site 
location in 3’UTR such as centered sites from position 4 or 5 to position 14 or 15.  
b) Microarray - Targets of a specific miRNA can be obtained by comparing specific miRNA 
over-expression profiles in cells or tissues with the non-expressed miRNA cell lines. This 
should be verified by either biochemical methods or loss- of-function assay by antagomir 
(Pandey et al., 2008; Nakamura, 2005). 
c) Luciferase reporter assay - The most widely used validation method after microarray or in-
silico analysis uses a luciferase reporter assay that measures the repression of the target, but it 
cannot distinguish between inhibition of translation and mRNA degradation.  
d) HITS-CLIP – RNA, miRNA and bound Argonaute protein are crosslinked by UV light 
followed by immunoprecipitation by using Anti-Ago antibodies, whereas the target RNA not 
bound by protein are digested by RNase. Then the RNAs are sequenced with the Genome 
Analyzer (Illumina, San Diego, CA) (Chi et al., 2009). 
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e) (p)SILAC – Proteins are metabolically labelled by isotope labelling in cells cultured in 
growth medium and the relative abundance of protein can be determined by mass 
spectrometry. This SILAC method has been modified to pulsed SILAC (pSILAC) by adding 
heavy isotope in growth medium for a very short time. This is measured by the ratio of heavy 
and medium-heavy isotope signal intensities that decreases when mRNA is a target of 
miRNA as compared to the similar signal intensities (Selbach et al., 2008).  
 
1.7.3 miR-30 family 
There are few literature studies about investigation of miR-30 family members (miR-30a, 
miR-30b, miR-30c, miR-30d and miR-30e). The cluster miR-30b/30d suppresses GalNAc 
transferases that promote metastasis by enhancing invasive capabilities of melanoma cells 
(Gaziel-Sovran et al., 2011). miR-30b is also present in the serum of the patients involving 
the cross-talk between TGF-β and PDGF pathways. MiR-30 family members inhibited 
mitochondrial fission through suppression of the expression of p53 and its downstream target, 
dynamin-related protein 1 (Drp1) (Li et al., 2010). Family members of miR-30 suppress 
transcription factors Smad1 and Runx2 and hence inhibit osteoblastic differentiation (Wu et 
al., 2012). There is yet another report stating that miR-30b is one of the effectors regulating 
T-cell intracellular protein (TIA), regulator of cellular homeostasis. Transient depletion of 
TIA upregulates 25 miRNAs including miR-30b by mediating the epigenetic switch linking 
dynamics of transcriptome and phenotypes (Sanchez-Jimenez et al., 2013).  Various studies 
confirm that miR-30 family is an oncogene. There are limited evidence of confirmed targets of 
miR-30b such as Myb oncogene (Martinez et al., 2011), DLL4 (Bridge et al., 2012), RUNX2 
(Zaragosi et al., 2011), GALNT7 (Gaziel-Sovran et al., 2011) and p53 (Li et al., 2010). 
Upregulation of DLL4 increases the secretion of matrix metalloproteinase-2 and influences 
gastric cancer progression. The above studies suggest that miR-30b may be a tumor 
suppressor. 
 
1.7.4 miRNAs in membrane trafficking 
Several previous studies have examined possible roles of miRNAs involved in membrane 
trafficking to maintain the normal functioning of the cell. miR-375 is the highest expressed in 
pancreatic endocrine cells and is required for the normal glucose homeostasis (Poy et al., 
2009). miR-29a mediates decrease in glucose-stimulated insulin secretion in pancreatic islets 
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through Syntaxin1a (Bagge, Dahmcke & Dalgaard, 2013). Furthermore, the COPII coat 
protein SEC23A is targeted by miR-200 and miR-375 that influences cancer cell secretome 
and promotes metastasis (Korpal et al., 2011; Szczyrba et al., 2011). RAB27A and RAB3A 
are targeted by miR-124 and miR-96 respectively that cause defects in insulin exocytosis 
(Tang, Tang & Özcan, 2008; Lovis, Gattesco & Regazzi, 2008).  Recently, Serva and 
colleagues demonstrated that the oncomir cluster miR-17-92 exert their influence on 
endocytic trafficking by targeting TBC1D2/Armus (Serva et al, 2012). There is a systemic 
identification of miRNAs and protein regulators of lipid droplets and cholesterol metabolism 
(Whittaker et al., 2010). 
1.8 Long non-coding RNA  
One of the most common but poorly understood RNA species lncRNAs are emerging to 
function in biological processes such as splicing, modulation of protein activity and 
epigenetic regulation. Dysegulation of lncRNAs leads to complex human diseases such as 
cancer, heart disease and Alzheimer’s disease (Sana, Faltejskova, Svoboda & Slaby, 2012). 
One of the lncRNAs, pseudogenes is long non-coding RNAs greater than 200nt in length 
which have close sequence similarity with protein-coding genes. Pseudogenes does not code 
for a protein due to existence of deleterious mutations, frameshifts or premature stop codons. 
They are also termed as ‘genomic fossils’ because they are important resources for 
evolutionary and comparative genomics. Pseudogenes arise largely from reverse transcription 
of mRNA of parent gene, followed by integration into genomic DNA (retrotransposed or 
processed pseudogene). Processed pseudogenes have characteristic features of polyA tail at 
3’end, no upstream regulatory elements, flanked by direct repeats such as Alu or LINEs and 
no intron (Khachane & Harrison, 2009). They are derived from coding sequence of genes by 
reverse-transcription from mRNA to cDNA and inserted in a genomic localization either in 
the same or different chromosome compared to its parental gene (D’Errico, Gadaleta & 
Saccone, 2004). After insertion two evolutionary processes occur i) involvement of 
accumulation of point mutations and ii) reduction of size when compared to the functional 
counterpart due to deletions rather than insertion. Less number of processed pseudogenes 
have been accounted for C.elegans and D.melanogaster when comapared to M. musculus and 
H.sapiens. There are ~20,000 pseudogenes out of which ~8000 are processed pseudogenes in 
the human genome (Svensson, Arvestad & Lagergren, 2006). Processed pseudogenes can 
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give rise to retrogenes, transcribed pseudogenes (also known as retroposed transcript) or non-
transcribed pseudogenes (Figure 1.8) (Harrison, Zheng, Zhang, Carriero & Gernstein, 2005). 
 
 
                          
Figure 1.8 Origin of processed pseudogene and retrogenes. Mature mRNA is reverse transcribed 
and integrated into a new genomic location with several mutations over time (processed pseudogene) 
or conservation as functional retrogene (adapted from Ding, Lin, Chen & Dai, 2006) 
 
Long known to be non-functional or junk, pseudogenes are gradually gaining regulatory 
function over protein-coding genes. The processed pseudogenes are transcribed using 
proximal regulatory elements that are tissue-specific (Pink et al., 2011). Pseudogene of neural 
nitrix oxide synthase in snail Lymnaea stagnalis interferes with the expression of the 
functional gene (Korneev, Park & O’Shea, 1999). Myosin light chain kinase pseudogene 
(MYLKP1) sharing 93% high similarity on nucleptide level with MYLK decreased the 
expression of the functional MYLK in cancer cells. Expression of MYLKP1 increased cell 
proliferation of normal cells, indicating a role during carcinogenesis (Han et al., 2011). 
Another example of putative association with thyroid tumour development is BRAF 
pseudogene for its wide expression in thyroid tumours (Zou et al., 2009). The most 
interesting novel finding was decoy mechanism of PTENP1 that involved regulation by 
miRNAs and in turn regulate the protein coding gene expression. 3’UTR of active PTENP1 
sharing the same miRNA-mediated post -transcriptional regulation as that of PTEN exert 
tumour suppressive activity (Poliseno et al., 2010). There are examples where the 
pseudogene has gained completely a new function when compared to its parental counterpart, 
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referred as retrogenes. ADP-ribosylation factor 6 (Arf6) is a retrogene localized on 
chromosome14q21 (Vinckenbosch, et al., 2006). It is functional and belonging to the class I 
Arfs, Arf3. Arf6 functions in trafficking of diverse cargo especially in endocytosis as well as 
recycling and regulates the actin cytoskeleton at the PM whereas ARF3 functions in cargo 
sorting at TGN (Donaldson & Honda, 2005; Manolea et al., 2010). Another example is 
Rab6C, a primate-specific retrogene derived from Rab6A’ transcript (Del-Nery, et al, 2006). 
Rab6C shares 91% identity to the parent gene Rab6A’and has been shown to evolve a new 
function different from its parent gene Rab6A’. Rab6C plays a role in localization to the 
centrosome as well as in cell cycle progression (Young, et al., 2010), whereas Rab6A’ is 
involved in the endosome to trans-Golgi network transport (Grigoriev, et al., 2007). 
1.9 Aims  
MicroRNAs as regulators of the membrane trafficking 
There is a growing evidence of miRNAs in various regulatory processes, including 
membrane trafficking. However, little is known about miRNAs as potential regulators of 
membrane trafficking that are crucial for growth and homeostasis.  
Therefore, the aims of the project are 
• High-throughput microscopy-based down-regulation screen of 875 miRNAs by Anti-
miRs and assess their role (facilitation or inhibition) in transport of secretory cargo 
tsO45-G. 
• To identify and validate novel functionally relevant targets that is responsible for the 
secretion defect. 
• Functionally assess the role of miRNA and its targets in different cargo trafficking 
across the membrane. 
There is a growing evidence of pseudogenes gaining regulatory function acting on its own 
protein coding gene, but however there is no knowledge of the pseudogenes on the action of 






Proof-of principle: Role of retroposed transcripts in anterograde transport 
The aims of this project are 
• To search for retroposed transcripts of membrane regulators by the bioinformatic 
approach and validate their expression in HeLa cells. 
• To focus on retroposed transcript of RAB42 and further assess their role in membrane 
trafficking along with the parent gene RAB42 (Y.T.Tsai thesis, Analysis of RAB42 
and RAB40c as novel regulators of secretory membrane trafficking). 
 




2. MATERIALS AND METHODS 
2.1 Material 
2.1.1 Instruments 
Instrument                                                                               Company 
Centrifuge                                                                                 Eppendorf                 
CO2 incubator (370C, 39.50C and 320C)                                  Thermo Electron Corporation 
DNA electrophoresis apparatus                                                Thermo Electron Corporation 
Electrophoresis power supply                                                   Cleaver Scientific Ltd 
Bacterial Culture Shaker                                                           Infors HT Minitron 
Light microscope CKX41                                                         Olympus  
Wide-field microscope                                                              Olympus 
Confocal microscope                                                                Leica TCS SP5 
Gel casting module                                                                   Hoefer 
NanoVue                                                                                   GE healthcare 
Mini personal PCR machine                                                     Bio-Rad 
Pipetboy                                                                                    Gilson 
Pipettes                                                                                      Pipetman 
Sterile work bench                                                                    Hera Safe Thermo Electron 
Trans Blot Semi-Dry Electrophoretic transfer Cell                  Cell Bio-Rad laboratories  
UV transilluminator                                                                  Unknown 
Vortexer                                                                                    VWR analog Vortex mixer   
Waterbath                                                                                  Grant 
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ECL Developing machine                                                         Intas ChemoCam Imager 3.2 
Pipette holder                                                                            Accu-jet® Pro 
Bottles                                                                                       Schott Duran 
Measuring cylinder                                                                   Schott Duran 
Dry bath                                                                                    Grant 
 
2.1.2 Disposables 
Name                                                                                         Company 
24- well plate                                                                             CellStar ® Grenier Bio-One  
96- well plate                                                                             Ibidi 
8 – well labtek                                                                           Ibidi        
Barrier sterile pipette tips                                                          Avant Guard 
Extra thick Blotting paper                                                         Bio-Rad 
Falcon tubes (15ml, 50ml)                                                        Grenier 
Cell culture dishes (10cm2)                                                       CellStar ® Grenier Bio-One 
Plastic pipettes (2, 5, 10, 25ml)                                                 CellStar ® Grenier Bio-One 
PVDF membrane (0.45um)                                                       Millipore  
Coverslips (12mm)                                                                    Marienfield GmbH & Co 
Pipette tips                                                                                 TipOne (STARLAB)                 
96-well assay plate                                                                    CoStar 
MicroAmp® Fast Optical 96-Well Reaction  





2.1.3 Chemicals and reagents 
Name                                                                                         Company 
Acrylamide / Bis-acrylamide solution                                       Roth 
Agar                                                                                           Fluka 
Agarose                                                                                     AppliChem 
Albumin                                                                                    Sigma Aldrich 
Ammonium peroxodisulfate (APS)                                          Gruessing GmbH 
Ampicillin                                                                                 AppliChem 
Bacto-Tryptone                                                                         Becton, Dickinson & Company 
Bromophenol Blue                                                                    Waldeck GmbH & Co 
Chloroform                                                                                Sigma Aldrich 
Dimethyl sulfoxide (DMSO)                                                     Gruessing GmbH 
dNTP mix (10mM)                                                                    Thermo Scientific 
Ethanol, absolute                                                                        Sigma Aldrich 
Ethidium bromide (EtBr)                                                           Sigma Aldrich 
Ethylenediaminetetraacetic acid (EDTA)                                  Merck & Co 
Glycine                                                                                       AppliChem 
Glycerol                                                                                      J.T.Baker 
Hydrogen chloride (HCl)                                                            VWR BDH Prolabo                  
Isopropanol                                                                                 Merck & Co 
Methanol                                                                                     Sigma Aldrich 
MOWIOL® 4-88 Reagent                                                          Calbiochem 
PBS Tablets                                                                                 Gibco 
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Penicillin / Streptomycin                                                             Gibco 
Protease inhibitor tablets                                                             Roche 
Skimmed milk powder                                                                Roth 
Sodium chloride (NaCl)                                                              VWR BDH Prolabo 
Sodium dodecyl sulfate (SDS)                                                    SERVA 
Tris-(hydroxymethyl)-aminomethane                                         Roth 
Triton X-100                                                                               Merck 
Tetramethyl ethylenediamine(TEMED)                                     Fluka 
Tween 20                                                                                     Roth 
Yeast Extract                                                                               Roth 
 
2.1.4 Kits 
Name                                                                                           Company 
Dual-luciferase Reporter assay                                                    Promega 
Enhanced Chemiluminescence (ECL) Kit                                  GE Healthcare (Amersham) 
Plasmid Midi kit                                                                          Qiagen 
NucleoSpin® Plasmid                                                                 Macherey Nagel 
TaqMan 2X master mix                                                               Applied Biosystems 
SYBR®Green master mix                                                           Applied Biosystems 
Wizard SV Gel & PCR Clean-Up system                                   Promega 
 
2.1.5 Size markers and loading buffer 
 6X DNA loading Dye                                                                Fermentas 
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 Quick-Load® DNA ladder (100bp , 1kb)                                 New England Biolabs                       
PageRuler™ Prestained Protein Ladder                                     ThermoScientific           
 
2.1.6 Cell lines 
All cells lines were purchased from the American Type Culture Collection (ATCC) 
(Manassas, VA, USA) 
HeLa                                  Henrietta Lacks cervical cancer 
Hek293                              Human Embryonic Kidney 293  
Huh7                                  Human Hepatocellular carcinoma  
A549                                  Human adenocarcinomic alveolar basal epithelial 
 
2.1.7 Enzyme 
Name                                                                                       Company 
Restriction enzymes (XbaI, NotI, XhoI,NheI, SacI )             New England Biolabs 
Phusion® High-Fidelity DNA Polymerase                             New England Biolabs 
T4 DNA ligase                                                                        New England Biolabs 
RNAse inhibitor                                                                      Applied Biosystems 
M-MLV Reverse Transcriptase                                              Applied Biosystems 
Benzonase                                                                               Sigma Aldrich 
 
2.1.8 Bacteria 
The E.coli DH5α from Invitrogen (Darmstadt, Germany) was used for the cloning of 3’UTR 







2.1.9 Media and solutions 
 
Name                                                                                     Company 
0.25% Trypsin-EDTA solution                                             Gibco 
Dulbecco’s Modified Eagle medium                                    Gibco 
Fetal Bovine Serum (FBS)                                                    Gibco   
L-glutamine, 200mM                                                            Gibco   
Lipofectamine 2000                                                               Invitrogen 
Non-essential amino acids (NEAA)                                     Gibco 
Nuclease- free water                                                             Gibco 
OptiMEM                                                                              Gibco 
Phusion® High-Fidelity buffer                                             New England Biolabs 
Restriction enzyme buffer 1-4                                              New England Biolabs 
T4 ligase buffer (10X)                                                          New England Biolabs 




Sample Buffer                                                                       58mM Tris, pH 6.8 
                                                                                              1.67% SDS 
                                                                                              5% Glycerol 
                                                                                              0.00025%  Bromophenol Blue 
 
Separating Gel buffer                                                           30% acrylamide mix 
                                                                                              1.5 M Tris-HCl, pH 8.8 
                                                                                              10% SDS 
                                                                                              10% APS 
                                                                            
Stacking gel buffer                                                               30% acrylamide mix 
                                                                                              0.5 M Tris-HCl, pH 6.8 
                                                                                              10% SDS 
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                                                                                              10% APS 
SDS-PAGE running buffer                                                  25mM Tris 
                                                                                              250mM glycine, pH 8.3 
                                                                                              0.1% SDS 
Transfer buffer                                                                      25mM Tris base 
                                                                                              192mM glycine 
                                                                                              0.01% SDS 
                                                                                              20% Methanol 
Luria Bertani (LB) medium                                                  10g tryptone 
                                                                                              5g yeast extract 
                                                                                              10g NaCl 
LB agar                                                                                 1000ml LB medium 
                                                                                              15g agar 
Tris-acetate-EDTA (TAE) buffer                                         40mM Tris 
                                                                                              20mM acetic acid 
                                                                                              1mM EDTA 
Washing buffer (PBS-T)                                                       1000ml PBS  
                                                                                              0.1% Tween 20 








The following primary antibodies were used: mouse anti-tsO45-G (generous gift from Prof. 
M.D. K. Simons, MPI-CBG, Germany), mouse anti-GM130 (610823, BD Transduction 
Laboratories), mouse anti-Golgin-97 (A21270, Invitrogen), mouse anti-SNX16 (HPA024730, 
Atlas antibodies), rabbit anti-SCAMP1(ab76190, Abcam), mouse anti-α-tubulin(3873,Cell 
Signaling Technology) and rabbit anti-AP3S1(ab128588, Abcam).  
Secondary Antibodies 
Anti-mouse Cy5 (GE Healthcare Biosciences) and anti-rabbit Cy3 (Amersham Biosciences) 
were used as secondary antibodies for immunofluorescence. Anti-mouse IgG (Jackson 
ImmunoResearch) and anti-rabbit HRP coupled (Amersham) were used for Western Blotting. 
Lectin ConcanavalinA-Alexa647 conjugate and Hoechst33342 were purchased from 
Invitrogen.  
2.1.12 miRNAs 
Ambion Anti-miR™ miRNA Inhibitors library (miRBase version 13, Catalog number 17005) 
and single miRNA inhibitor and precursors were purchased from Ambion (USA). miRIDIAN 
miRNA mimic and Hairpin inhibitor of miR-30b were purchased from Thermo Scientific  
Dharmacon (USA). The negative controls used in the experiments were Anti-miR Negative 
control and Pre-miR precursor negative Control. 
2.1.13 siRNAs 
All small interfering RNAs (siRNAs) were purchased from Qiagen (Hilden, Germany). All 
Stars Negative control siRNA from Qiagen (Hilden, Germany) was used as negative control 
for all the experiments. 
               Table 2.1. List of siRNAs with respective sequences  
Gene symbol Product ID Target Sequence (5’       3’) 
All Stars SI03650318  
α-COP SI00351491  





AP3S1 SI00019950 CAAGGCGATCCTAATCTTCAA 
SI03093769 CTGATATCTACTTTAGCAATA 
SI0317825 TACAACCCTCTGACTCAACAA 
AP4E1 SI04152302 CAGGCGCACTCTTCTAATACA 
SI04292050 CAGAGCACTAACCTAGTAGAA 
SI04353909 ATCGTCAATTTGGTCGGCAAA 
ARF4 SI04159029 AACGTTAAATGAAATTGGATA 
SI04253347 GGGCAGACATATCTTCATTAA 
SI04307142 CAAGACAACCATTCTGTATAA 
GOLGA1 SI04195296 TCCCTTGTTTAGAACACGAAT 
SI04315346 AACACGCATTTGCAACGTTAA 
SI04349786 TTCTGCAAGTTTGATGGGTAA 








RAB15 SI04159890 TAGCTCGTAGGAGGCCCTTTA 
SI04271330 TGCAGCTACGCTCACCCTAAA 
SI04308346 CACTGCGTGGCTGCAGCCAAA 
RAB32 SI00092232 TTGCCATCATATGGAAGATAA 
SI02662198 CTCTGCAAAGGATAACATAAA 
SI02662765 CACCAAAGCTTTCCTAATGAA 
RAB8A SI00076090 CACGTTGTATATTCAGAGAGA 
SI00076104 ATGCTCTGTTTACATCGATAA 
SI02662254 TCGCCAGAGATATCAAAGCAA 
SCAMP1 SI03227175 TAGATCGTCGGGAACGAGAAA 
SI04232487 TACATGGACTATATCGCACAA 
SI00711424 CACCATTAACTTATATCCCAA 
SEC23A SI03019464 CAGACTCATAATAATATGTAT 
SI04144238 CAGAGCCGGTTCTTCTTGATA 
SI04238815 CACTACAACCTTAGCCATATA 
SEC24D SI04145197 AACGACCTCAGAAATGATATT 
SI04228938 CCCATTTATGCAGTTCATCGA 
SI04275831 ATCCGGGAAATTCTAGTTAAT 
SEC61A2 SI00714154 TCGCGTTGATCTGCCCATTAA 
SI04131960 CCGAGATACCTCTATGGTTCA 
SI04203962 ATGATCATTACCATTGGGCAA 
SNX16 SI04288627 AAGATAGACCATCTACACCTA 
SI04304300 CCAGTCGGTATGCTTTCTAAA 
SI04318482 TCCACGTAATCTTTATCTCTA 






       
        Table 2.2 List of siRNAs for pseudogenes and parent genes 
Gene symbol Product ID Target Sequence (5’→3’) 
ARF6p-1  CGCGCTCTCGCGGCATAACTA 
RAB5cp-2  CAGGAGAGCATAATCAGAGCA 
ARF6p-2  CCGCACCGATGAGGCTTGCCA 
RAB5cp-1  GACTATGGAGACATCAGTAAA 
SH3GL1p-1  AACATTGAGCAGGTGAGTCAA 
SH3GL1p-2  CACGCTGATCAACCAGATCAA 
RAB28p-1  CACGCCCGGCTCCCTACTGTA 
RAB28p-2  CAGGATGCAAACATCACACAA 
VTI1Bp-1  TGCACCCGTATCTTTCCATAA 
ARL4Ap-1  ACCAAGAGAAATTCTAAAGCA 
RAB11FIP1p-1  AGGCATGCTTATGGAGGTCAA 
RAB11FIP1p-2  CAGAATAACGAGAGTCTTCTT 
RAB42p-1  GAGTCAAGGGTTTCTACAGAA 
RAB42p-2  CAGCTGCATCACCGGGTCCTT 
RAB28 SI03024686 TTGGAGCATATGCGAACAATA 
ARL4A SI00303492 ATGGGCATGTAAACTAATAAA 
VTI1B SI00087892 TCGGATTGCCACAGAGACTGA 
ARF6 SI00300559 CAAATAATGAGTAATATTGTA 
RAB42 SI03151757 ATGAGTGAGGTGGATGCTTCA 
RAB28 SI00061705 ACCCTTCAAATTTGGGATATA 
RAB5c SI00065590 GAACAAGATCTGTCAATTTAA 
SH3GL1 SI03108049 TACACTAGCGCTGACTCCCAA 
 
2.1.14 Oligonucleotides 
All oligonucleotides were purchased from Metabion (Martinsried, Germany). 
      Table 2.3 List of PCR primers for the cloning miRNA binding site and 3’UTRs in luciferase      
                     vector. 






















































Table 2.4 List of primers of validated targets for qRT-PCR (from Primerbank, MGH, Harvard) 
Genes Primers (5’→3’) 
AP3S1 FW:  TACCAGCCCTACAGTGAAGATAC 
RV:  ATCAGTTTGTTGTCAGATCCTCC 
GOLGA1 FW:  GAGAACTTAGTCGTACCCAGGA 
RV:  CCAGCGTTGAGTAGTGTCTCT 
SCAMP1 FW:  GAAAAGCCGCAGAATTAGATCGT 
RV:  GAAACAAGGTCCGACAGGAAA 
SNX16 FW:  TTCCAGGTTTTCGACTAGCAC 
RV:  AGGCAGTTAGCAATGTCCTTG 
GAPDH FW: CATGAGAAGTATGACAACAGCCT 
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FW:  GCGAGATTACGAGGCGAGGCT 
RV:  TGTGTATCTTCACTGTAGGGCTGGT 
160bp 
AP3S1p 
FW:  GGCTCTCCAAGTTCTACCGCCC 
RV:  GCTGGAGCTCCCACTAAGCCA 
432bp 
GOLGA2 FW:  AGCAGGGTGATCTTTGCGAGGT RV:  GGCACATGATGGGGGCGGAG 889bp 
GOLGA2p FW:  TGTCAATGGGGAGGGCCCTG RV:  GCCTCTCCTCCTGCTCTCGG 974bp 
RAB5C FW:  AGCGGCTGAAAGGCGGAAGT RV:  TGAGGAAGGCCGCTCCAATTG 494bp 
RAB5Cp1 FW:  TTGAGATCTGGGGCAGCGCT RV:  GGGCTTTCTTGCTGGCCAGG 186bp 
RAB5Cp2 FW:  CCCTCTTGCCTGCCCACTGC RV:  AGCTGCTCCAAACACGCCGT 244bp 
RAB11FIP1 FW:  TGTCCCTAATGGTCTCGGCTGGC RV:  ACTGTCGACCGAAGGTGTCGT 605bp 
RAB11FIP1p FW:  TAGGGCCAGGGGCCAAGAAC RV:  GGAGGCAGCACCTGATGCAC 391bp 
CHMP5 FW:  GCATATTGCGCTTGCGCACGG 
RV:  AGCATCAACCGTGGTCTTGGTGT 429bp 
CHMP5p FW:  TCCGCTGCCCAGCCTGAATG RV:  TGGGTGCGATTGTCCTGCTGC 210bp 
FNBP1 FW:  CACCGAGCTCTGGGATCAGTTTGAC RV:  GCCCTGTCCGCCTCTTTGCAAT 441bp 
FNBP1p FW:  CCAGGGTCAGCTGTGGTGGC 
RV:  GCCTGCCTTCAACCTCAGGCA 718bp 
RAB18 FW:  GGTGGGCAAGTCCAGCCTGCTCTT RV:  TTTACCCGGGGTCGATGAGTGGG 722bp 
RAB18p FW:  TCGAGCCCCTCGGGGTTCAG RV:  CCGACTGCTTCAGCCGTGGA 269bp 
VAMP5 FW:  CGGCAGCAGCGATGGCAGGAATA RV:  GGGTCCGTGGGGCACTACTG 327bp 
VAMP5p FW:  CCAGCGGCAAGCGAACAAGG RV:  AGGCCCTGAGGTGGTGCCTG 313bp 
ATP6V0C FW:  TGCTGGTATTTAGAGCGCAGCGG RV: AGCTGGAGGAAGCTCTTGTAGAGGC 421bp 
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ATP6V0Cp FW:  GCCCACACTCAGCCTAGCGC RV:  CCTGGCCCTTATGCGGCTGG 172bp 
ARF4 FW:  CGGTGACGCGATTCTGTCCG RV:  CCAGCAGCATCCAATCCAACCATC 404bp 
ARF4p1 FW:  GGGCCTCACCATCTCCTCCC RV:  TGTCTTGACCACCAACATCCCGT 215bp 
ARF4p2 FW:  AGCCCCTCTGCTTCTGCCCA RV:  CTTTTCTGCAGCGCGTCCGC 662bp 
LAMP1 FW:  GTGTCTTCTTCGTGCCGGCGTC RV:  TCATGTTCTTAGGGCCACTCTTGGT 362bp 
LAMP1p FW:  CAGCTGTTCCGACTGATGCTCA RV:  GCAGACTGGTCCCACTTGTGC 656bp 
VTI1B FW:  GCACTTCTCGGGTTCCGCG RV:  CTCTGCCAGCGTTTCATTTGCTTC 490bp 
VTI1Bp1 FW:  ATCTTCCGCGGCCTCCATGA RV:  GGCTTTCAGTGCCTTGCGGA 368bp 
VTI1Bp2 FW:  CTACAAGGGGTGCCCGAGCA 
RV:  CTCCTCGCCCTCCTGGTGTG 250bp 
VTI1Bp3 FW:  AGCAGCTGCACGAGATGTGC RV:  GCCCAGGCTTTTGGTGCCTT 361bp 
Sh3gl1 FW: ATGGAGAAGAAGGTGGATGTCACCA RV:  AGGGCCGAGAGCTGACTCAC 548bp 
Sh3gl1p1 FW:  AGCTGACCATGCTGAACGCG RV:  GTGTCCAGGACCGCATGCTG 414bp 
Sh3gl1p2 FW:  GCAGTTGGAGGGGCTCCTGA RV:  GGCCCGGAGTTGACTCACCT 388bp 
Sh3gl1p3 FW:  GAGCCCATGAAGCACCTGGC RV:  ATACTCCCGCCTGGGTCGTG 408bp 
Sh3gl1p4 FW:  TGGGAGCCCTTTGACCTCGG RV:  GCAGAGGCATGAGCACGTCC 322bp 
RAB43 FW:  GACCCGGACGAGCAGTACGATT RV:  AGGTCTGACTTGTTCCCGATCAGCA 377bp 
RAB43p FW:  CCGAGCGTGGGTCCCAGTCTAGTT RV:  AAGCCCTGTCCAGGCCCCAA 557bp 
SAR1A FW:  GTGGGCACGAGCAAGCACGT RV:  GACCTGCACCAGCACGTGGG 584bp 
SAR1Ap FW:  GGCTTCAGCAGTGTGCCCCA RV:  GAACACTTCCGCGGGGCGAA 498bp 
RAB13 FW:  TTTGCCAACCGTCCAGTCCCG RV:  GGATAATGCCCATGGCTCCACGG 330bp 
RAB13p FW:  ACTCGGGGGTGGGCAAGACT RV:  TGCTCCACCCCAGCTGAGGC 301bp 




RV:  CGGTTTCCGTCTTCCGTCTTCAA 
RAB6Cp FW:  TCTCGTGGAGATGATCTATTAGCTTG RV:  GTGGGCTTGGTCGGACTGCT 361bp 
RAB42 FW:  AGCGCTTCAGGTGCATCACGA RV:  GTGCTGCTTCCTGCTGGGGG 434bp 
RAB42p FW:  CCTGGCCTTTGACGCCCTCA RV:  TAGAAACCCTTGACTCTAAAATCCAGG 314bp 
ARL4A FW:  TGTCCAACCTGCCTTCATTTCAGTCT RV:  TGATGAGCTCAGTTCACCCATTGC 443bp 
ARL4Ap1 FW:  CGTGGGGTGCTTATCCCTCGT RV:  TCCAGGAGGGCAGACAGGCAA 862bp 
ARL4Ap2 FW:  TGTCCAGTCTGCCTTCATTTCAATCC RV:  TGATGAGCTCAGTTCACCTGTTGC 443bp 
RAB28 FW:  CGGGGGTCCTGCCGCAACTA RV:  GCCTACCAAGGCAACCAGTGGC 492bp 
RAB28p FW:  AGGGAACAGCACCTCCCGGA RV:  TGCCTGCGGTTGGGAGGAAC 759bp 
GPAA1 FW:  ACCAACGTGTACGGCATCC RV:  TGACATCGTGGTAGGCTTCAA 229bp 
GPAA1p FW:  AGCGGTCACGTGAAGGACCG 
RV:  GGCCGATGGAGACGAAGCGG 534bp 
ARF6 FW:  CCCAAGGTCTCATCTTCGTAGT RV:  GTGGGGTTTCATGGCATCG 158bp 
ARF6p FW:  CGCGCTCTCGCGGCATAACT RV:  CCGTCCCCTGAGGTGGCACA 270bp 
ARL5A FW:  TAGCGCATGAGGACCTAAGAA 
RV:  CGCCAGTTAGAGCACAGCA 159bp 
ARL5Ap FW:  CGCATGAGGACCTAAGGAAAGCTGG RV:  AGTCGTGACATCGTCCATTCAAGTC 199bp 
RAB1B FW:  GGACTTCAAGATCCGAACCATC RV:  CGTTGGCGTAGGATTCCTGG 167bp 
RAB1Bp FW:  AGGCGTGGGCAAGTCATGCC RV:  GGGGTGGGAGGGAGACCGAC 879bp 
RAB1A FW:  GGGAACAAATGTGATCTGACCA RV:  GGGACCCATTCGCTTTTTAATCT 168bp 
RAB1Ap FW:  GCAGCGGTGGCAGCTACAGT RV:  CCAGCTGTTGCTCCAGGACCC 882bp 
ARF1 FW:  TCAGAGCCGCCATCTTGTGGG RV:  CCACGAAGATCAGGCCTTGTGTG 456bp 
ARF1p FW:  CAGGCCACCTGTGCCACCAG RV:  AGGGCCCACGGGCCTACATC 385bp 
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2.1.5 Plasmids  
The psiCHECKTM -2 vector from Promega (Karlsruhe, Germany) was used for the validation 
of miRNA targeting in luciferase assays (Figure 2.1). 3’UTRs of potential miRNA target 
genes were amplified by PCR using human genomic DNA from HeLa cell line. Amplified 
PCR products were cloned into the psiCHECK-2 vector downstream of luciferase ORF by 
using XhoI and NotI restriction sites. Firefly luciferase signal was used to normalize the 
Renilla luciferase signal (hRluc) which are both located on the vector. 
                          
Figure 2.1 psiCHECKTM-2 vector map. Amplified PCR products were cloned into the psiCHECK-2 
vector downstream of luciferase ORF by using NHE1 and ECOR1 restriction sites. 
 
2.2 Methods 
2.2.1 Cell Culture 
HeLa cells (ATCC) was cultured in Dulbecco’s Modified Eagle Medium (DMEM) obtained 
from Gibco (Life Technologies). The medium was supplemented with 10% FBS, 1% 
Pen/Strep, 1% Glu, referred to as growth medium. The cells were incubated at 370C with 5% 
CO2 and split 2 -3 times per week in 10 cm2 new culture dish. One day prior to each 
transfection cells were seeded, depending on the plate used: 5500 cells / well in 96-well plate 
or 7000 cells / well in 8 well-labtek or 25,000 cells/ well in 24 well plate. 
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2.2.2 Transfection of cells 
The transient transfection of siRNA, miRNA (Pre- and Anti-miRNAs) and plasmids were 
done using Lipofectamine 2000 and OptiMem according to the manufacturer’s instructions. 
The final concentration of 50nM of siRNA, miRNA mimics and miRNA inhibitors was used 
in all the experiments, unless specified. For luciferase assays, 10ng of plasmids were co-
transfected with miRNA mimic. Even the transfection of Anti-miR miRNA inhibitor library 
from Ambion was performed in liquid-phase transfection. Liquid-phase transfection is the 
seeding of cells followed by the transfection of siRNAs after 24h. 
2.2.3 Preparation of protein lysates 
The cells were suspended in 60µl of sample buffer supplemented with protease inhibitor and 
lysed for 10min at 950C. The lysates were cooled down and treated with 5µl of 650mM DTT 
which was subjected to the final heating at 950C for 5 mins. 
2.2.4 Western Blot 
15µl of the protein lysate was separated by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) with SDS-PAGE running buffer. The SDS-PAGE was 
subjected to constant 130V for the proteins to migrate through the stacking gel and reduced to 
95V through the separating gel. 8%, 10% and 12% separating gels were used for GOLGA1, 
SCAMP1 and AP3S1 proteins, respectively. The materials used for preparing gel (for two 
gels) are listed below. 
 







Component Separating gel Stacking gel 
 
8% 10% 12% 4% 
Autoclaved water 9.3 ml 7.9 ml 6.6 ml 6.1 ml 
Acrylamide mix 5.3 ml 6.7 ml 8 ml 1.3 ml 
Tris  5 ml 5 ml 5 ml 2.5 ml 
10% SDS 200 µl 200 µl 200 µl 100 µl 
10% APS 200 µl 200 µl 200 µl 60 µl 
Temed 20 µl 20 µl 20 µl 20 µl 
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2.2.5 Blot and Development 
Proteins were transferred from SDS-PAGE to polyvinylidene fluoride (PVDF) membrane by 
using the semi-dry electrophorese system (Bio-Rad). The gel and blotting papers were 
incubated in transfer buffer for 10 mins. The filter paper was soaked in 100% methanol 
before incubating in transfer buffer. The items were placed in the following order and run for 
60min at 240mA (for two gels): 
- 2 x thick blotting papers 
- PVDF membrane 
- Polyacrylamide gel with separated proteins and marker 
- 2 x thick blotting papers 
The PVDF membrane was blocked with blocking buffer for 1h at room temperature (RT). 
The membrane was incubated with respective primary antibodies over night at 40C and next 
day with secondary antibody for either 1h at RT or 2h at 40C. The membrane bound proteins 
were visualized with ECL kit from Amersham and images were acquired using ChemoCam 
imager. The intensity of the respective protein bands were quantified using ImageJ software 
and a ratio between the test protein and endogenous control α-tubulin protein was obtained. 
2.2.6 qRT-PCR for mRNAs 
At first, the total RNA was isolated using Tri Reagent from Ambion. The cells from 24-well 
plate were homogenized in 400 µl of Trizol and incubated for 5 min at RT. 40 µl of 
chloroform was mixed and incubated for 10min at RT. The mixture was centrifuged at 12,000 
x g for 15mins at 40C, which separated the RNA in the aqueous phase. The aqueous phase in 
a separate tube was treated with 200 µl of isopropanol and after brief mixing and incubation, 
centrifuged at 12,000x g for 15mins at 40C. A transparent pellet was observed post-treatment 
with 75% ethanol and dissolved in RNAse free-water after brief air-dry. The RNA 
concentration was measured with NanoVue. In order to anneal oligo-dT primers to the total 
RNA, the following components were mixed and incubated 3min at 700C. 
        
 
 
Components Volume or Amount 
Total RNA 1µg 
Oligo dT 1µl 
RNAse free water Add upto 12µl 
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The next step comprises of conversion to cDNA by adding following components and 
incubating for 1h at 42 0C, 10min at 700C. 
Components Volume or Amount 
5 X Reaction buffer 2µl 
RNAse inhibitor (20U/µl) 1µl 
dNTP mix (10mM) 2µl 
M-MLV RT (200U/µl) 1µl 
 
cDNA for PCR was diluted by 15 µl of nuclease free-water. All components were next used 
for Sybr Green PCR on MicroAmp 96-well plate in StepOne Plus Real time PCR system with 
the following parameters. The data were analyzed according to ∆∆Ct method and normalized 
to the housekeeping genes GAPDH. 
Components Volume 
cDNA (10ng) 2µl 
Forward primer (10µM) 0.4µl 
Reverse primer (10µM) 0.4µl 
Sybr Green mix 10 µl 
Water Add upto 20µl 
  
                              Parameters for the PCR reaction  
 Temperature Time Cycles 
Holding stage 950C 10min  
Cycling Stage 950C 15sec 40 
600C 1min 
 
2.2.7 Cloning of 3’UTRs for luciferase assay 
3’UTR of the potential predicted targets of miR-30b were amplified by PCR using genomic 




                                                   Components of PCR reaction  
Components Volume 
5 x Phusion® High-Fidelity buffer 10µl 
Forward primer (10µM) 2.5 µl 
Reverse primer (10µM) 2.5 µl 
Genomic DNA (100ng) 0.5 µl 
Phusion® High-Fidelity polymerase (2U/ µl) 0.5 µl 
dNTPs (10mM) 1µl 
Nuclease-free water Add to 50µl 
 
                                                     Parameters of PCR program 
Condition Temperature Time Cycle 
Initial denaturation 980C 30sec 1 
Denaturation 980C 10sec 30-35 
Annealing x 0C 30sec 
Elongation 720C x min 
Final elongation 720C 10min 1 
                            where x depends on the length of amplified 3’UTR 
The amplified PCR product were checked on 1% agarose gel and the correct sized band was 
excised and purified with Wizard PCR Clean-Up system according to the manufacturer’s 
instructions. The purified PCR product and psiCheck-2 vector were digested with the 
respective restriction enzymes for 2h at 370C. 
                                             Components for double digestion 
Components Volume 
10 x Buffer 5 µl 
BSA (100ng/µl) 0.5 µl 
DNA (1µg) x µl 
Nuclease-free water Add to 50 µl 
Enzyme 1 (10U/µl) 0.5 µl 




The digested products were purified from the gel using the above same method. The digested 
purified 3’UTRs were ligated into digested psiCheck-2 vector in 1:3 molar ratios with the 
following components for 2h at RT. A negative control was also set up without the addition 
of the insert.                                          
                                           Components for ligation reaction 
Components Volume 
10 x T4 DNA ligase buffer 2 µl 
Vector (100ng) x µl 
Insert (1 : 3) x µl 
Nuclease-free water Add to 20 µl 
T4 DNA ligase (10U/ µl) 1 µl 
                  Insert (ng) = [100ng of vector x size of the insert x 3] / [size of the vector] 
Following the ligation, the transformation of the product was performed into chemically 
competent E.coli (strain DH5α) using the heat shock method for 90sec at 420C and plated 
onto Ampicillin resistant plates. The colonies were picked the next day and cultured in 5ml 
LB+Amp medium. The plasmids were purified with Miniprep kit according to the 
manufacturer’s instructions. The cloning was confirmed by two ways: digestion of the cloned 
product and sequencing by GATC Biotech AG.  
The mutagenesis of the miR-30b binding site in 3’UTR was performed with cloned 
psiCheck-2-AP3S1- 3’UTR and psiCheck-2-GOLGA1- 3’UTR in the same above way except 
the phosphorylation of primer oligonucleotides in the following manner at 370C for 30min.  
Components Volume 
Forward or Reverse oligonucleotides (300pmol) 3 µl 
10 x T4 DNA ligase buffer 5 µl 
Nuclease-free water Add to 50 µl 
T4 DNA ligase  1 µl 
 
2.2.8 Luciferase reporter assay 
3’UTR of the miRNA sequence predicted from TargetScan was cloned downstream of the 
reporter gene, psiCheck-2 as mentioned above. 40 x 103 cells/well were plated on 24-well 
plate and on the next day, co-transfection of plasmid (10ng) with miRNA mimics or negative 
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control (50nM) was performed by Lipofectamine method. After 24h, the cells were 
homogenized by 100µl of 1 x passive lysis buffer prepared from 5 x lysis buffer diluted in 
PBS. The homogenized cells were plated in 96-well assay plate and the luminescence was 
detected with Glomax 96 well microplate luminometer (Promega) according to 
manufacturer’s instructions. Signal from the Renilla luciferase was normalized to firefly 
luciferase activity. The mean and standard error of the mean were computed from the ratio 
values of the three replicates. 
2.2.9 VSV-G (tsO45-G) trafficking assay 
The well established tsO45-G transport assay (Starkuviene & Pepperkok, 2007) was 
performed for the screen as well as small-scale experiments. 5 x 103 or 8 x 103 HeLa 
cells/well were seeded onto 96-well plate or 8-well labtek, respectively. The siRNAs, miRNA 
mimics, miRNA inhibitors at a final concentration of 50nM each along with respective 
controls were transfected as described above for individual experiments. After 48h of 
transfection, the cells were transduced with recombinant adenovirus encoding tsO45-G-YFP 
or tsO45-G-CFP diluted with Opti-Mem for 30min at 370C. Cells were washed with the 
transfection medium and incubated at 39.50C for 6h in a humified 5% CO2. The cells were 
transferred to 320C in the presence of 100µg/ml cyclohexamide for the synchronized release 
of tsO45-G from the ER. One hour later, cells were fixed with 3% paraformaldehyde (PFA) 
for 15min and washed with PBS twice. The plasma membrane (PM) traversed tsO45-G was 
immunostained with mouse anti-tsO45-G antibody; followed by secondary antibody, each for 
30min. Nuclei were stained with 0.3µg/ml Hoechst 33342. Images were acquired by 
fluorescence microscope (Olympus) using 10x UplanSApo objective (NA 0.4). The total 
fluorescence intensity of single cell-associated PM and the total fluorescence intensity of 
tsO45-G were measured by image analysis software ScanˆR Analysis module (Olympus), and 
extracted data were further analyzed as described in ‘Statistical data analysis’. 
2.2.10 Golgi complex integrity assay 
HeLa cells were seeded 8-well labtek and transfected for indicated time as described above. 
Cells were fixed with 3% PFA and permeabilized with 0.1% Triton-X solution. The Golgi 
complex was immunostained for either GM130 (cis-Golgi marker) (Nakamura et al., 1995) or 




2.2.11 Transferrin assay 
To study single round of transferrin endocytosis and recycling, HeLa cells were plated on 8-
well labtek and starved in serum free DMEM supplemented with 0.5% BSA and 20mM 
Hepes for 1h and incubated on ice in serum free DMEM/Hepes/BSA containing 20µg/ml 
transferrin. The cells were washed and transferred to 37°C for indicated length of time. At 
each time point, the cells were acid-stripped, washed with ice cold PBS and fixed 
immediately.  
2.2.12 Computational miRNA target prediction 
For in silico prediction of miRNA target genes, 3 different target prediction tools miRanda 
(August 2010 release, http://www.microrna.org), PicTar (http://pictar.mdc-berlin.de/) and 
TargetScan 5.1 (April 2009 release, http://www.targetscan.org) were used. A list of common 




data.html) and miRDB (http://mirdb.org/miRDB/). 
 
2.2.13 Pseudogene data set selection 
Gene ontology terms 'protein transport' (GO: 0015031), 'endocytosis' (GO:0009306), 'protein 
secretion' (GO:0006897) and 'small GTPase mediated signal transduction' (GO:0007264) 
were used to obtain a primary list of protein coding genes (1612) related to protein trafficking 
from Ensembl database (Genes 67). Using gene Ensembl identifiers we selected and retrieved 
corresponding human pseudogenes (2473 genes correspond to 381 protein-coding parental 
genes) from Yale collection (pseudogene.org, Build 65). Majority of them (1721) were 








   Table 2.6 Protein trafficking related pseudogenes and their classes 
Pseudogene origin Parental genes Processed Duplicated Ambiguous Total 
RP genes 79 1468 71 182 1721 
Other than RP 
genes 
302 446 100 206 752 
All 381 1914 171 388 2473 
 
Hereinafter we will use pseudogene originated from other than RP genes (highlighted by 
grey). In addition, this data set was expanded by previousely described in the literature 
(Khachane & Harrison, 2009; Vinckenbosch, Dupanloup & Kaessmann, 2006) 
 
2.2.14 Primer design ad evaluation of transcription evidences 
pseudogene.org database was used to obtain genomic coordinates for each pseudogene (PG).  
and its transcription potential was investiagted using the following tracks the UCSC genome 
browser tracks. BEDTools were used in order to extract requested feautures from 
corresponding UCSC tables with pseudogene coordinates (hg19) (V. Kuryshev). Genomic 
features like presence of CpG islands and transcription start sites at 5' termini of 
pseudogenes, polyadenylation signals at the 3' termini were extracted from the UCSC 
genomic browser as well. Primers for transcription evaluation of selected candidate genes by 
RT-PCR were designed using Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-
blast/) and primer3 software. Parental and pseudogene sequences were aligned by 
MAFFT(Version 6, http://mafft.cbrc.jp/alignment/server/). Manual verification of obtained 
alignments were performed with Genedoc (http://en.bio-soft.net/format/GeneDoc.html). 
 
2.2.15 Microscopy 
Wide-field microscopy was done with ScanˆR Acquisition module (Olympus) on IX81 
motorized inverted fluorescence microscope (Olympus). Imaging was performed using 10 
x/0.4 numerical apertures (NA) or 20x / 0.75 NA air objective lens (UPlanSApo; Olympus 
Biosystems). 150W Hg/Xe light source along with the combination of emission/ excitation 
filters were used. 
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                            Table 2.7 List of excitation and emission filters 
Fluorophore Excitation filter Emission filter 
Hoechst 33342 352 461 
YFP 513 527 
CFP 434 477 
Alexa-647 650 665 
Alexa-488 495 519 
Alexa-568 578 603 
Cy5 650 670 
 
Confocal imaging was performed with the laser scanning microscope TCS SP5 (Leica 
Microsystems) using 63X oil immersion objective lens. To excite Alexa-488 dye, Alexa-568 
dye and Alexa-647 dye, an argon (λ = 488nm) , diode laser (λ = 561nm) and helium/neon (λ 
= 633nm) , respectively was used.  
2.2.16 Statistical analysis  
(i) For screen:  36 or 20 images/well were acquired and thresholds for total intensity 
were set for individual experiment. The lower threshold eliminates the cells not 
infected with tsO45-G. Next the transport rate was measured by the ratio over the 
cells. Normalization was performed using R programming language (http://cran.r-
project.org/) and RNAither (Rieber et al., 2009) package from Bioconductor 
(http://bioconductor.org/). For normalization in 96-well plate, z-score was used for 
by the following equation (Birmingham et al., 2009) 
                  Z    = =    − 	
/	
 
                  The thresholds of +/- 1.5 were set to identify hit miRNAs. 
(ii) For small-scale experiments : For normalization in 8-well plate, the mean of the 
transport rate of the negative control was subtracted from mean in each control by 
the following equation 
                  Norm(x)    =    − 
/
 
where x is the mean of transport rate, i is the well, µ(ctl) and σ(ctl) are mean and 
standard deviation of the negative controls. Rest of the results were presented as 
the mean ± SD. Statistical analysis was performed using two-sided Student’s t-test 
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(* P<0.05; ** P<0.01; *** P<0.001). Transferrin internalization was normalized 












I. MicroRNAs as regulators of the membrane trafficking 
3.1 Large-scale Anti-miR screen 
To study which miRNAs changes the secretion of tsO45-G, down-regulation (875 Anti-miRs) 
screen was carried out in order to identify miRNAs involved in membrane trafficking. The 
down-regulation screen was performed on HeLa cells in 96 well-plate format. To increase 
and monitor the robustness of the miRNA screen, each plate contained positive controls (si-α-
COP and si-β-COP) and negative controls (Anti-miR negative control (ANC) and si-Control 
(scramble)). Individual knockdown of α-COP and β-COP results in a large and significant 
inhibition of tsO45-G transport on HeLa cells (Simpson et al., 2012). We performed a well-
described quantitative fluorescence intensity-based tsO45-G transport assay that is widely 
used to follow anterograde traffic (Figure 3.1a) (Starkuviene et al 2004; Starkuviene & 
Pepperkok, 2007). Data collection of fluorescence signal from three channels (total 
intracellular tsO45-G protein, protein on cell surface and nucleus) was made on a wide-field 
microscope through SCAN^R acquisition software. Quality control was performed manually 
with cell density, image quality and performance of the positive controls before feeding the 
data to analysis software. SCAN^R analysis software detects the nucleus of the cell and 
masks the entire cell for total and surface intensity. Threshold of total tsO45-G intensity was 
set to separate the cells with low and high infection of tsO45-G. For each well, transport rate 
was calculated by the ratio of intensity of tsO45-G on PM to the total tsO45-G intensity (Fig 
3.1b).     
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    a)                          
  b)    
Figure 3.1 Microscopy-based tsO45-G screen on miRNAs a) Schematic overview of the high-
throughput screening protocol to study the transport of tsO45-G to PM when miRNAs were over-
expressed in cells. b) Cells were transfected with siRNA against α-COP and scrambled Control. 
TsO45-G-YFP was transduced in the cells after 48h of transfection, kept at 39.50C for 7hrs, then 
shifted to the permissive temperature 320C and surface tsO45-G detected by antibody. Nuclei were 
marked by Hoechst. 
 
The effect on tsO45-G secretion was quantified using z-score. Z-Score of the individual 
miRNA of each well of the plate was normalized against the mean transport rate of the plate. 
Average z-score of negative control ANC was set to 0. Positive z-scores indicate acceleration 
while negative z-scores indicate inhibition of tsO45-G secretion. The positive controls α-COP 
and β-COP had average z-score of -9 (p-value 8, 98e-44) and -6 (p-value 1, 67e-37), 
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respectively.  In our screen, we have considered miRNAs whose z-score > ± 1,5 as hits. In 
total, the screen identified 134 miRNAs that significantly affected cargo transport rate, 
comprising of 15% of the library (Appendix Table 6.1). Out of these 134 miRNAs, 41 
miRNAs were inhibitors and 93 miRNAs were accelerators of tsO45-G trafficking when they 
are down-regulated. miRNAs known to be involved in regulation of core regulators of 
membrane trafficking did not overlap with the hits obtained from this screen. 
 
 
Figure 3.2 Effectors of tsO45-G transport with Anti-miR hits. 41 primary candidates whose z-
score ≤ -1.5 inhibits tsO45-G trafficking rate and 93 candidates showed facilitation of cargo 
trafficking (not shown). The dashed line shows the cut-off 1.5 
 
3.1.1 Additional phenotype: Golgi complex integrity  
The Golgi complex is a highly dynamic organelle that serves as a major sorting and 
modification center trafficking. We hypothesized that miRNA hits that affects tsO45-G 
secretion from ER to PM may affect the Golgi complex integrity. Therefore, we investigated 
whether randomly selected 80 miRNAs, when down-regulated are associated with 
corresponding changes in the Golgi complex morphology. Transfection of cells with 80 Anti-
miRs in 8-well labtek was performed along with controls α-Cop and ANC. After 48hr of 
transfection, the cells was fixed, permeabilized and immunostained for GM130 and 




















































































































































































































































                   
Figure 3.3 cis-Golgi phenotype with down-regulation of miRNA. Cells were transfected on 8 well 
labtek with Anti-miR negative control and after 48h, they were fixed and permeabilized with 0,1% 
TritonX-100. They were immunostained with three antibodies: GM130, ConA and Dapi. 
 
A fully automated image analysis platform for quantification was developed which has been 
described in thesis (A.Serva, Functional analysis of microRNAs as regulators of membrane 
trafficking). To estimate the change, number of Golgi fragments was calculated. When cells 
were down-regulated by Anti-miRs, only 5 out of 80 miRNAs fragmented the cis-Golgi 
morphology (Table 3.1). 
                Table 3.1 List of Golgi hits transfected with Anti-miRs                
miRNA Number of Golgi fragments 









3.2 Choice of miR-30b  
44 hits from the over-expression screen of miRNAs (A.Serva thesis, Functional analysis of 
microRNAs as regulators of membrane trafficking) were compared with 134 hits from the 
down-regulation screen and 8 commons miRNAs (miR-532-5p, miR-30b, miR-20b, miR-
553, miR-604, miR-346, miR-365 and miR-517a) were found. Except for miR- 20b, over-
expression of 7 miRNAs inhibited tsO45-G transport and down-regulation of these miRNAs 
facilitated the transport. To check the activity of Pre-miRs and Anti-miRs, we randomly 
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selected 4 miRNAs (miR-19b, miR- 20b, miR-365 and miR-30b) that were expressed and 
other 4 miRNAs (miR-517a, miR-532-5p, miR-553 and miR-604) were not expressed in 
HeLa cells. We relied on the data of microarray miRNA expression profiling (A.Serva thesis, 
Functional analysis of microRNAs as regulators of membrane trafficking). MiRNA binding 
sites obtained from miRBase were cloned in psiCheckTM-2 vector (Appendix Table 6.2) and 
transfected together with respective Pre-miR and Anti-miR in separate wells and tested for 
dual-luciferase reporter activity. We showed that over-expression of miR-19b, miR- 20b, 
miR-365 and miR-30b decreased luciferase expression, whereas their down-regulation by 
Anti-miR increased luciferase expression (Figure 3.4). For non-expressed miRNAs (miR-
517a, miR-532-5p, miR-553 and miR-604), we observed that addition of miRNAs indeed 
decreased luciferase signal. But there was no change in luciferase activity when these non-
expressed miRNAs were down-regulated by Anti-miR. This experiment validated the 
expression of 8 miRNAs as obtained from microarray data. 
 
               
Figure 3.4 Test of Pre-miRs and Anti-miRs. HeLa cells were co-transfected with Pre-miRs or Anti-
miRs and reporters containing miRNA binding sites of 8 miRNAs. Dual-luciferase reporter activity 
was measured 24h following co-transfection. The bars show mean fold changes of luciferase activity 
and the error bars show standard error mean derived from 2 independent normalized against the 
control sample.  
 
Over-expression of miR-30b, miR-432, miR-637, miR-765, miR-517b, miR-517c and miR-
517a induced fragmentation of the Golgi morphology (A.Serva thesis, Functional analysis of 




































screen hits, Golgi morphology hits and luciferase assay showed miR-30b to be the common 
candidate. Down-regulation of miR-30b accelerated the transport of tsO45-G by Anti-miR 
(Figure 3.5).  
 
a) b)  
Figure 3.5 Effect of miR-30b on the transport of tsO45-G. HeLa cells were transfected with 
different concentrations of Anti-miR and tsO45-G assay was performed. a) HeLa cells transfected 
with Pre-miR-30b and Anti-miR-30b were tested for tsO45-G transport assay. Negative and positive 
z-scores represent inhibition and facilitation, respectively. Bars are presented as the mean ± SD of 
three independent experiments * p < 0.05, **p < 0.001. b) Example images of cells transfected with 
Pre-miR-30b and Anti-miR-30b. 
 
3.3 Selection of putative targets 
A single miRNA targets hundreds of genes leading to their degradation or translational 
inhibition (Filipowicz, Bhattacharya & Sonenberg, 2008). To investigate the targets of miR-
30b, putative targets were searched with available computational algorithms. The most 
commonly used algorithms to search for gene targets are miRBase(Griffiths-Jones et al., 
2006), TargetScan (Maziere & Enright, 2007) and PicTar (Krek et al., 2005). MiRBase, 
TargetScan and PicTar found 4267, 875 and 702 targets of miR-30b, respectively. The targets 
were overlapped in the form of Venn diagram and created a list of 444 common targets 
between three programs (Appendix Table 6.3) (Figure 3.6). The genes were manually 
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selected for core trafficking regulators. 16 out of 33 genes were small GTPases such as RAB 
and ARF, adaptor and coat proteins. Golga1 and Golga4, structural components of Golgi, fall 
under ‘vesicle mediated transport’ (Appendix Table 6.4). In total, 18 core trafficking 
regulators were selected for validation purpose. 
 
                                       
                                        
Figure 3.6 Venn diagram showing common predicted targets of miR-30b. Three miRNA target 
prediction algorithms (miRBase, PicTar and TargetScan) were searched for targets of miR-30b and 
444 targets were found to overlap. 
 
Apart from the three commonly used programs, the likelihood of the occurrence of 18 targets 
were confirmed in other prediction programs, miRTarBase, Microcosm, miRWalk, PITA and 
miRDB (Table 3.2). Our results showed that the targets chosen for validation were detected 
by different algorithms. 
 
                  Table 3.2 Overlap of the targets with other prediction programs 
Gene name Prediction programs 
AP2A1 miRTarBase, Microcosm, miRWalk, PITA 
AP3S1 Microcosm, PITA, miRDB 
AP4E1 Diana-MicroT 
ARF4 PITA, miRDB 




RAB10 PITA, miRDB 
RAB15 miRWalk, PITA, miRDB 
RAB32 Microcosm, miRWalk, PITA, miRDB 
RAB11A PITA, miRDB 
RAB38 Microcosm, miRWalk, miRDB 
RAB8A PITA, miRWalk 
SCAMP1 PITA 
SEC23A Diana-MicroT, miRWalk, PITA, miRDB 
SEC24D miRWalk 
SEC61A2 miRWalk 
SNX16 Microcosm, miRWalk, PITA, miRDB 
TBC1D15 PITA, miRDB 
 
   
3.4 Validation of targets 
3.4.1 tsO45-G assay on 18 putative targets 
In loss-of-function experiment, 3 different siRNAs (Appendix Table 6.5) against each of 18 
putative genes were used. Knockdown of 8 genes inhibited the transport of tsO45-G, 
phenocopying the inhibition effect induced by miR-30b over-expression. The gene was 
considered to be a hit in case atleast one or two siRNAs gave an inhibition on tsO45-G 
transport (Figure 3.7). The other two genes, RAB11a and RAB38 also inhibited tsO45-G 
transport when they were knocked down by individual siRNAs (Y.T.Tsai thesis, Analysis of 
RAB42 and RAB40c as novel regulators of secretory membrane trafficking). To gather 
information about these 18 targets, we compared them with genome-wide RNAi screen of 
tsO45-G secretion (Simpson et al., 2012). 4 genes (ARF4, AP3S1, RAB11A and RAB8A) 
were found to overlap and down-regulation of these 4 genes inhibited tsO45-G transport in 
the screen of Simpson et al., 2012. Here, we found that down-regulation of RAB11a and 
AP3S1 also inhibited tsO45-G transport. It has been shown that double knockdown of ARF1 
and ARF4 inhibited the transport of VSV-G from the ER and VTCs (Volpicelli-Daley, Li, 
Zhang & Kahn, 2005). This information pointed out ARF4 involving in VSV-G transport 
shown by our knockdown results. In total, 10 out of 18 targets inhibited tsO45-G transport. 
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a)            
 
        b)                        
Figure 3.7 Effect on tsO45-G secretion with down-regulation of predicted targets of miR-30b. a) 
HeLa cells were seeded on 96 well plate and transfected with siRNAs targeting miR-30b predicted 
genes for 48h. Similar automated microscopy-based secretion assay was performed.  Down-regulation 
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3.4.2 Dual-Luciferase reporter assay of miR
 
To validate these 10 targets, a
Full-length 3’UTR of the respective gene was cloned into the luciferase reporter vector 
psiCHECKTM-2 to generate a luciferase
to clone AP2A1 therefore no luciferase assay was performed. 
expressed, four genes (SCAMP1, Golgin
significantly decreased the luciferase signal by more than 20%, 
targets of mir-30b (Figure 3.8). 
 
         
Figure 3.8 Four genes are targeted by miR
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3.4.3 Over-expression of miR-30b decreases mRNA and protein level of 3 targets 
Repression of proteins mediated by miRNA can be either by translational repression or 
mRNA degradation. Therefore mRNA of SCAMP1, Golgin-97 (GOLGA1), AP3S1 and 
SNX16 was quantified by qRT-PCR under three conditions: i) miR-30b was over-expressed 
ii) down-regulated and iii) knockdown by individual siRNAs (Figure 3.9). All targets showed 
a significant reduction of mRNA level by more than 50% when miR-30b was over-expressed. 
Transient transfection of Anti-miR-30b that down-regulates endogenous miR-30b 
significantly increased mRNA expression. Moreover, decreased level of mRNA by siRNA 
confirmed that the phenotype observed was due to knockdown of the individual genes.  
 
                        
Figure 3.9 Expression of four targets on RNA level. Over-expression of miR-30b decreased the 
expression level of SCAMP1, Golgin-97 (GOLGA1), SNX16 and AP3S1 mRNAs as determined by 
qRT-PCR. The relative expression levels of these four genes after treatment with siRNAs, Pre-miR-
30b and Anti-miR-30b were normalized to the expression level when control siRNAs and control Pre-
miR or Anti-miR were transfected. Bars show mean of the relative mRNA expression levels and error 
bars show standard error mean derived from 3 independent experiments. 
 
Protein levels of AP3S1, Golgin-97, SCAMP1 and SNX16 were validated by Western Blot to 
find out whether over-expression of miR-30b and knockdown of these genes decreases the 
protein. Protein lysates were obtained from HeLa cells transfected with Pre-miR-30b and 
siRNA of the genes (Figure 3.10).  With the over-expression of miR-30b, protein amount of 
AP3S1, Golgin-97 (GOLGA1) and SCAMP1 decreased by 40-50%. There was no change of 
protein level of SNX16. We were unable to derive any conclusion for SNX16 with the 
antibodies used. Knockdown of genes by siRNA also resulted in decrease of protein amount 
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significantly by 20-50%. Therefore, from the above data we confirmed AP3S1, Golgin-97 
and SCAMP1 to be the true targets of miR-30b. We also checked the specificity of siRNAs 
against other proteins. When AP3S1 was down-regulated by siRNA, protein levels against 
Golgin-97 and SCAMP1 remain unchanged. The same result holds true for both Golgin-97 
and SCAMP1 siRNAs. 
    
            
Figure 3.10 Expression of four targets on protein level. HeLa cells were transfected with Pre-miR-
30b and siRNAs of AP3S1, GOLGA1 and SCAMP1 and SNX16. After 48h, cell lysates were 
collected and Western Blot was performed. 
 
Till now, we observed the changes of protein level and tsO45-G with one fixed concentration 
of Pre-miR-30b at 50nM. We calculated protein levels two other concentrations, 10nM and 
25nM of Pre-miR-30b. We observed that there was a decrease in protein level of AP3S1, 
GOLGA1 and SCAMP1 with higher concentrations of Pre-miR-30b (Figure 3.11). Though 
the change for SCAMP1 protein was not significant, we could suggest that effect on protein 
amount is concentration dependent.   
 
                           
Figure 3.11 Effect on protein amount with varying concentrations of miR-30b. HeLa cells were 
transfected with 10, 25 and 50nM of Pre-miR-30b and protein level of AP3S1, GOLGA1 and 
SCAMP1 was calculated.With the increase in concentration of Pre-miR-30b, there was a decrease in 

































3.4.3 Mutagenesis of miR-30b binding site 
The number of conserved miRNA binding sites of three genes was assessed by TargetScan. 
Golgin-97 (GOLGA1) and AP3S1 contain one predicted miR-30b binding site in its 3’UTR. 
To determine the specificity of interaction between miR-30b and its putative binding site on 
3’UTRs of AP3S1 and Golgin-97, we mutated miR-30b seed sequences of AP3S1 and 
Golgin-97 into complementary sequences to abolish the potential base-pairing. We did not 
produce mutants of 3’UTR of SCAMP1 due to the presence of two miR-30b predicted seed 
binding sites. Ectopic expression of miR-30b repressed luciferase activity of Luc-AP3S1 
(WT) and Luc-GOLGA1 (WT) by 50% and 30% respectively, whereas Luc-AP3S1 (Mut) 
and Luc-GOLGA1 (Mut) did not change miR-30b mediated decrease in luciferase activity 
(Figure 3.12). This result suggests that miR-30b directly binds to the 3’UTR of AP3S1 and 
GOLGA1.  
 
                         
 
Figure 3.12 AP3S1 and GOLGA1 are directly targeted by miR-30b. miR-30b targets 3’UTRs of 
AP3S1 as determined by a luciferase reporter assay. HeLa cells were co-transfected with the reporters 
containing wild-type 3’UTRs of AP3S1 and mutated 3UTR of AP3S1, Pre-miR-17. Luciferase 
activity was measured 24h following co-transfection. The error bars show s.e.m. derived from 2 






3.4.4  Rescue effects of Anti-miR-30b  
HeLa cells were transfected with Anti-miR-30b for 24h followed by siRNA of respective 
gene for another 24h and tsO45-G transport was measured. It was found that single 
knockdown of AP3S1, GOLGA1 or SCAMP1 did not change the facilitation effect induced 
by Anti-miR-30b. We next tested the combinatorial RNAi strategy of AP3S1, GOLGA1 and 
SCAMP1 genes to analyze the concerted effect on Anti-miR-30b. The cocktail of siRNAs of 
3 genes at different concentrations (in pools of 17 nmol/litre and 25 nmol/litre final 
concentrations for each gene) could rescue Anti-miR-30b induced facilitation of tsO45-G 
transport in HeLa cells (Figure 3.13). This suggested that all three genes in concert might be 
required for the regulation of miR-30b in transport. 
 
 
           
Figure 3.13 Rescue of tsO45-G transport inhibition of miR-30b by combinatorial knockdown of 
3 targets. HeLa cells were transfected with Anti-miR-30b alone or along with si-Triple. Transport of 
tsO45-G was observed on the corresponding transfected cells. Bars are presented as the mean ± SD of 
two independent experiments. 
 
 
When siRNAs against 3 genes were mixed together at different concentrations as noted 
above, we observed that combinatorial knockdown inhibited tsO45-G transport to the same 
degree as that of over-expressed miR-30b. This suggested that all three genes in concert 

























3.5 Post-Golgi inhibition of tsO45-G transport  
Time-course tsO45-G transport was performed to determine the site of action of AP3S1, 
GOLGA1 and SCAMP1 when down-regulated. 0, 10, 20, 30, 40, 50 and 60 mins after shift to 
permissive temperature were chosen to examine the course of tsO45-G transport from ER to 
PM when AP3S1, Golgin-97 (GOLGA1) and SCAMP1 were down-regulated (Figure 3.14). 
In control cells, tsO45-G travels out of the ER after 0min, then to the Golgi complex within 
20 mins and finally reaches PM in between 40 and 60mins.  si-α-COP showed total blockade 
of transport to PM as compared to the negative control (AllStars) since α-COP is an essential 
component between ER and Golgi. As a positive control, RAB6a was selected because 
trafficking of tsO45-G was delayed from Golgi to PM when RAB6a was depleted by siRNA 
as reported by Miserey-Lenkei et al., 2010. Down-regulation of AP3S1, GOLGA1 and 
SCAMP1 as well as over-expression of miR-30b showed no change in transport from 0 to 
20mins but decrease in tsO45-G transport started after 20 mins when compared to negative 
control.  
 








































                                       
           b)                    
Figure 3.14 Time course transport of tsO45-G. a) Over-expression of miR-30b slowed tsO45-G 
transport after 20mins at permissive temperature. Similar effect of transport inhibition was observed 
for AP3S1, Golgin-97 and SCAMP1 when down-regulated. si-α-COP showed total blockade of 
transport to PM and si-Rab6a blocked the transport from TGN to PM as reported in literature. b) 
Example images showing tsO45-G transport at 0 and 60min  
 
 
To confirm that cargo transport inhibition occurs at the Golgi complex, we used 200C TGN 
block of tsO45-G cargo. Two temperature blocks of the cargo protein were applied 
sequentially, first at 39.50C to accumulate tsO45-G in ER and next at 200C for 2h to release 
the block from the ER and accumulate at TGN (Griffiths et al., 1985), before the chase at 
permissive temperature. Down-regulation of AP3S1, SCAMP1 and GOLGA1 as well as 
over-expression of miR-30b, inhibited the transport of tsO45-G from TGN to PM (Figure 
3.15).  We observed that tsO45-G was trapped around the Golgi complex in cells transfected 
with Pre-miR-30b and siRNAs (not shown). 
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Figure 3.15 Post-Golgi transport of tsO45-G.  HeLa cells were transfected with Pre-miR-30b and 
AP3S1, SCAMP1 and GOLGA1 siRNA. Shift in temperature at 200C delayed the tsO45-G 
transport from TGN to PM when AP3S1, Golgin-97 and SCAMP1 were down-regulated.  
 
 
3.6 Over-expression of miR-30b inhibits transferrin recycling 
To test the trafficking of additional basolateral cargo transferrin (Tf), we studied the effect by 
over-expression of miR-30b and down-regulation of respective genes AP3S1, Golgin-97 and 
SCAMP1. Tf recycles through a series of endosomal compartments such as sorting 
endosomes, early endosomes and recycling endosomes known as Tf cycle (Klausner, 
Ashwell, van Renswoude, Harford & Bridges, 1983). In control cells, the uptake of Tf was 
within 4 min, then recycled back to the PM by ~15min and finally in 45mins the Tf was 
found to be in the periphery of the cell. In contrast, over-expression of miR-30b showed no 
internalization defects at 4 min but significant recycling defects at 45 min. It was observed 
that Tf was accumulated in the perinuclear region. Down-regulation of AP3S1 also inhibited 
the recycling of Tf (Figure 3.16). Similar to tsO45-G, Pre-miR-30b and si-AP3S1 inhibited 
Tf recycling although it was difficult to say whether the degree of inhibiton was similar 
between tsO45-G and Tf transport. We could not observe much significant inhibition in 
recycling at 45 min when SCAMP1 and Golgin-97 were down-regulated.  



















                      
Figure 3.16 Over-expression of miR-30b inhibits transferrin recycling. HeLa cells were treated 
with Pre-miR-30b or si-Triple or control for 48h and subjected to transferrin recycling assay at 
indicated time points. Scale bar, 10µm. The amount of transferrin internalized was measured and 
plotted in line chart. Bars are presented as the mean ± SD of three independent experiments. 
 
3.7 Morphology of the Golgi complex  
 
To further investigate whether the Golgi complex retains the normal morphology when 
down-regulated by siRNAs, we double immunostained the Golgi complex with GM130 and 
TGN46 markers. Over-expression of miR-30b fragmented the Golgi complex. When AP3S1, 
GOLGA1 and SCAMP1 were down-regulated, the Golgi complex (both cis and trans) 
showed fragmentation but to varying degrees as compared to over-expressed miR-30b 
(Figure 3.17). Quantification of the Golgi complex along with investigation on perturbed 
































                            
Figure 3.17 Effect on Golgi morphology with down-regulation of AP3S1, GOLGA1 and 
SCAMP1. HeLa cells were transfected with siRNA of AP3S1, GOLGA1 and SCAMP1 for 48h. cis- 
and trans- Golgi were fragmented in cells over-expressed with miR-30b and down-regulated with its 












II. Testing hypothesis: Role of Retroposed transcripts in membrane 
trafficking 
3.8 Bioinformatic search of Retroposed transcripts of Rab GTPases 
Bioinformatic search of retroposed transcripts were done by V.Kuryshev (collaboration with 
EMBL). We searched for retroposed transcripts arising from mRNA of known regulators 
involved in protein trafficking. We focussed on 68 RAB GTPases as parental genes and 
aligned the sequences of mRNAs to the human genome. By using bioinformatic tools 
including pseudogene.org, 15  retroposed transcripts were retrieved having features such as 
high identity to its parent gene, polyA signal at 3’termini and retroposed elements at both 
ends of insertion (Appendix Table VI).  
3.8.1 Transcriptional and experimental evidence  
Transcriptional evidence of 6 out of 15 retroposed transcripts was found from EST and Burge 
RNA-seq tracks of UCSC browser and were further tested for expression in HeLa cells. 
Specific primers were designed for each parent and its respective pseudogene due to high 
nucleotide identity between parent gene and pseudogene. If a PCR product is generated from 
RNA sample that is not reverse transcribed (minus-RT control), then the product was 
amplified from contaminating DNA. All PCR reactions were performed with ‘minus RT’ to 
confirm the absence of genomic DNA contamination (Figure 3.18). The PCR products were 
sequenced. 3 pseudogenes were found to be transcribed in HeLa cells.  
 
              
Figure 3.18 Expression of retroposed transcripts RAB42p and RAB5Cp. Examples showing RT-
PCR of parent (RAB5C, RAB42) and its pseudogene (RAB5Cp and RAB42p) along with ‘minus RT’ 
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(- RT) reaction. M is 100bp marker.  
 
In order to know the ubiquitous expression of RAB5Cp, RAB42p and RAB28p across 
different human cells, they were tested for transcription in lung A549, hepatocytes Huh7, 
kidney HEK293 and skin fibroblast BJ5 cells. Cell-type specific expression of RAB5Cp, 
RAB42p and RAB28p was observed (Table 3.3). Further investigation has to be carried to 
find the specific expression of RAB42p and not RAB42 in Hek293 cells. 
 
Table 3.3 Expression of parent and retroposed transcript of RAB GTPases in different cell lines 
(+ expressed ; - not expressed) 
Name A549 Hek293 BJ5 Huh7 
RAB5C + + + + 
RAB5Cp + - + + 
RAB42 + - + + 
RAB42p + + - + 
RAB28 + + + + 
RAB28p + - + - 
 
 
3.8.2 Initial Characterization of RAB42p 
We decided to knockdown parent gene and its respective retroposed transcript by siRNA and 
to test tsO45-G transport described before. For parent gene, already designed siRNAs are 
available but siRNA for retroposed transcript was designed along with the help of Qiagen. We 
have considered hits of those siRNAs whose z-score > ±1,5. RAB42p inhibited tsO45-G 




                    
Figure 3.19   Down-regulation of RAB42p inhibited tsO45-G transport in HeLa cells.  HeLa cells 
were transfected with specific siRNAs against RAB5cp, RAB42p and RAB28p and tsO45-G assay 
was performed. Only RAB42p siRNA inhibited the transport.  
 
 
It was observed that RAB42 also inhibited tsO45-G transport similar to its retroposed 
transcript RAB42p (Y.T.Tsai thesis, Analysis of RAB42 and RAB40c as novel regulators of 
secretory membrane trafficking). To confirm the existence of RAB42p, we designed another 
pair of primers for RT-PCR which gave the same results after sequencing (data not shown).  
In order to find out whether the transport inhibition by knockdown of siRNA is an off-target 
effect, we used different siRNA design of RAB42p. The inhibition of the transport was found 
similar to the first RAB42p siRNA, confirming the true effect of RAB42p (data not shown). 
We observed that both RAB42 and RAB42p showed similar inhibition effect. To validate 
whether siRNA was specific for transcripts, qRT-PCR was performed. The siRNAs had 
specific knockdown for the expression of RAB42 and RAB42p (Figure 3.20). Western Blot 
was performed for RAB42 protein by RAB42 antibody and showed a knockdown in protein 







     
Figure 3.18 qRT-PCR of RAB42 and RAB42p. Knockdown of RAB42 and RAB42p was quantified 






































































4.1 Large-scale assay to analyze membrane trafficking 
Cells transport a large number of newly synthesized cargo proteins from ER to PM by using 
the secretory pathway to maintain growth, survival and homeostasis. There are number of 
high-throughput siRNA screens with tsO45-G as cargo protein to investigate regulators 
involved in its secretion. There are small screens of knockdown by siRNAs against 47 
proteins and over-expression by cDNAs against 100 ORFs to assess tsO45-G transport which 
identified a large number of novel regulators (Simpson et al., 2007; Liebel et al., 2003; 
Starkuviene et al., 2004). The recent genome-wide RNAi screen in HeLa-Kyoto cells showed 
554 proteins influencing secretion of tsO45-G. However, little is known about miRNAs 
regulating the cargo secretion. In this study, we performed tsO45-G assay with 875 Anti-
miRs which down-regulated endogenous miRNAs (Figure 3.4). We identified 134 miRNAs 
that modulate the transport rate in HeLa cells when down-regulated revealing that 15% of 
human miRNAs can be linked to the cellular process. α-COP and β-COP were used as 
positive controls in the screen that gave marked stronger inhibition (z-score ≤ -10) in tsO45-
G transport. As shown before, these proteins are subunits of the COPI coat complex and 
essential components of the ER to Golgi transport. Single knockdown of COPI subunits has 
shown significant secretion inhibition which infers conventional cargo like tsO45-G must 
pass through the Golgi complex coated with COPI (Simpson et al., 2012; Styers et al., 2008; 
Szul & Sztul, 2011). Although gain-of-function screens are mostly used because of the easier 
interpretation (Serva, Claas & Starkuviene, 2011), but gain- and loss-of-function screens 
complement each other and can provide a strong correlation of phenotypic expression. 
Therefore, we overlapped the 134 hits from down-regulation screen by Anti-miRs with 44 
hits from complementary over-expression screen by Pre-miRs (A.Serva thesis, Functional 
analysis of microRNAs as regulators of membrane trafficking).  We found 8 miRNAs 
showing opposing effects on tsO45-G secretion when miRNAs were down-regulated and 
over-expressed. miR-30b was one of the effectors which inhibited tsO45-G transport when 
over-expressed and facilitated the transport when down-regulated.  
The Golgi complex is the central organelle whose morphology changes when the imbalanced 
transport is indicated by the altered flow of membrane transport towards or away from the 
complex. There has been an image-based kinome- and phosphatome –wide RNAi screen 
analysing the perturbations in Golgi morphology. 159 out of 948 genes changed the Golgi 
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phenotype, revealing 20% of the tested set was essential for the maintenance of Golgi 
organization (Chia et al., 2012). Previous study also indicated the scattering of the Golgi into 
numerous ministacks when the cells were treated with nocodazole, a microtubule 
depolymerising drug (Liebel et al., 2003). The recently accomplished siRNA screen 
(Simpson et al., 2012) showed morphological changes (fragmentation, condensation or 
dispersion) in the Golgi complex with the screen hits which inhibit tsO45-G transport. In our 
study, 5 out of 134 miRNA hits fragmented the Golgi complex showing only 6% of the hits 
tested. MiR-211 has been shown to be involved in melanoma adhesion by targeting a gene 
NUAK1 (Bell et al., 2013). NUAK1 (novel kinase family 1) is a tumor suppressor through 
direct interaction with p53 (Hou et al., 2011). Previous studies showed that kinases are key 
players in maintenance of Golgi structure as well as regulation of vesicles carrying cargo 
protein (Hausser et al., 2005; Preisinger & Barr, 2005). This may explain the contribution of 
miR-211 in our hits to the maintenance of the Golgi structure and transport defect of tsO45-
G. 
4.2 miR-30b and membrane trafficking  
Over-expression of miR-30b induces cell apoptosis which in turn fragments the Golgi 
complex (Mukherjee et al., 2007; Li et al., 2010). This observation suggests the fragmented 
phenotype of over-expressed miR-30b. miR-30b is known to target few proteins in 3’UTR 
involved in various diseases such as cardiac apoptosis, fibrosis and vascular calcifaction. The 
direct targets of miR-30b are Bcl-2(antiapoptotic gene) (Wei, Li & Gupta, 2013), PDGFB 
(profibrotic growth factor)(Tanaka et al., 2013), CaMKIIδ(Ca/Calmodulin dependent protein 
kinase)(He et al., 2013), Runx2(osteoblast transcription factor)(Balderman et al., 2012), 
Caspase-3 (apoptosis–related cysteine peptidase)(Quintavalle et al., 2013), catalase(ROS 
scavengers)(Haque et al., 2012), CCNE2 (cell cycle-related gene)(Ichikawa et al., 2012) and 
GALNT7 (GalNAc transferase)(Gaziel-Sovran et al., 2011). For the first time in our study we 
report about targets of miR-30b that regulates membrane trafficking. Putative targets were 
searched by overlapping between three prediction programs. 23 regulators were manually 
selected and overlapped with published tsO45-G secretion data of Simpson et al., 2012. Out 
of 23 putative targets, 5 genes (CADPS, MYH10, COG2, TMED2 and SYPL1) were not 
taken into our siRNA experiment due to their specific action in neurons (Daily et al., 2010; 
Luo et al., 2011), embryonic development (Huang et al., 2013) or no effect on tsO45-G 
secretion upon knockdown or over-expression (Sohda et al., 2007). When the screen hits 
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from Simpson et al., 2012 was compared with our RNAi hits of targets, ARF4, AP3S1, 
RAB11a and RAB8a were among the inhibitors of tsO45-G secretion. RAB11a and AP3S1 
are shown to be strong and mild inhibitors of tsO45-G secretion (Chen et al, 1998; Simpson 
et al., 2012) which gives positive outlook to our RNAi screen against 18 putative targets.  
18 targets were validated by luciferase assay, qRT-PCR and Western blot. With over-
expression of miR-30b, decrease in SNX16 mRNA followed by null effect on protein 
expression may be due to low quality of siRNA and antibody. Only 3 out of 18 genes were 
confirmed to be direct targets of miR-30b constituting 16% of the predicted target set. 
Prediction of miRNA targets by computational methods is much greater in use though 
number of verified targets is relatively few. It has been noticed that all prediction programs 
suffer high false-positive rates of ~70%, verifying our result in validation of predicted targets 
(Ritchie, Flamant & Rasko, 2009; Liu, Li & Cairns, 2012; Zheng et al., 2013). Interestingly, 
majority of the predicted targets of miR-30b are known to play role in late secretory pathway 
except the coat proteins of early secretory pathway SEC23A, SEC24D and SEC61A2. Not 
much information is known about AP3 except that this complex is hetero tetrameric clathrin 
coated similar to AP-2. The published data on AP3 and AP4 localized on TGN may imply 
their significant role in basolateral secretion. Ubiquitously expressed AP3 is clathrin-coated 
adaptor protein complex (Kural et al., 2012) localized to TGN and in peripheral structures 
containing transferrin receptor (Dell’Angelica et al., 1997). Over-expression of the delta 
subunit of AP3 caused inhibition of tsO45-G transport from TGN to PM in BHK cells 
(Nishimura et al., 2002).  Golgins known to be structural matrix components of the Golgi 
complex play important roles in the secretion and maintenance of the complex. The 
anterograde transport of VSV-G has not affected by the over-expressed GOLGA4 but 
disrupted the GPI transport from TGN to cell periphery (Kakinuma et al., 2004). Golgin-97 is 
a peripheral membrane protein which localizes to the tight perinuclear TGN. It was shown 
that the GRIP domain of Golgin-97 is necessary for their targeting to TGN and also plays a 
role in retrograde transport of Shiga toxin B to TGN (Lu et al., 2004).  Further knockdown of 
GOLGA1 or over-expression of the GRIP domain of GOLGA4 blocks the exit of E-cadherin 
transport from the TGN (Lock et al., 2005) which certifies the defect of VSV-G anterograde 
transport on knockdown. SCAMP1 is an integral membrane protein which localize at the 
perinuclear recycling endosomes 3 min post-uptake of transferrin and significant 
colocalization with RAB11 (Wu & Castle, 1997 ; Castle & Castle, 2005).  No previous data 
 of GOLGA1 and SCAMP1 function on tsO45
three genes are located in the perinuclear region 
In our study, we showed that the degree of inhibition from TGN
knockdown and miR-30b over
make the effect of miR-30b. It is unclear whether 
30b which contributes to the inhibition effect
transferrin to PM was arrested at t
2012). tsO45-G mild secretion inhibi
be due to the greater impact of three genes. 
AP3S1 and SCAMP1 indicates the connection wi
already established interactors from the experiments are denoted as purple such as GOLGA1 
with RAB6a and ARL1 (Lu, Tai and Hong, 2004). The blue
indirect functions based on databases or text
Golgi complex and acts in the fission of transport carriers from the Golgi complex
interaction with TGOLN2 (Miserey
 
                              
Figure 4.1 Network analysis between AP3S1, GOLGA1 and SCAMP1
SCAMP1 shows common connection to TGN protein
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These 3 targets directly or indirectly might function as cargo loading, budding and 
progression to the next compartment as well as influence endocytosis. Once in the Golgi, 
tsO45-G travels to the PM or endosomes via coated vesicles or tubular carriers. The 
biogenesis of carriers from TGN includes membrane deformation, tubulation and fission 
(Anitei & Hoflack, 2011).  The number and size of Golgi-derived transport carriers due to 
overloading of VSV-G can be determined over the knockdown of targets as well as over-
expression on miR-30b. The difference in tsO45-G transport and transferrin recycling may 
impart to cargo specificity for miR-30b regulation. Trafficking of apical cargo E-cadherin is 
ongoing. It will be interesting to investigate whether defects in protein trafficking induced by 
over-expression of miR-30b cause disease development and examine their mechanism of 
regulation. 
4.3 Retroposed transcripts: potential novel regulators of membrane 
trafficking  
RAB GTPases are the largest family of small Ras-like GTPases with 68 members in human. 
Rabs function as molecular switches between GTP- and GDP bound state which is regulators 
in vesicular traffic in a timely and spatially coordinated fashion (Hutagalung & Novick, 
2011). The first knowledge of existence of pseudogene in RAB GTPases is RAB9 which may 
be involved in cell vacuolation leading to Chediak-Higashi syndrome. The best example of 
retroposed transcript gaining a new function is RAB6C. So our study opens the door to the 
search of new retroposed pseudogenes of RAB GTPases. An intronless gene RAB6C was 
generated from retrotransposition of RAB6A’ mRNA showing 91% identity on nucleotide 
level. Rab6C plays a role in localization to the centrosome as well as in cell cycle progression 
(Young, et al., 2010), whereas Rab6A’ is involved in the endosome to trans-Golgi network 
transport (Grigoriev, et al., 2007). The differential expression of the pseudogenes can be 
checked in cancerous and non-cancerous cells and tissues. From RT-PCR results, those 
pseudogenes showing only one band were sequenced. The findings of the initial research 
have opened a new branch that needs further investigation of mechanistic regulation of 
retroposed transcript and its parent gene. Once the expression data is confirmed, the full 
length sequence of RAB42p RNA transcript should be obtained by 5’ and 3’ RACE (Rapid 
Amplification of cDNA ends).Once the sequence data is known, it will be essential to 
understand how RAB42p is regulated. The measurement of transcription factor, promoters 
and transcription start site are required to understand the differential expression between 
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RAB42p and RAB42. From the alignment data of RAB42 and RAB42p, it has been shown 
that RAB42p may potentially code for a protein. Though the sequence identity is 97% on 
amino acid level, the antibody specific to RAB42p can be developed and used for the protein 
expression. We found common miRNAs (miR-24 and miR-197) targeting both RAB42 and 
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Appendix Table 6.1. Accession numbers and IDs of 875 mature human miRNAs in Anti-miRTM 
miRNA Inhibitor Library. Library contains all human miRNAs annotated in miRBase v13. Z-scores 
of ts-O45-G trafficking rate changes and standard errors of the mean (S.E.M.) induced by 
overexpression of each miRNA are given. The median cargo transport rate is adjusted to Z-score of 0. 














 All Stars 0  MIMAT0000102 miR-105 -1,69 0,30 
 α-Cop -9,24 8,97E-44 MIMAT0000684 miR-302a -1,67 0,29 
 β-Cop -5,71 1,67E-37  miR-129-3p -1,67 0,11 
 ANC 0  MIMAT0005582 miR-1228* -1,66 0,07 
 miR-488 -5,84 0,20 MIMAT0007347 miR-1469 -1,66 0,12 
MIMAT0003230 miR-566 -4,56 0,22 MIMAT0000270 miR-181a* -1,65 0,66 
MIMAT0001413 miR-20b -4,18 0,19 MIMAT0000232 miR-199a/b-3p -1,61 0,27 
MIMAT0000086 miR-29a -3,63 0,24 MIMAT0004903 miR-300 -1,6 0,25 
MIMAT0004761 miR-483-5p -3,6 0,33 MIMAT0004752 miR-20b* -1,59 0,05 
MIMAT0004560 miR-183* -3,53 0,03 MIMAT0003301 miR-33b -1,49 0,01 
MIMAT0000228 miR-198 -3,47 0,11 MIMAT0002849 miR-524-5p -1,48 0,30 
MIMAT0001630 miR-453 -3,15 0,17 MIMAT0000426 miR-132 -1,47 0,29 
MIMAT0005592 miR-1237 -2,72 0,22 MIMAT0002873 miR-502-5p -1,46 0,31 
MIMAT0000268 miR-211 -2,68 0,26 MIMAT0002815 miR-432* -1,44 0,24 
MIMAT0004632 miR-487b -2,65 0,47 MIMAT0004901 miR-298 -1,44 0,18 
MIMAT0000242 miR-129-5p -2,63 0,11 MIMAT0000444 miR-126* -1,4 002 
MIMAT0005932 miR-302f -2,62 0,08 MIMAT0003320 miR-650 -1,39 0,32 
MIMAT0002854 miR-521 -2,54 0,09 MIMAT0002823 miR-512-3p -1,36 0,28 
MIMAT0004949 miR-877 -2,47 0,24 MIMAT0007979 miR-1254 -1,31 005 
MIMAT0004979 miR-936 -2,4 0,21 MIMAT0003888 miR-766 -1,31 0,48 
MIMAT0000063 let-7b -2,25 0,51 MIMAT0004678 miR-99b* -1,3 0,24 
MIMAT0004986 miR-943 -2,23 0,82 MIMAT0000066 let-7e -1,27 0,45 
MIMAT0004548 miR-129* -2,23 0,02 MIMAT0004481 let-7a* -1,23 0,25 
MIMAT0004586 miR-15b* -2,23 0,22 MIMAT0000080 miR-24 -1,23 015 
MIMAT0000084 miR-27a -2,21 0,11 MIMAT0003283 miR-615-3p -1,18 0,13 
MIMAT0004946 miR-744* -2,2 0,03 MIMAT0003311 miR-641 -1,16 0,23 
MIMAT0004946 miR-665 -2,14 0,33 MIMAT0004798 miR-548b-5p -1,13 0,22 
MIMAT0000754 miR-337-3p -2,04 0,41 MIMAT0002807 miR-491-5p -1,13 0,31 
MIMAT0004501 miR-27a* -1,99 0,19 MIMAT0002840 miR-523 -1,13 0,17 
MIMAT0000419 miR-27b -1,92 0,00 MIMAT0004680 miR-130b* -1,13 070 
MIMAT0006767 miR-1827 -1,9 0,42 MIMAT0005945 miR-1255b -1,12 0,44 
MIMAT0005929 miR-1275 -1,88 0,20 MIMAT0001629 miR-329 -1,12 0,20 
MIMAT0000451 miR-150 -1,8 0,10 MIMAT0004768 miR-497* -1,69 0,11 
MIMAT0003324 miR-661 -1,79 0,27 MIMAT0000067 let-7f -1,11 0,34 
MIMAT0003277 miR-609 -1,76 0,22 MIMAT0003249 miR-584 -1,1 0,47 
MIMAT0004565 miR-218-1* -1,1 0,33 MIMAT0005923 miR-1269 -0,87 0,03 
MIMAT0000418 miR-23b -1,1 0,57 MIMAT0004486 let-7f-1* -0,87 0,10 
MIMAT0002837 miR-519b-3p -1,09 0,21 MIMAT0000737 miR-382 -0,85 0,27 
MIMAT0000750 miR-340* -1,08 0,41 MIMAT0005586 miR-1231 -0,85 0,62 
MIMAT0002860 miR-516a-3p -1,08 0,20 MIMAT0003883 miR-767-3p -0,84 0,90 
MIMAT0005877 miR-1286 -1,08 0,49 MIMAT0004594 miR-132* -0,82 0,48 
MIMAT0006765 miR-1825 -1,07 0,68 MIMAT0003879 miR-758 -0,8 0,65 
MIMAT0000442 miR-9* -1,06 0,12 MIMAT0002174 miR-484 -0,79 0,21 
MIMAT0004908 miR-220b -1,05 0,62  miR-660 -0,79 0,05 
MIMAT0005799 miR-1283 -1,04 0,33 MIMAT0004555 miR-10a* -0,78 0,97 
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MIMAT0004803 miR-548a-5p -1,04 0,13 MIMAT0002858 miR-520g -0,77 0,22 
MIMAT0004928 miR-147b -1,04 0,23 MIMAT0004797 miR-582-3p -0,77 0,45 
MIMAT0003222 miR-558 -1,03 0,16 MIMAT0008227 miR-548n -0,75 0,61 
MIMAT0000261 miR-183 -1,01 0,62 MIMAT0004600 miR-144* -0,74 0,36 
MIMAT0003269 miR-601 -1,01 0,84 MIMAT0004450 miR-297 -0,74 0,24 
MIMAT0000075 miR-20a -1,01 0,73 MIMAT0002809 miR-146b-5p -0,73 0,75 
MIMAT0005887 miR-1299 -0,99 0,76 MIMAT0004692 miR-340 -0,73 0,82 
MIMAT0002850 miR-524-3p -0,99 0,28 MIMAT0003393 miR-425 -0,73 0,45 
MIMAT0005873 miR-1208 -0,99 0,47 MIMAT0004607 miR-138-1* -0,72 0,70 
MIMAT0003298 miR-629* -0,99 0,15 MIMAT0005946 miR-1280 -0,72 0,63 
MIMAT0000756 miR-326 -0,97 0,94 MIMAT0004598 miR-141* -0,71 0,47 
MIMAT0003386 miR-376a* -0,97 0,40 MIMAT0000446 miR-127-3p -0,7 0,71 
MIMAT0004569 miR-222* -0,97 0,73 MIMAT0005938 miR-1274b -0,7 0,88 
MIMAT0000258 miR-181c -097 0,36 MIMAT0004673 miR-29c* -0,7 0,09 
MIMAT0004614 miR-193a-5p -0,96 0,56 MIMAT0004909 miR-450b-5p -0,68 0,30 
MIMAT0004611 miR-185* -0,94 0,25 MIMAT0005918 miR-1265 -0,67 0,10 
MIMAT0002828 miR-519e* -0,94 0,36 MIMAT0005950 miR-1306 -0,67 0,43 
MIMAT0004780 miR-532-3p -0,94 0,49 MIMAT0003254 miR-548b-3p -0,67 0,17 
MIMAT0004549 miR-148a* -0,94 0,33 MIMAT0000727 miR-374a -0,66 0,48 
MIMAT0003881 miR-668 -0,93 0,90 MIMAT0005902 miR-1250 -0,64 0,64 
MIMAT0000281 miR-224 -0,92 0,41 MIMAT0004571 miR-200b* -0,64 0,86 
MIMAT0002826 miR-515-5p -0,92 0,06 MIMAT0001080 miR-196b -0,63 0,55 
MIMAT0004925 miR-876-3p -0,92 0,12 MIMAT0005955 miR-1197 -0,63 0,37 
MIMAT0000096 miR-98 -0,91 0,77 MIMAT0007348 miR-1470 -0,63 0,49 
MIMAT0004496 miR-23a* -091 0,37 MIMAT0002814 miR-432 -0,62 0,73 
MIMAT0003280 miR-612 -0,91 0,50 MIMAT0000257 miR-181b -0,62 0,24 
MIMAT0007889 miR-1914 -0,9 0,49 MIMAT0000095 miR-96 -0,61 0,08 
MIMAT0004597 miR-140-3p -0,89 0,37 MIMAT0000227 miR-197 -0,6 0,70 
MIMAT0005583 miR-1228 -0,89 0,40 MIMAT0004766 miR-146b-3p -0,6 0,07 
MIMAT0004676 miR-34b -0,88 0,16 MIMAT0004492 miR-19b-2* -0,6 0,06 
MIMAT0004284 miR-675 -0,88 0,67 MIMAT0004774 miR-501-3p -0,59 0,12 
MIMAT0003281 miR-613 -0,88 0,09 MIMAT0000734 miR-380* -0,59 0,81 
MIMAT0004485 let-7e* -0,59 0,75 MIMAT0009206 miR-2113 -0,39 0,78 
MIMAT0001625 miR-431 -0,58 0,38 MIMAT0004694 miR-342-5p -0,39 0,34 
MIMAT0007978 miR-1253 -0,57 0,32 MIMAT0003243 miR-578 -0,38 0,26 
MIMAT0003276 miR-608 -0,57 0,22 MIMAT0004773 miR-500 -0,38 0,80 
MIMAT0004794 miR-551b* -0,57 0,45 MIMAT0003258 miR-590-5p -0,37 0,40 
MIMAT0000093 miR-93 -0,56 0,71 MIMAT0005906 miR-1255a -0,36 0,46 
MIMAT0002857 miR-517b -0,56 0,28 MIMAT0000680 miR-106b -0,36 0,78 
MIMAT0005881 miR-1291 -0,56 0,54 MIMAT0002822 miR-512-5p -0,35 0,52 
MIMAT0004980 miR-937 -0,54 0,60 MIMAT0000264 miR-203 -0,35 0,64 
MIMAT0002874 miR-503 -0,54 0,11 MIMAT0005593 miR-1238 -0,34 0,19 
MIMAT0005953 miR-1322 -0,53 0,30 MIMAT0000449 miR-146a -0,34 0,31 
MIMAT0004553 miR-7-1* -0,53 0,12 MIMAT0004910 miR-450b-3p -0,34 0,37 
MIMAT0004690 miR-379* -0,53 0,41 MIMAT0004185 miR-802 -0,33 0,42 
MIMAT0002846 miR-520c-3p -0,52 0,04 MIMAT0005576 miR-1226* -0,33 0,43 
MIMAT0009978 miR-2053 -0,52 0,50 MIMAT0000430 miR-138 -0,33 0,47 
MIMAT0003339 miR-421 -0,52 0,08 MIMAT0002876 miR-505 -0,32 0,97 
MIMAT0003218 miR-92b -0,51 0,46 MIMAT0009452 miR-1977 -0,32 0,76 
MIMAT0000222 miR-192 -0,51 0,31 MIMAT0003289 miR-620 -0,32 0,42 
MIMAT0004602 miR-125a-3p -0,51 0,50 MIMAT0004557 miR-34a* -0,31 0,42 
MIMAT0000245 miR-30d -0,49 0,18 MIMAT0003948 miR-770-5p -0,3 0,71 
MIMAT0002825 miR-520e -0,49 0,64 MIMAT0003219 miR-555 -0,3 0,79 
MIMAT0003165 miR-545 -0,49 0,08  abi-13242 -0,3 0,69 
MIMAT0001500 aga-miR-125 -0,48 0,39 MIMAT0000267 miR-210 -0,29 0,75 
MIMAT0004796 miR-576-3p -0,48 0,43 MIMAT0000758 miR-135b -0,29 0,83 
MIMAT0000078 miR-23a -0,48 0,66 MIMAT0000081 miR-25 -0,28 0,74 
MIMAT0005825 miR-1180 -0,47 0,50 MIMAT0005876 miR-1285 -0,27 0,52 
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MIMAT0003240 miR-575 -047 0,59 MIMAT0003290 miR-621 -0,25 0,89 
MIMAT0004927 miR-708* -0,47 0,43 MIMAT0003321 miR-651 -0,25 0,39 
MIMAT0000721 miR-369-3p -0,46 0,26 MIMAT0001343 miR-425* -0,24 0,83 
MIMAT0005937 miR-1279 -0,44 0,25 MIMAT0004495 miR-22* -0,24 0,30 
MIMAT0004762 miR-486-3p -0,44 0,85 MIMAT0004595 miR-135a* -0,23 0,82 
MIMAT0000414 let-7g -0,44 0,04 MIMAT0001412 miR-18b -0,22 0,77 
MIMAT0004764 miR-490-5p -044 0,31 MIMAT0007399 miR-1537 -0,22 0,49 
MIMAT0007888 miR-1913 -0,43 0,45 MIMAT0005897 miR-1245 -0,22 0,79 
MIMAT0000065 let-7d -0,43 0,50 MIMAT0002176 miR-485-3p -0,21 0,44 
MIMAT0005954 miR-720 -0,42 0,53 MIMAT0004981 miR-938 -0,21 0,78 
MIMAT0005588 miR-1233 -0,42 0,64 MIMAT0005942 miR-1288 -0,2 0,66 
MIMAT0006790 miR-675* -0,41 0,82 MIMAT0000437 miR-145 -0,2 0,32 
MIMAT0004499 miR-26a-1* -041 0,77 MIMAT0003945 miR-765 -0,19 0,63 
MIMAT0002172 miR-376b -0,41 0,98 MIMAT0005941 miR-1284 -0,19 0,52 
MIMAT0004562 miR-196a* -0,41 0,22 MIMAT0005948 miR-664* -0,19 0,93 
MIMAT0004804 miR-615-5p -0,4 0,70 MIMAT0003295 miR-626 -0,19 0,67 
MIMAT0003317 miR-647 -0,39 0,09 MIMAT0003264 miR-596 -0,19 0,39 
MIMAT0003279 miR-611 -0,18 0,71 MIMAT0006789 miR-1468 -0,04 0,71 
MIMAT0004511 miR-99a* -0,18 0,58 MIMAT0004800 miR-550 -0,04 0,61 
MIMAT0004915 miR-220c -0,18 0,81 MIMAT0000253 miR-10a -0,04 0,52 
MIMAT0005882 miR-548k -0,17 0,71 MIMAT0004779 miR-509-5p -0,03 0,47 
MIMAT0000752 miR-328 -0,17 0,27 MIMAT0000435 miR-143 -0,03 0,77 
MIMAT0005788 miR-513b -0,17 0,41 MIMAT0003248 miR-583 -0,03 0,85 
MIMAT0004493 miR-20a* -0,15 0,61 MIMAT0005940 miR-1282 -0,03 0,99 
MIMAT0000453 miR-154* -0,15 0,77 MIMAT0009450 miR-1975 -0,03 0,51 
MIMAT0000077 miR-22 -0,15 0,67 MIMAT0000685 miR-34b* -0,02 0,85 
MIMAT0004507 miR-92a-1* -0,14 0,75 MIMAT0009451 miR-1976 -0,02 0,62 
MIMAT0004592 miR-125b-1* -0,14 0,56 MIMAT0007400 miR-1538 -0,02 0,61 
MIMAT0000263 miR-199b-5p -0,14 0,69 MIMAT0004955 miR-374b -0,02 0,87 
MIMAT0000688 miR-301a -0,14 0,40 MIMAT0003284 miR-616* -0,01 0,48 
MIMAT0003319 miR-649 -0,13 0,93 MIMAT0004490 miR-19a* -0,01 0,83 
 miR-450a -0,13 0,69 MIMAT0002805 miR-489 -0 0,46 
MIMAT0003257 miR-550* -0,13 0,52 MIMAT0003268 miR-600 -0 0,45 
MIMAT0000738 miR-383 -0,12 0,66 MIMAT0003161 miR-493 -0 0,96 
MIMAT0000448 miR-136 -0,12 0,20 MIMAT0003336 miR-658 -0 0,60 
MIMAT0009454 miR-1979 -0,11 0,29  ANC 0 0,35 
MIMAT0004922 miR-875-5p -0,11 0,68 MIMAT0003312 miR-642 0,01 0,45 
MIMAT0000434 miR-142-3p -0,09 0,76 MIMAT0003326 miR-663 0,01 0,67 
MIMAT0005926 miR-1273 -0,09 0,88 MIMAT0004672 miR-106b* 0,01 0,62 
MIMAT0003220 miR-556-5p -0,08 0,60 MIMAT0000094 miR-95 0,01 0,67 
MIMAT0000456 miR-186 -0,08 0,38 MIMAT0004811 miR-33b* 0,01 0,54 
MIMAT0000278 miR-221 -0,06 1,00  miR-219-2-3p 0,01 0,91 
MIMAT0007884 miR-1910 -0,06 0,74 MIMAT0000089 miR-31 0,01 0,77 
 Allstars -0,06 0,01 MIMAT0001621 miR-369-5p 0,02 0,62 
MIMAT0005827 miR-1182 -0,06 0,62 MIMAT0003385 miR-363* 0,02 0,97 
MIMAT0004686 miR-367* -0,06 0,46 MIMAT0000751 miR-330-3p 0,03 0,96 
MIMAT0007883 miR-1909 -0,06 0,69 MIMAT0000269 miR-212 0,03 0,46 
MIMAT0003328 miR-653 -0,05 0,96 MIMAT0002833 miR-520a-5p 0,03 0,47 
MIMAT0004688 miR-374a* -0,05 0,54 MIMAT0003315 miR-645 0,04 0,53 
MIMAT0005826 miR-1181 -0,05 0,88 MIMAT0005893 miR-1305 0,04 0,78 
MIMAT0002848 miR-518c -0,04 0,44 MIMAT0005791 miR-1264 0,04 0,70 
MIMAT0000762 miR-324-3p -0,04 0,80 MIMAT0005920 miR-1266 0,05 0,44 
MIMAT0002847 miR-518c* -0,04 0,89 MIMAT0004696 miR-323-5p 0,05 0,62 
MIMAT0006789 miR-1468 -0,04 0,71 MIMAT0000069 miR-16 0,06 0,88 
MIMAT0004800 miR-550 -0,04 0,61 MIMAT0003241 miR-576-5p 0,06 0,55 
MIMAT0000253 miR-10a -0,04 0,52 MIMAT0003330 miR-654-5p 0,06 0,46 
MIMAT0004779 miR-509-5p -0,03 0,47 MIMAT0000691 miR-130b 0,06 0,98 
MIMAT0000435 miR-143 -0,03 0,77 MIMAT0003294 miR-625 0,07 0,44 
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MIMAT0000762 miR-324-3p -0,04 0,80 MIMAT0002810 miR-202* 0,07 0,44 
MIMAT0002847 miR-518c* -0,04 0,89 MIMAT0000681 miR-29c 0,17 0,99 
MIMAT0002830 miR-520f 0,07 0,43 MIMAT0005829 miR-1184 0,17 0,29 
MIMAT0004699 miR-148b* 0,07 0,73 MIMAT0007401 miR-1539 0,18 0,60 
MIMAT0005878 miR-1287 0,07 0,43 MIMAT0005572 miR-1225-5p 0,18 0,67 
MIMAT0000445 miR-126 0,07 0,70 MIMAT0004770 miR-516a-5p 0,18 0,82 
MIMAT0000427 miR-133a 0,08 0,48 MIMAT0005899 miR-1247 0,18 0,94 
MIMAT0003163 miR-539 0,08 0,37 MIMAT0004589 miR-30b* 0,18 0,18 
MIMAT0002820 miR-497 0,09 0,94 MIMAT0004608 miR-146a* 0,19 0,75 
MIMAT0004819 miR-671-3p 0,09 0,31 MIMAT0003389 miR-542-3p 0,19 0,24 
MIMAT0003296 miR-627 0,09 0,97 MIMAT0000461 miR-195 0,19 0,76 
MIMAT0000064 let-7c 0,1 0,95 MIMAT0000432 miR-141 0,19 0,79 
MIMAT0004587 miR-23b* 0,1 0,53 MIMAT0003314 miR-644 0,19 0,68 
MIMAT0007882 miR-1909* 0,1 0,76 MIMAT0003307 miR-637 0,19 0,62 
MIMAT0000450 miR-149 0,1 0,90 MIMAT0004585 let-7i* 0,2 0,44 
MIMAT0002866 miR-517c 0,1 0,33 MIMAT0001631 miR-451 0,21 0,59 
MIMAT0004674 miR-30c-1* 0,1 0,52 MIMAT0003282 miR-614 0,21 0,55 
MIMAT0000753 miR-342-3p 0,1 0,75 MIMAT0003886 miR-769-5p 0,21 0,96 
MIMAT0007881 miR-1908 0,11 0,88 MIMAT0004612 miR-186* 0,21 0,62 
MIMAT0003329 miR-411 0,11 0,99 MIMAT0000100 miR-29b 0,21 0,86 
MIMAT0007890 miR-1914* 0,11 0,81 MIMAT0004657 miR-200c* 0,21 0,32 
MIMAT0002839 miR-525-3p 0,11 0,46 MIMAT0004809 miR-628-5p 0,22 0,80 
MIMAT0000732 miR-378 0,11 0,47 MIMAT0007885 miR-1911 0,22 0,37 
 miR-361-3p 0,12 0,97 MIMAT0005907 miR-1256 0,22 0,87 
MIMAT0004516 miR-105* 0,12 0,70 MIMAT0002170 miR-412 0,22 0,65 
MIMAT0003327 miR-449b 0,13 0,60 MIMAT0005864 miR-1201 0,22 0,90 
MIMAT0004505 miR-32* 0,13 0,63 MIMAT0000693 miR-30e* 0,23 0,32 
MIMAT0004757 miR-370 0,13 0,57 MIMAT0007886 miR-1911* 0,23 0,65 
MIMAT0002811 miR-202 0,13 0,92 MIMAT0000417 miR-15b 0,23 0,97 
MIMAT0005951 miR-1307 0,13 0,44 MIMAT0004567 miR-219-1-3p 0,24 0,37 
MIMAT000283 miR-518a-3p 0,14 0,63 MIMAT0000431 miR-140-5p 0,24 0,50 
MIMAT0001639 miR-409-3p 0,14 0,86 MIMAT0002834 miR-520a-3p 0,24 0,92 
MIMAT0005457 miR-518a-5p 0,14 0,77 MIMAT0003263 miR-595 0,24 0,54 
MIMAT0003887 miR-769-3p 0,14 0,99 MIMAT0000280 miR-223 0,24 0,41 
MIMAT0004509 miR-93* 0,15 0,76 MIMAT0004494 miR-21* 0,24 0,80 
MIMAT0002870 miR-499-5p 0,15 0,72 MIMAT0004677 miR-34c-3p 0,25 0,35 
MIMAT0003236 miR-571 0,15 0,17 MIMAT0000272 miR-215 0,25 0,40 
MIMAT0000731 miR-378* 0,16 0,54 MIMAT0004929 miR-190b 0,26 0,38 
MIMAT0004920 miR-541 0,16 0,39 MIMAT0003223 miR-559 0,26 0,42 
MIMAT0009447 miR-1972 0,16 0,35 MIMAT0004517 miR-106a* 0,26 0,86 
MIMAT0000271 miR-214 0,16 0,74 MIMAT0005892 miR-1304 0,26 0,80 
MIMAT0005956 miR-1324 0,17 0,51 MIMAT0003221 miR-557 0,27 0,25 
MIMAT0005900 miR-1248 0,17 0,02 MIMAT0003260 miR-592 0,27 0,74 
MIMAT0003291 miR-622 0,17 0,48 MIMAT0000259 miR-182 0,27 0,21 
MIMAT0000279 miR-222 0,17 0,08 MIMAT0002878 miR-506 0,37 0,52 
MIMAT0004484 let-7d* 0,27 0,25 MIMAT0002835 miR-526b 0,37 0,75 
MIMAT0003251 miR-548a-3p 0,27 0,53 MIMAT0001636 miR-452* 0,37 0,77 
MIMAT0005947 miR-1308 0,27 0,38 MIMAT0004985 miR-942 0,38 0,71 
MIMAT0000250 miR-139-5p 0,27 0,60 MIMAT0005874 miR-548e 0,38 0,91 
MIMAT0004767 miR-193b* 0,28 0,89 MIMAT0005863 miR-1200 0,39 0,24 
MIMAT0000717 miR-302c 0,28 0,41 MIMAT0003214 miR-551a 0,39 0,55 
MIMAT0000260 miR-182* 0,28 0,89 MIMAT0000720 miR-376c 0,39 0,39 
MIMAT0003246 miR-581 0,28 0,81 MIMAT0003253 miR-587 0,39 0,86 
MIMAT0009198 miR-224* 0,28 0,93 MIMAT0002859 miR-516b 0,39 0,09 
MIMAT0004972 miR-922 0,29 0,71 MIMAT0004506 miR-33a* 0,39 0,32 
MIMAT0004950 miR-877* 0,29 0,50 MIMAT0001541 miR-449a 0,4 0,36 
MIMAT0003270 miR-602 0,29 0,43 MIMAT0002173 miR-483-3p 0,4 0,12 
MIMAT0000275 miR-218 0,29 0,36 MIMAT0002879 miR-507 0,4 0,55 
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MIMAT0001635 miR-452 0,29 0,23 MIMAT0000425 miR-130a 0,4 0,68 
MIMAT0005865 miR-1202 0,29 0,60 MIMAT0003292 miR-623 0,41 0,11 
MIMAT0004948 miR-885-3p 0,29 0,36 MIMAT0004503 miR-29a* 0,42 0,58 
MIMAT0000723 miR-371-3p 0,29 0,26 MIMAT0002374 miR-1 0,42 0,87 
MIMAT0000510 miR-320 0,3 0,09 MIMAT0004552 miR-139-3p 0,42 0,44 
MIMAT0003322 miR-652 0,3 0,82 MIMAT0004777 miR-513-3p 0,42 0,69 
MIMAT0003232 miR-568 0,31 0,37 MIMAT0002836 miR-526b* 0,42 0,68 
MIMAT0000735 miR-380 0,31 0,29 MIMAT0005933 miR-1277 0,43 0,42 
MIMAT0005870 miR-1206 0,31 0,39 MIMAT0004772 miR-499-3p 0,43 0,68 
MIMAT0004491 miR-19b-1* 0,31 0,89 MIMAT0003337 miR-659 0,43 0,27 
MIMAT0009199 miR-365* 0,32 0,34 MIMAT0004912 miR-890 0,44 0,46 
MIMAT0000266 miR-205 0,32 0,51 MIMAT0000716 miR-302c* 0,44 003 
MIMAT0005927 miR-1274a 0,32 0,56 MIMAT0004508 miR-92a-2* 0,44 0,23 
MIMAT0004956 miR-374b* 0,32 0,90 MIMAT0005952 miR-1321 0,44 0,48 
MIMAT0005459 miR-1224-3p 0,32 0,35 MIMAT0004975 miR-509-3-5p 0,44 0,02 
MIMAT0003310 miR-640 0,33 0,25 MIMAT0003275 miR-607 0,44 0,07 
MIMAT0000424 miR-
128a/128b 
0,33 0,27 MIMAT0004596 miR-138-2* 0,45 0,08 
MIMAT0005800 miR-1298 0,33 0,76 MIMAT0000252 miR-7 0,45 0,33 
 miR-331-5p 0,33 0,39 MIMAT0003245 miR-580 0,45 0,29 
MIMAT0003288 miR-619 0,34 0,31 MIMAT0003299 miR-630 0,46 0,25 
MIMAT0001536 miR-429 0,34 0,16 MIMAT0009197 miR-205* 0,46 0,19 
MIMAT0007891 miR-1915* 0,34 0,30  abi-13253 0,46 0,73 
MIMAT0002872 miR-501-5p 0,35 0,54 MIMAT0003313 miR-643 0,46 0,37 
MIMAT0005789 miR-513c 0,36 0,37 MIMAT0003302 miR-632 0,47 0,38 
MIMAT0000760 miR-331-3p 0,36 0,13 MIMAT0004924 miR-876-5p 0,47 0,40 
MIMAT0000719 miR-367 0,36 0,72 MIMAT0000687 miR-299-3p 0,47 0,96 
MIMAT0002868 miR-522 0,37 0,73 MIMAT0004683 miR-362-3p 0,47 0,73 
MIMAT0003331 miR-655 0,37 0,94 MIMAT0002808 miR-511 0,48 0,97 
MIMAT0009196 miR-103-2* 0,37 0,26 MIMAT0004917 miR-888* 0,48 0,65 
MIMAT0000273 miR-216a 0,48 0,51 MIMAT0000088 miR-30a* 0,61 0,82 
MIMAT0003244 miR-579 0,48 0,17 MIMAT0002841 miR-518f* 0,62 0,29 
MIMAT0004610 miR-150* 0,49 0,95 MIMAT0005884 miR-1294 0,62 0,33 
MIMAT0002175 miR-485-5p 0,49 0,46 MIMAT0003286 miR-617 0,62 0,79 
MIMAT0003273 miR-605 0,49 0,07 MIMAT0009201 miR-196b* 0,62 0,39 
MIMAT0000436 miR-144 0,5 0,07 MIMAT0003333 miR-549 0,63 0,16 
MIMAT0003234 miR-569 0,5 0,13 MIMAT0005888 miR-1300 0,63 0,23 
MIMAT0004681 miR-26a-2* 0,5 0,33 MIMAT0003316 miR-646 0,63 0,17 
MIMAT0004953 miR-873 0,5 0,64 MIMAT0004698 miR-135b* 0,63 0,34 
MIMAT0000755 miR-323-3p 0,51 0,29 MIMAT0000447 miR-134 0,63 0,56 
MIMAT0004588 miR-27b* 0,51 0,31 MIMAT0000415 let-7i 0,63 0,25 
MIMAT0004695 miR-337-5p 0,52 0,50 MIMAT0009453 miR-1978 0,64 0,48 
MIMAT0004960 miR-208b 0,52 0,39 MIMAT0004606 miR-136* 0,64 0,33 
MIMAT0003880 miR-671-5p 0,53 0,19 MIMAT0002821 miR-181d 0,64 0,15 
MIMAT0005883 miR-1293 0,53 0,62 MIMAT0002804 miR-488* 0,65 0,80 
MIMAT0000443 miR-125a-5p 0,53 0,42 MIMAT0010133 miR-2110 0,65 0,29 
MIMAT0004921 miR-889 0,53 0,67  miR-654-3p 0,65 0,72 
MIMAT0000092 miR-92a 0,54 0,92 MIMAT0000318 miR-200b 0,65 0,50 
MIMAT0002851 miR-517* 0,55 0,06 MIMAT0000439 miR-153 0,66 0,76 
MIMAT0000455 miR-185 0,55 0,14 MIMAT0005868 miR-1204 0,66 0,22 
MIMAT0003323 miR-548d-3p 0,55 0,38 MIMAT0005921 miR-1267 0,66 0,19 
MIMAT0000422 miR-124 0,55 0,32 MIMAT0004978 miR-935 0,66 0,27 
MIMAT0002178 miR-487a 0,55 0,43 MIMAT0003318 miR-648 0,66 0,25 
MIMAT0004911 miR-874 0,55 0,12 MIMAT0005909 miR-1258 0,67 0,06 
MIMAT0004482 let-7b* 0,55 0,06 MIMAT0005924 miR-1270 0,67 0,24 
MIMAT0000085 miR-28-5p 0,56 0,52 MIMAT0000274 miR-217 0,67 0,97 
MIMAT0004812 miR-548d-5p 0,57 0,22 MIMAT0002882 miR-510 0,67 0,38 
MIMAT0003278 miR-610 0,57 0,28 MIMAT0005898 miR-1246 0,67 0,36 
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MIMAT0001075 miR-384 0,57 0,43 MIMAT0000772 miR-345 0,68 0,36 
MIMAT0005793 miR-320c 0,57 0,37 MIMAT0005913 miR-1261 0,68 0,04 
MIMAT0004977 miR-934 0,57 0,22 MIMAT0003164 miR-544 0,68 0,56 
MIMAT0004498 miR-25* 0,58 0,32 MIMAT0000736 miR-381 0,68 0,42 
MIMAT0007402 miR-103-as 0,58 0,82 MIMAT0000726 miR-373 0,68 0,07 
MIMAT0005456 miR-518d-5p 0,59 0,81 MIMAT0002827 miR-515-3p 0,69 0,08 
MIMAT0003285 miR-548c-3p 0,6 0,38 MIMAT0004566 miR-218-2* 0,69 0,07 
MIMAT0005869 miR-1205 0,6 0,54 MIMAT0000251 miR-147 0,69 0,06 
MIMAT0005891 miR-1303 0,6 0,25 MIMAT0000104 miR-107 0,69 0,16 
MIMAT0000718 miR-302d 0,6 0,63 MIMAT0003884 miR-454* 0,69 0,66 
MIMAT0007947 miR-1178 0,61 0,12 MIMAT0000103 miR-106a 0,69 0,46 
MIMAT0009449 miR-1974 0,61 0,65 MIMAT0000099 miR-101 0,7 0,22 
MIMAT0002819 miR-193b 0,61 0,94 MIMAT0005944 miR-1252 0,7 0,22 
MIMAT0005828 miR-1183 0,61 0,09 MIMAT0005917 miR-548m 0,84 0,17 
MIMAT0004970 miR-920 0,7 0,19 MIMAT0003237 miR-572 0,85 0,28 
MIMAT0002812 miR-492 0,71 0,28 MIMAT0003265 miR-597 0,85 0,07 
MIMAT0004487 let-7f-2* 0,71 0,15 MIMAT0005796 miR-1271 0,85 0,26 
MIMAT0002890 miR-299-5p 0,71 0,87 MIMAT0009977 miR-2052 0,86 0,06 
MIMAT0000429 miR-137 0,71 0,36 MIMAT0003271 miR-603 0,87 0,06 
MIMAT0005589 miR-1234 0,72 0,06 MIMAT0002855 miR-520d-5p 0,87 0,71 
MIMAT0003217 miR-554 0,72 0,72 MIMAT0003325 miR-662 0,87 0,09 
MIMAT0003267 miR-599 0,72 0,52 MIMAT0004813 miR-411* 0,87 0,11 
MIMAT0000255 miR-34a 0,73 0,03 MIMAT0005934 miR-548p 0,88 0,17 
MIMAT0005591 miR-1236 0,73 0,01 MIMAT0003885 miR-454 0,88 0,00 
MIMAT0002838 miR-525-5p 0,73 0,97 MIMAT0005914 miR-1262 0,88 0,08 
MIMAT0004947 miR-885-5p 0,73 0,45 MIMAT0005886 miR-1297 0,88 0,31 
MIMAT0000730 miR-377 0,73 0,15 MIMAT0003303 miR-633 0,89 0,21 
MIMAT0001620 miR-200a* 0,73 0,35 MIMAT0004810 miR-629 0,89 0,16 
MIMAT0001532 miR-448 0,74 0,19 MIMAT0004918 miR-892b 0,89 0,04 
MIMAT0004703 miR-335* 0,74 0,89 MIMAT0004757 miR-431* 0,89 0,78 
MIMAT0000763 miR-338-3p 0,74 0,73 MIMAT0003239 miR-574-3p 0,89 0,91 
MIMAT0007887 miR-1912 0,74 0,04 MIMAT0000617 miR-200c 0,9 0,07 
MIMAT0005798 miR-1185 0,74 0,26  miR-181a-2* 0,9 0,07 
MIMAT0000079 miR-24-1* 0,74 0,20 MIMAT0003256 miR-589* 0,91 0,57 
MIMAT0004974 miR-924 0,75 0,08 MIMAT0004907 miR-892a 0,91 0,52 
 miR-330-5p 0,75 0,22 MIMAT0003305 miR-635 0,91 0,04 
MIMAT0006766 miR-1826 0,76 0,18 MIMAT0005584 miR-1229 0,91 0,15 
MIMAT0000070 miR-17 0,76 0,02 MIMAT0004702 miR-339-3p 0,92 0,12 
MIMAT0006764 miR-320d 0,76 0,13 MIMAT0000428 miR-135a 0,92 0,23 
MIMAT0005922 miR-1268 0,77 0,76 MIMAT0004687 miR-371-5p 0,92 0,23 
MIMAT0004795 miR-574-5p 0,77 0,01 MIMAT0009979 miR-2054 0,92 0,08 
MIMAT0003287 miR-618 0,78 0,01 MIMAT0000733 miR-379 0,92 0,12 
MIMAT0000231 miR-199a-5p 0,79 0,23 MIMAT0005894 miR-1243 0,92 0,23 
MIMAT0000703 miR-361-5p 0,79 0,00 MIMAT0004958 miR-301b 0,93 0,22 
MIMAT0002844 miR-518b 0,8 0,20  miR-124* 0,93 0,04 
MIMAT0004502 miR-28-3p 0,8 0,83 MIMAT0003266 miR-598 0,94 0,10 
MIMAT0004805 miR-616 0,8 0,17 MIMAT0004902 miR-891a 0,94 0,80 
MIMAT0005915 miR-1263 0,8 0,07 MIMAT0005912 miR-548g 0,94 0,13 
MIMAT0000757 miR-151-3p 0,8 0,68 MIMAT0005935 miR-548i 0,94 0,17 
MIMAT0004913 miR-891b 0,81 0,01 MIMAT0003231 miR-567 0,94 0,05 
MIMAT0004919 miR-541* 0,81 0,12 MIMAT0005577 miR-1226 0,96 0,16 
MIMAT0004793 miR-556-3p 0,82 0,45 MIMAT0001341 miR-424 0,96 0,02 
MIMAT0002417 miR-100 0,82 0,51 MIMAT0003228 miR-564 0,96 0,12 
MIMAT0004951 miR-887 0,83 0,56 MIMAT0003235 miR-570 0,96 0,61 
MIMAT0005903 miR-1251 0,83 0,02 MIMAT0004983 miR-940 0,97 0,86 
MIMAT0004497 miR-24-2* 0,83 0,06 MIMAT0000452 miR-154 0,97 0,36 
MIMAT0005890 miR-1302 0,83 0,66 MIMAT0002806 miR-490-3p 0,97 0,73 
MIMAT0004802 miR-593 0,84 0,15 MIMAT0003150 miR-455-5p 0,98 0,03 
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MIMAT0003238 miR-573 0,98 0,04 MIMAT0003340 miR-542-5p 1,14 0,04 
MIMAT0005943 miR-1292 0,98 0,55 MIMAT0000689 miR-99b 1,14 0,29 
MIMAT0005458 miR-1224-5p 0,98 0,77 MIMAT0003309 miR-639 1,15 0,15 
MIMAT0000692 miR-30e 0,98 0,25 MIMAT0004679 miR-296-3p 1,15 0,07 
MIMAT0000682 miR-200a 0,99 0,28 MIMAT0000097 miR-99a 1,15 0,11 
MIMAT0004916 miR-888 0,99 0,05 MIMAT0004987 miR-944 1,15 0,34 
MIMAT0004701 miR-338-5p 1 0,69 MIMAT0005930 miR-1276 1,16 0,09 
MIMAT0005792 miR-320b 1 0,13 MIMAT0000764 miR-339-5p 1,16 0,73 
MIMAT0000729 miR-376a 1 0,26 MIMAT0000765 miR-335 1,17 0,08 
MIMAT0002869 miR-519a 1 0,76 MIMAT0004954 miR-543 1,17 0,07 
MIMAT0004500 miR-26b* 1 0,33 MIMAT0003227 miR-563 1,19 0,34 
MIMAT0004513 miR-101* 1,01 0,21 MIMAT0000243 miR-148a 1,2 0,06 
MIMAT0000683 miR-302a* 1,01 0,36 MIMAT0000458 miR-190 1,21 0,13 
MIMAT0005911 miR-1260 1,02 0,27 MIMAT0000761 miR-324-5p 1,21 0,06 
MIMAT0004957 miR-760 1,02 0,01 MIMAT0004568 miR-221* 1,21 0,93 
MIMAT0005889 miR-548l 1,02 0,11 MIMAT0004603 miR-125b-2* 1,23 0,41 
MIMAT0005875 miR-548j 1,02 0,19 MIMAT0007892 miR-1915 1,23 0,23 
MIMAT0004906 miR-886-3p 1,03 0,12 MIMAT0000262 miR-187 1,24 0,17 
MIMAT0004483 let-7c* 1,03 0,10 MIMAT0000076 miR-21 1,25 0,32 
MIMAT0004971 miR-921 1,03 0,13 MIMAT0003306 miR-636 1,25 0,13 
MIMAT0005867 miR-663b 1,03 0,08 MIMAT0009448 miR-1973 1,25 0,16 
MIMAT0005871 miR-1207-5p 1,03 0,76 MIMAT0004615 miR-195* 1,26 0,20 
MIMAT0001526 aga-miR-9a 1,04 0,82 MIMAT0000087 miR-30a 1,26 0,04 
MIMAT0002813 miR-493* 1,04 0,41 MIMAT0003300 miR-631 1,26 0,32 
MIMAT0004776 miR-505* 1,04 0,07 MIMAT0004689 miR-377* 1,27 0,14 
MIMAT0000457 miR-188-5p 1,04 0,42 MIMAT0000725 miR-373* 1,27 0,24 
MIMAT0005872 miR-1207-3p 1,04 0,71 MIMAT0005866 miR-1203 1,27 0,05 
MIMAT0003242 miR-577 1,04 0,17 MIMAT0000728 miR-375 1,27 0,06 
MIMAT0002883 miR-514 1,04 0,33 MIMAT0005919 miR-548o 1,27 0,04 
MIMAT0003252 miR-586 1,05 0,04 MIMAT0002877 miR-513-5p 1,28 0,55 
MIMAT0002829 miR-519e 1,06 0,41 MIMAT0004570 miR-223* 1,28 0,44 
MIMAT0000072 miR-18a 1,07 0,14 MIMAT0004749 miR-424* 1,29 0,83 
MIMAT0005797 miR-1301 1,08 0,15 MIMAT0000244 miR-30c 1,29 0,32 
MIMAT0003882 miR-767-5p 1,09 0,64 MIMAT0004613 miR-188-3p 1,3 0,57 
MIMAT0004808 miR-625* 1,09 0,20 MIMAT0009203 miR-449b* 1,3 0,90 
MIMAT0004604 miR-127-5p 1,09 0,18 MIMAT0005910 miR-1259 1,3 0,07 
MIMAT0004775 miR-502-3p 1,1 0,06 MIMAT0000091 miR-33a 1,3 0,19 
MIMAT0005931 miR-302e 1,1 0,26 MIMAT0002856 miR-520d-3p 1,3 0,68 
MIMAT0000686 miR-34c-5p 1,1 0,19 MIMAT0003259 miR-591 1,31 0,20 
MIMAT0004609 miR-149* 1,1 0,37 MIMAT0004751 miR-18b* 1,32 0,29 
MIMAT0005885 miR-1295 1,1 0,06 MIMAT0005879 miR-1289 1,33 0,72 
MIMAT0004554 miR-7-2* 1,12 0,29 MIMAT0002880 miR-508-3p 1,33 0,24 
MIMAT0000459 miR-193a-3p 1,12 0,16 MIMAT0000440 miR-191 1,34 0,39 
MIMAT0005573 miR-1225-3p 1,13 0,34 MIMAT0003226 miR-562 1,56 0,10 
MIMAT0000462 miR-206 1,14 0,79 MIMAT0000082 miR-26a 1,56 0,19 
MIMAT0003215 miR-552 1,14 0,13 MIMAT0002832 miR-519c-3p 1,57 0,33 
MIMAT0003225 miR-561 1,14 0,10 MIMAT0002842 miR-518f 1,57 0,04 
MIMAT0000421 miR-122 1,34 042 MIMAT0000433 miR-142-5p 1,57 0,27 
MIMAT0000071 miR-17* 1,34 0,56 MIMAT0005450 miR-518e* 1,57 0,22 
MIMAT0004905 miR-886-5p 1,34 0,51  miR-708 1,58 0,10 
MIMAT0001627 miR-433 1,34 0,20 MIMAT0000226 miR-196a 1,59 0,32 
MIMAT0004510 miR-96* 1,35 0,25 MIMAT0000420 miR-30b 1,59 0,14 
MIMAT0000256 miR-181a 1,35 0,27 MIMAT0004543 miR-192* 1,59 0,05 
MIMAT0003304 miR-634 1,35 0,60 MIMAT0004792 miR-92b* 1,59 0,29 
MIMAT0004564 miR-214* 1,36 0,16 MIMAT0000083 miR-26b 1,59 0,06 
MIMAT0001638 miR-409-5p 1,36 0,15  miR-423-5p 1,62 0,63 
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MIMAT0004518 miR-16-2* 1,36 0,12 MIMAT0000277 miR-220 1,62 0,09 
MIMAT0002816 miR-494 1,36 0,07 MIMAT0004976 miR-933 1,63 0,04 
MIMAT0004806 miR-548c-5p 1,37 0,08 MIMAT0004785 miR-545* 1,64 0,83 
MIMAT0004982 miR-939 1,37 0,15 MIMAT0000068 miR-15a 1,65 0,07 
MIMAT0001339 miR-422a 1,37 0,26 MIMAT0000101 miR-103 1,67 0,41 
MIMAT0004959 miR-216b 1,38 0,09 MIMAT0004945 miR-744 1,67 0,06 
MIMAT0003233 miR-551b 1,38 0,06 MIMAT0000073 miR-19a 1,67 0,08 
MIMAT0004601 miR-145* 1,4 0,23 MIMAT0000771 miR-325 1,68 0,10 
MIMAT0002864 miR-518d-3p 1,4 0,61 MIMAT0000705 miR-362-5p 1,68 0,30 
MIMAT0003247 miR-582-5p 1,4 0,19 MIMAT0000707 miR-363 1,68 0,69 
MIMAT0004551 miR-30d* 1,41 0,14 MIMAT0004584 let-7g* 1,69 0,09 
MIMAT0000724 miR-372 1,42 0,56 MIMAT0004559 miR-181c* 1,69 0,13 
MIMAT0003255 miR-588 1,42 0,16 MIMAT0000714 miR-302b* 1,7 0,08 
MIMAT0003274 miR-606 1,42 0,09 MIMAT0004556 miR-10b* 1,7 0,10 
MIMAT0005925 miR-1272 1,42 0,07 MIMAT0000276 miR-219-5p 1,71 0,03 
MIMAT0007349 miR-1471 1,43 0,37 MIMAT0005908 miR-1257 1,71 0,05 
MIMAT0003293 miR-624* 1,45 0,05 MIMAT0003272 miR-604 1,71 0,09 
MIMAT0005895 miR-548f 1,46 0,10 MIMAT0004550 miR-30c-2* 1,74 0,22 
MIMAT0003332 miR-656 1,46 0,09 MIMAT0002875 miR-504 1,8 0,14 
MIMAT0002853 miR-519d 1,47 0,27 MIMAT0004599 miR-143* 1,81 0,24 
MIMAT0003261 miR-593* 1,48 0,36 MIMAT0004489 miR-16-1* 1,82 0,13 
MIMAT0004984 miR-941 1,48 0,03 MIMAT0000715 miR-302b 1,85 0,09 
MIMAT0004590 miR-122* 1,48 0,24 MIMAT0002824 miR-498 1,86 0,70 
MIMAT0000074 miR-19b 1,48 0,15 MIMAT0004504 miR-31* 1,87 0,12 
MIMAT0000646 miR-155 1,49 0,27 MIMAT0002818 miR-496 1,89 0,98 
MIMAT0005880 miR-1290 1,51 0,25 MIMAT0004488 miR-15a* 1,89 0,06 
MIMAT0002891 miR-18a* 1,51 0,20 MIMAT0004765 miR-491-3p 1,91 0,20 
MIMAT0000265 miR-204 1,51 0,04 MIMAT0004658 miR-155* 1,93 0,12 
MIMAT0003335 miR-657 1,55 0,12 MIMAT0000438 miR-152 1,95 0,15 
MIMAT0004514 miR-29b-1* 1,95 0,18 MIMAT0000710 miR-365 2,4 0,26 
MIMAT0004807 miR-624 1,99 0,07 MIMAT0002861 miR-518e 2,46 0,10 
MIMAT0005901 miR-1249 2 0,18 MIMAT0000773 miR-346 2,47 0,28 
MIMAT0002881 miR-509-3p 2,01 0,21 MIMAT0000460 miR-194 2,47 0,32 
MIMAT0002817 miR-495 2,01 0,06 MIMAT0003250 miR-585 2,5 0,13 
 miR-423-3p 2,05 0,05 MIMAT0000454 miR-184 2,52 0,06 
MIMAT0004512 miR-100* 2,07 0,12 MIMAT0003216 miR-553 2,55 0,20 
MIMAT0004801 miR-590-3p 2,09 0,17 MIMAT0003308 miR-638 2,57 0,13 
MIMAT0003297 miR-628-3p 2,1 0,07 MIMAT0002871 miR-500* 2,59 0,10 
MIMAT0002177 miR-486-5p 2,1 0,13  miR-589 2,59 0,06 
MIMAT0005949 miR-664 2,11 0,25 MIMAT0000090 miR-32 2,61 0,35 
MIMAT0002867 miR-520h 2,13 0,23 MIMAT0004593 miR-130a* 2,62 0,10 
 miR-455-3p 2,15 0,21 MIMAT0001181 let-7a 2,72 0,17 
MIMAT0004697 miR-151-5p 2,17 0,18 MIMAT0000759 miR-148b 2,73 0,25 
MIMAT0005936 miR-1278 2,18 0,18 MIMAT0002843 miR-520b 2,74 0,37 
MIMAT0004685 miR-302d* 2,18 0,10 MIMAT0000241 miR-208 2,82 0,04 
MIMAT0004561 miR-187* 2,19 0,31 MIMAT0002888 miR-532-5p 3,16 0,02 
MIMAT0005939 miR-1281 2,19 0,25 MIMAT0004778 miR-508-5p 3,31 0,21 
MIMAT0004671 miR-194* 2,2 0,16 MIMAT0004923 miR-875-3p 3,33 0,15 
MIMAT0002852 miR-517a 2,25 0,18 MIMAT0002171 miR-410 3,64 0,85 
MIMAT0000690 miR-296-5p 2,25 0,02 MIMAT0000770 miR-133b 3,86 0,23 
MIMAT0000254 miR-10b 2,26 0,25 MIMAT0001618 miR-191* 4,52 0,03 
MIMAT0005794 miR-1296 2,3 0,12     
MIMAT0004515 miR-29b-2* 2,32 0,26     






          Appendix Table 6.2.  List of miRNAs showing quantitative analysis of Golgi features. 
siRNA / miRNA Fragments / cell siRNA / miRNA Fragments / cell 
AllStars 1 mir-521 0.98 
α-COP 3.51 mir-27a 1.04 
Let-7a 0.97 let7b 1.01 
miR-302b 0.83 mir27b 1.02 
miR-133b 0.80 mir495 1.04 
miR-150 0.98 mir151-3p 1.01 
miR-211 2.35 mir455-3p 0.97 
miR-194 1 mir10b 1.10 
miR-129-5p 1.10 mir365 1.03 
mir 500* 0.99 mir553 1.03 
mir 1237 1.04 mir3585 1.09 
mir 1469 1.03 mir638 1.19 
mir 1827 0.96 mir589 1.02 
mir 181a* 1.03 mir532-5p 0.96 
mir 191* 0.96 mir520b 1.09 
mir 148b 1.01 mir410 1.07 
mir 208 0.97 miR-19b 1.13 
mir 184 0.93 miR-604 1 
mir 346 1.05 miR-30b 0.98 
mir 296-5p 0.93 miR-129* 0.99 
mir 1296 0.88 miR-509-3p 0.97 
mir1281 0.87 miR-744* 0.99 
mir-520h 0.81 miR-29a 1.10 
mir 219-5p 0.83 miR-453 0.97 
mir 486-5p 0.83 miR-198 0.98 
mir19a 0.70 miR-1227 0.71 
miR-488 3.13 miR-943 3.02 
mir-20b 1.31 mir-566 3.66 














Appendix Table 6.3. Predicted target genes of miR-30b. Merged list of genes shown are predicted 
by three target site prediction tools TargetScan PicTar and miRanda. The genes related to the 
membrane trafficking which are down-regulated upon overexpression of miR-30b are marked in 
yellow. 
Gene  
Name Protein Name 
A2BP1 RNA binding protein fox-1 homolog 
ABL1 Tyrosine-protein kinase ABL1 
ACTC1 Actin alpha cardiac muscle 1 
ACTN1 Alpha-actinin-1 
ACTR1A Alpha-centractin 
ACVR1 Activin receptor type-1 
ADAM19 Disintegrin and metalloproteinase domain-containing protein 19 
ADAMTS3 A disintegrin and metalloproteinase with thrombospondin motifs 3 
ADAMTS9 A disintegrin and metalloproteinase with thrombospondin motifs 9 
ADRB1 Beta-1 adrenergic receptor 
ADRB2 Beta-2 adrenergic receptor 
AMOTL2 
 
Angiomotin-like protein 2 
 
ANKHD1 Ankyrin repeat and KH domain-containing protein 1 
ANKRA2 Ankyrin repeat family A protein 2 
ANKRD17 
 




AP-2 complex subunit alpha-1 
 




AP-4 complex subunit epsilon-1 
 
ARF4 ADP-ribosylation factor 4 
ARHGEF6 
 
Rho guanine nucleotide exchange factor 6 
 
ARID1A AT-rich interactive domain-containing protein 1A 
ARID3A AT-rich interactive domain-containing protein 3A 
ARID4A AT-rich interactive domain-containing protein 4A 
ARID4B AT-rich interactive domain-containing protein 4B 
ARL6IP6 ADP-ribosylation factor-like protein 6-interacting protein 6 
ASB3 Ankyrin repeat and SOCS box protein 3 
ATP2A2 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 
ATP2B1 Plasma membrane calcium-transporting ATPase 1 
ATP2B2 Plasma membrane calcium-transporting ATPase 2 
B3GNT5 Lactosylceramide 13-N-acetyl-beta-D-glucosaminyltransferase 
BAHD1 Bromo adjacent homology domain-containing 1 protein 
BCL11B B-cell lymphoma/leukemia 11B 
BCL2L11 Bcl-2-like protein 11 
BCL6 B-cell lymphoma 6 protein 









BNC1 Zinc finger protein basonuclin-1 
BNIP3L BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like 
BRD1 Bromodomain-containing protein 1 
C10orf76 UPF0668 protein C10orf76 
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C13orf18 Uncharacterized protein KIAA0226-like 
C13orf23 Proline and serine-rich protein 1 
C15orf29 KATNB1-like protein 1 
C20orf108 Protein FAM210B 
C4orf26 Uncharacterized protein C4orf26 
C9orf72 
 
Uncharacterized protein C9orf72 
 
CA10 Carbonic anhydrase-related protein 10 
CACNB2 Voltage-dependent L-type calcium channel subunit beta-2 
CADPS Calcium-dependent secretion activator 





CAMK2D Calcium/calmodulin-dependent protein kinase type II subunit delta 
CAMKK2 Calcium/calmodulin-dependent protein kinase kinase 2 














CBFB Core-binding factor subunit beta 
CBLB E3 ubiquitin-protein ligase CBL-B 
CCDC120 Coiled-coil domain-containing protein 120 
CCNE2 G1/S-specific cyclin-E2 
CCNK Cyclin-K 





CDC37L1 Hsp90 co-chaperone Cdc37-like 1 
CECR6 Cat eye syndrome critical region protein 6 





CHD7 Chromodomain-helicase-DNA-binding protein 7 
CHD9 Chromodomain-helicase-DNA-binding protein 9 
CHST1 Carbohydrate sulfotransferase 1 
CHST2 Carbohydrate sulfotransferase 2 
CIT 
 
Citron Rho-interacting kinase 
 
CLOCK Circadian locomoter output cycles protein kaput 
CNR1 
 






COG2 Conserved oligomeric Golgi complex subunit 2 
COL13A1 Collagen alpha-1(XIII) chain 
COPS7B 
 
COP9 signalosome complex subunit 7b 
 
CPEB2 Cytoplasmic polyadenylation element-binding protein 2 
CPEB3 Cytoplasmic polyadenylation element-binding protein 3 





CPSF6 Cleavage and polyadenylation specificity factor subunit 6 
CSDA DNA-binding protein A 
CSNK1A1 Casein kinase I isoform alpha 
CSNK1G1 Casein kinase I isoform gamma-1 
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DDAH1 N(G)N(G)-dimethylarginine dimethylaminohydrolase 1 
DDIT4 DNA damage-inducible transcript 4 protein 
DDX46 Probable ATP-dependent RNA helicase DDX46 
DET1 De-etiolated homolog 1 (Arabidopsis) 
DEXI Dexamethasone-induced protein 
DGKZ Diacylglycerol kinase zeta 
DHX40 DEAH (Asp-Glu-Ala-His) box polypeptide 40 
 
 
DLG5 Disks large homolog 5 
DLGAP4 Disks large-associated protein 4 
DLL4 
 
Delta-like protein 4 
 
DMD Dystrophin 
DMTF1 Cyclin-D-binding Myb-like transcription factor 1 
DNMT3A DNA (cytosine-5)-methyltransferase 3A 
DOC2A Double C2-like domain-containing protein alpha 
DOCK7 Dedicator of cytokinesis protein 7 
DOLPP1 Dolichyldiphosphatase 1 
DPYSL2 
 








Transcription factor E2F7 
 
EAF1 ELL-associated factor 1 
EBF3 
 
Transcription factor COE3 
 
EDC3 Enhancer of mRNA-decapping protein 3 





EDNRB Endothelin B receptor 
EED Polycomb protein EED 
EFNA3 Ephrin-A3 
EGR3 Early growth response protein 3 
EHBP1 EH domain-binding protein 1 
EIF2C1 Protein argonaute-1 
EIF5A2 Eukaryotic translation initiation factor 5A-2 
ELAVL2 
 
ELAV-like protein 2 
 
ELL RNA polymerase II elongation factor ELL2 
ELMO1 
  
Engulfment and cell motility protein 1 
 
ELMOD2 ELMO domain-containing protein 2 
ELOVL5 Elongation of very long chain fatty acids protein 5 
EML4 Echinoderm microtubule-associated protein-like 4 
EPC2 Enhancer of polycomb homolog 2 
EPHB2 Ephrin type-B receptor 2 
ERG Potassium voltage-gated channel subfamily H member 2 
ESCO1 N-acetyltransferase ESCO1 
ESPN Espin 
ESRRG Estrogen-related receptor gamma 
EXTL2 Exostosin-like 2 
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EYA2 Eyes absent homolog 2 
FAM40A Family with sequence similarity 40 member A 
FAM43A Family with sequence similarity 43 member A 
FAM46C Family with sequence similarity 46 member C 
FAM49A Family with sequence similarity 49 member A 
FAM83F Family with sequence similarity 83 member F 
FBXL17 F-box/LRR-repeat protein 17 
FBXL20 F-box/LRR-repeat protein 20 




 FRK Tyrosine-protein kinase FRK 
FRMPD1 FERM and PDZ domain-containing protein 1 
FXR1 Fragile X mental retardation syndrome-related protein 1 
FYCO1 FYVE and coiled-coil domain-containing protein 1 
GABRA5 Gamma-aminobutyric acid receptor subunit alpha-5 
GALNT1 Polypeptide N-acetylgalactosaminyltransferase 1 
GALNT2 Polypeptide N-acetylgalactosaminyltransferase 2 
GALNT3 Polypeptide N-acetylgalactosaminyltransferase 3 
GALNT7 Polypeptide N-acetylgalactosaminyltransferase 7 
GFPT2 Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 
GJA1 
 
Gap junction alpha-1 protein 
 
GLCE D-glucuronyl C5-epimerase 
GLDC Glycine dehydrogenase [decarboxylating] mitochondrial 
GMEB2 Glucocorticoid modulatory element-binding protein 2 
GNAI2 Guanine nucleotide-binding protein G(i) subunit alpha-2 
GNAO1 Guanine nucleotide-binding protein G(o) subunit alpha 
GOLGA1 Golgin subfamily A member 1 
GOLGA4 Golgin subfamily A member 4 
GPR124 G-protein coupled receptor 124 
GRB10 Growth factor receptor-bound protein 10 
GRHL1 
 




Grainyhead-like protein 2 homolog 
 
GRK5 G protein-coupled receptor kinase 5 
GRM3 Metabotropic glutamate receptor 3 
GRM5 Metabotropic glutamate receptor 5 
GTF2E2 Transcription initiation factor IIE subunit beta 
GTF2H1 General transcription factor IIH subunit 1 
GZF1 GDNF-inducible zinc finger protein 1 
HECTD2 Probable E3 ubiquitin-protein ligase HECTD2 
HERC2 E3 ubiquitin-protein ligase HERC2 
HIAT1 Hippocampus abundant transcript 1 protein 
HIC2 Hypermethylated in cancer 2 protein 
HLF Hepatic leukemia factor 
HOXA1 Homeobox protein Hox-A1 
HOXA11 Homeobox protein Hox-A11 
HSPA5 78 kDa glucose-regulated protein 
ICK Serine/threonine-protein kinase ICK 
IDH1 Isocitrate dehydrogenase [NADP] cytoplasmic 
IER2 Immediate early response gene 2 protein 
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IGF2R Insulin-like growth factor type II receptor 
IHPK3 Inositol hexakisphosphate kinase 3 
IL1A Interleukin-1 alpha 
INSIG2 Insulin-induced gene 2 protein 
IRF4 Interferon regulatory factor 4 
IRS1 Insulin receptor substrate 1 









ITGB3 Integrin beta-3 
ITPK1 Inositol-tetrakisphosphate 1-kinase 
JAG2 Protein jagged-2 
JMJD1A Janus kinase and microtubule-interacting protein 2 
JDP2 Jun dimerization protein 2 
JPH4 Junctophilin-4 
KCNJ12 ATP-sensitive inward rectifier potassium channel 12 
KCNJ3 ATP-sensitive inward rectifier potassium channel 3 
KCNMB2 Calcium-activated potassium channel subunit beta-2 
KCTD3 BTB/POZ domain-containing protein KCTD3 
KCTD5 BTB/POZ domain-containing protein KCTD5 
KCTD7 BTB/POZ domain-containing protein KCTD7 
KCTD8 BTB/POZ domain-containing protein KCTD8 
KIAA0355 Uncharacterized protein KIAA0355 
KIAA1033 Uncharacterized protein KIAA1033 
KIAA0746 Uncharacterized protein KIAA0746 
KIAA1576 Uncharacterized protein KIAA1576 
KIAA1622 Uncharacterized protein KIAA1622 
KIF5B Kinesin-1 heavy chain 
KPNA3 Importin subunit alpha-3 
LARGE Glycosyltransferase-like protein LARGE1 
LGI1 Leucine-rich glioma-inactivated protein 1 
LHX8 LIM/homeobox protein Lhx8 
LIN28 Protein lin-28 homolog B 
LPHN3 Latrophilin-3 
LPP Lipoma-preferred partner 
LPPR4 Lipid phosphate phosphatase-related protein type 4 
LRRC17 Leucine-rich repeat-containing protein 17 
LYCAT Lysocardiolipin acyltransferase 1 
MAB21L1 Protein mab-21-like 1 
MAML1 Mastermind-like protein 1 
MAN1A2 Mannosyl-oligosaccharide 12-alpha-mannosidase IB 
MAN1B1 Endoplasmic reticulum mannosyl-oligosaccharide 12-alpha-mannosidase 
MAP3K12 Mitogen-activated protein kinase kinase kinase 12 
MAP3K5 Mitogen-activated protein kinase kinase kinase 5 
MAPRE1 Microtubule-associated protein RP/EB family member 1 
MARCH6 E3 ubiquitin-protein ligase MARCH6 
MARCKS Myristoylated alanine-rich C-kinase substrate 
MARK3 MAP/microtubule affinity-regulating kinase 3 





MBD6 Methyl-CpG-binding domain protein 6 
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MBNL2 Muscleblind-like protein 2 
MBNL3 Muscleblind-like protein 3 
MCF2 Proto-oncogene DBL 
MEIS2 Homeobox protein Meis2 
MEOX2 Homeobox protein MOX-2 
MGC42367 
 MKRN3 Probable E3 ubiquitin-protein ligase makorin-3 
MMD Monocyte to macrophage differentiation factor 
MNT Max-binding protein MNT 
MTDH Protein LYRIC 
MYBL2 Myb-related protein B 
MYH10 Myosin-10 
NAALADL2 Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 
NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 
NAV3 Neuron navigator 3 
NCAM1 Neural cell adhesion molecule 1 
NCOR2 Nuclear receptor corepressor 2 
NDEL1 Nuclear distribution protein nudE-like 1 
NEDD4 E3 ubiquitin-protein ligase NEDD4 
NEDD4L E3 ubiquitin-protein ligase NEDD4-like 
NEGR1 Neuronal growth regulator 1 
NEK4 Serine/threonine-protein kinase Nek4 
NEUROD1 Neurogenic differentiation factor 1 
NEUROD6 Neurogenic differentiation factor 6 
NEUROG1 Neurogenin-1 
NFAT5 Nuclear factor of activated T-cells 5 
NFIB Nuclear factor 1 B-type 
NHLH2 Helix-loop-helix protein 2 
NHS Nance-Horan syndrome protein 
NKX2-2 Homeobox protein Nkx-2.2 
NLGN1 Neuroligin-1 
NOTCH1 Neurogenic locus notch homolog protein 1 
NOVA1 RNA-binding protein Nova-1 
NR3C1 Glucocorticoid receptor 
NR4A2 Nuclear receptor subfamily 4 group A member 2 
NR5A2 
 




Nuclear receptor subfamily 6 group A member 1 
 
NRBF2 Nuclear receptor-binding factor 2 
NRIP1 Nuclear receptor-interacting protein 1 







OMG Oligodendrocyte-myelin glycoprotein 
P4HA1 Prolyl 4-hydroxylase subunit alpha-1 
P4HA2 Prolyl 4-hydroxylase subunit alpha-2 
PAPD4 Poly(A) RNA polymerase GLD2 
PAPOLA Poly(A) polymerase alpha 
PAPOLB Poly(A) polymerase beta 
PAWR PRKC apoptosis WT1 regulator protein 






PDCD10 Programmed cell death protein 10 
PDCL Phosducin-like protein 
PDE4D cAMP-specific 3'5'-cyclic phosphodiesterase 4D 
PDGFRB Platelet-derived growth factor receptor beta 
PELI1 E3 ubiquitin-protein ligase pellino homolog 1 
PER2 Period circadian protein homolog 2 
PFN2 Profilin-2 
PGGT1B Geranylgeranyl transferase type-1 subunit beta 
PGM1 Phosphoglucomutase-1 
PHF16 Protein Jade-3 
PHF6 PHD finger protein 6 
PHTF2 Putative homeodomain transcription factor 2 
PIK3R2 Phosphatidylinositol 3-kinase regulatory subunit beta 
PIP5K1B Phosphatidylinositol 4-phosphate 5-kinase type-1 beta 
PLAG1 Zinc finger protein PLAG1 
PLS1 Plastin-1 
PNN Pinin 
PON2 Serum paraoxonase/arylesterase 2 
POU4F2 POU domain class 4 transcription factor 2 
PPARGC1A Peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
PPARGC1B Peroxisome proliferator-activated receptor gamma coactivator 1-beta 
PPP1R12A Protein phosphatase 1 regulatory subunit 12A 
PPP1R14C Protein phosphatase 1 regulatory subunit 14C 
PPP3CB Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform 
PPP3R1 Calcineurin subunit B type 1 
PRDM1 PR domain zinc finger protein 1 
PRICKLE1 Prickle-like protein 1 
PSEN2 Presenilin-2 
PSMD7 26S proteasome non-ATPase regulatory subunit 7 
PSME3 Proteasome activator complex subunit 3 
PTGFRN Prostaglandin F2 receptor negative regulator 
PTP4A1 Protein tyrosine phosphatase type IVA 1 
PTPN13 Tyrosine-protein phosphatase non-receptor type 13 
R3HDM1 R3H domain-containing protein 1 
RAB10 
 




















Ras-related protein Rab-8A 
 
RAD23B UV excision repair protein RAD23 homolog B 
RAI14 Ankycorbin 
RANBP10 Ran-binding protein 10 
RANBP9 Ran-binding protein 9 
RAP1B Ras-related protein Rap-1b 
RAP2C Ras-related protein Rap-2c 
RAPGEF4 Rap guanine nucleotide exchange factor 4 
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RAPH1 Ras-associated and pleckstrin homology domains-containing protein 1 
RARB Retinoic acid receptor beta 
RARG Retinoic acid receptor gamma 
RASA1 Ras GTPase-activating protein 1 
RASD1 Dexamethasone-induced Ras-related protein 1 
RASL12 Ras-like protein family member 12 
REEP3 Receptor expression-enhancing protein 3 
REV1 DNA repair protein REV1 
RGL1 Ral guanine nucleotide dissociation stimulator-like 1 
RGS2 Regulator of G-protein signaling 2 
RHEBL1 GTPase RhebL1 
RHOB Rho-related GTP-binding protein RhoB 
RND3 Rho-related GTP-binding protein RhoE 
RNF122 RING finger protein 122 
RNF44 RING finger protein 44 
ROD1 Polypyrimidine tract-binding protein 3 
RRAD GTP-binding protein RAD 
RUNX1 Runt-related transcription factor 1 
SAP30 Histone deacetylase complex subunit SAP30 
SATB1 DNA-binding protein SATB1 
SATB2 DNA-binding protein SATB2 
SCARA5 Scavenger receptor class A member 5 
SCN2A Sodium channel protein type 2 subunit alpha 
SCN3A Sodium channel protein type 3 subunit alpha 
SCN8A Sodium channel protein type 8 subunit alpha 
SCYL3 Protein-associating with the carboxyl-terminal domain of ezrin 
SEC23A Protein transport protein Sec23A 
SEC24D Protein transport protein Sec24D 




SERPINE1 Plasminogen activator inhibitor 1 
SETD3 Histone-lysine N-methyltransferase setd3 
SGCB Beta-sarcoglycan 
SH3RF1 E3 ubiquitin-protein ligase SH3RF1 
SIRT1 
 
NAD-dependent protein deacetylase sirtuin-1 
 
SLAIN1 SLAIN motif-containing protein 1 
SLC25A14 Brain mitochondrial carrier protein 1 
SLC38A2 Solute carrier family 41 member 2 
SLC4A7 Sodium bicarbonate cotransporter 3 
SLC5A11 Sodium/myo-inositol cotransporter 2 
SLC7A10 Asc-type amino acid transporter 1 
SLC9A8 Sodium/hydrogen exchanger 8 
SNAI1 Zinc finger protein SNAI1 
SNX16 Sorting nexin-16 
SOCS1 Suppressor of cytokine signaling 1 
SOCS3 Suppressor of cytokine signaling 3 
SON Son of sevenless homolog 1 
SORCS3 VPS10 domain-containing receptor SorCS3 
SOX12 Transcription factor SOX-12 
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SOX4 Transcription factor SOX-4 
SOX9 Transcription factor SOX-9 
SP4 
 
Transcription factor Sp4 
 
SPAST Spastin 
SPEN Msx2-interacting protein 
SSBP2 Single-stranded DNA-binding protein 2 
SSH2 Protein phosphatase Slingshot homolog 2 
SSX2IP 
 
Afadin- and alpha-actinin-binding protein 
 
ST8SIA4 CMP-N-acetylneuraminate-poly-alpha-28-sialyltransferase 
STAC SH3 and cysteine-rich domain-containing protein 2 
STAG2 Cohesin subunit SA-2 
STC1 Stanniocalcin-1 
STIM2 Stromal interaction molecule 2 
STK35 Serine/threonine-protein kinase 35 
STK39 Serine/threonine-protein kinase 39 
STX2 Syntaxin-2 
SUPT3H Transcription initiation protein SPT3 homolog 
SYNGR3 Synaptogyrin-3 
SYPL1 Synaptophysin-like protein 1 
TAOK1 Serine/threonine-protein kinase TAO1 
TASP1 Threonine aspartase 1 
TBC1D10B TBC1 domain family member 10B 
TBC1D15 TBC1 domain family member 15 
TBPL1 TATA box-binding protein-like protein 1 
TCP11L1 T-complex protein 11-like protein 1 
TDG G/T mismatch-specific thymine DNA glycosylase 
THBS2 Thrombospondin-2 
TIA1 Nucleolysin TIA-1 isoform p40 
TIMP3 Metalloproteinase inhibitor 3 
TLL2 Tolloid-like protein 2 
TMED2 Transmembrane emp24 domain-containing protein 2 
TMEFF1 Tomoregulin-1 
TMEM121 Transmembrane protein 121 
TMEM47 Transmembrane protein 47 
TMEM87A Transmembrane protein 87A 
TNRC6A Trinucleotide repeat-containing gene 6A protein 
TNXB Tenascin-X 
TP53INP1 Tumor protein p53-inducible nuclear protein 1 
TRPM7 Transient receptor potential cation channel subfamily M member 7 
TRPS1 Zinc finger transcription factor Trps1 
TSGA14 Centrosomal protein of 41 kDa 
TSPAN33 Tetraspanin-33 
TTLL7 Tubulin polyglutamylase TTLL7 
TUBGCP3 Gamma-tubulin complex component 3 
TULP4 Tubby-related protein 4 
UBE2D2 Ubiquitin-conjugating enzyme E2 D2 
UBE2F NEDD8-conjugating enzyme 
UBE2I 
 
SUMO-conjugating enzyme UBC9 
 
UBE2J1 Ubiquitin-conjugating enzyme E2 J1 
UBE2V2 Ubiquitin-conjugating enzyme E2 variant 2 
UNC5C Netrin receptor UNC5C 
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UNC5D Netrin receptor UNC5D 
URM1 Ubiquitin-related modifier 1 homolog 
USP15 Ubiquitin carboxyl-terminal hydrolase 15 
USP37 Ubiquitin carboxyl-terminal hydrolase 37 
USP44 Ubiquitin carboxyl-terminal hydrolase 44 
USP48 Ubiquitin carboxyl-terminal hydrolase 48 
VAT1 Synaptic vesicle membrane protein VAT-1 homolog 
VIM Vimentin 
VIP Vasoactive intestinal polypeptide 
VKORC1L1 Vitamin K epoxide reductase complex subunit 1-like protein 1 
WDR44 WD repeat-containing protein 44 
WDR7 WD repeat-containing protein 7 
WIPF1 WAS/WASL-interacting protein family member 1 
XPO1 Exportin-1 
XPR1 Xenotropic and polytropic retrovirus receptor 1 
YBX1 Nuclease-sensitive element-binding protein 1 
YPEL5 Protein yippee-like 5 
YTHDC1 YTH domain-containing protein 1 
YWHAZ 14-3-3 protein zeta/delta 
ZBTB7A Zinc finger and BTB domain-containing protein 7A 
ZCCHC2 Zinc finger CCHC domain-containing protein 2 
ZDHHC17 Palmitoyltransferase ZDHHC17 
ZDHHC21 Palmitoyltransferase ZDHHC21 
ZEB2 Zinc finger E-box-binding homeobox 2 
ZFAND5 
 




Zinc finger FYVE domain-containing protein 26 
 
ZMYND8 Protein kinase C-binding protein 1 
ZNF644 Zinc finger protein 644 
ZNF706 Zinc finger protein 706 
ZNF746 Zinc finger protein 746 
ZNRF1 E3 ubiquitin-protein ligase ZNRF1 
ZRANB2 Zinc finger Ran-binding domain-containing protein 2 
 
 
        Appendix Table 6.4 List of selected regulators of functional class ‘Transport’   
Gene Name Gene Name Gene Name 
AP2A1 RAB10 SCAMP1 
AP3S1 RAB15 SEC23A 
AP4E1 RAB32 SEC24D 
ARF4 RAB11A SEC61A2 
GOLGA1 RAB38 SNX16 












Product IDa  Target Sequence (5’        3’) z-score
b
 p-valuec 
All Stars  SI03650318 
 
0 0,32 
α-COP 1314 SI00351491 CTGGCGCATGAATGAATCAAA -10,01 0,014 
AP2A1 160 
SI04371283 AGGCGGAAATTAAGAGAATCA -2,91 0,04 
SI04146429 CGCGGTGTTCATCTCCGACAT -6,76 0,04 
SI04157993 CTCGGTGCAGTTCCAGAATTT 5,83 0,03 
AP3S1 1176 
SI00019950 CAAGGCGATCCTAATCTTCAA -3,36 0,04 
SI03093769 CTGATATCTACTTTAGCAATA 3,622 0,06 
SI0317825 TACAACCCTCTGACTCAACAA -4,86 0,04 
AP4E1 23431 
SI04152302 CAGGCGCACTCTTCTAATACA 3,04 0,17 
SI04292050 CAGAGCACTAACCTAGTAGAA 0,47 0,66 
SI04353909 ATCGTCAATTTGGTCGGCAAA 0,11 0,65 
ARF4 378 
SI04159029 AACGTTAAATGAAATTGGATA -0,007 0,94 
SI04253347 GGGCAGACATATCTTCATTAA 1,02 0,14 
SI04307142 CAAGACAACCATTCTGTATAA 0,66 0,36 
GOLGA1 2800 
SI04195296 TCCCTTGTTTAGAACACGAAT -1,31 0,45 
SI04315346 AACACGCATTTGCAACGTTAA -0,29 0,83 
SI04349786 TTCTGCAAGTTTGATGGGTAA -1,61 0,01 
GOLGA4 2803 
SI04177572 CCGTGGAGTCTTTGTTTCGAA -1,18 0,18 
SI04207000 CAGGATAAATCACTTCGGAGA -0,57 0,39 
SI04211095 AAGGAGATGCAAGAAACGTTA 1,84 0,44 
RAB10 10890 
SI00113701 CAAATTCGGTTTCATATTCTA 0,96 0,03 
SI00113708 AAGGGACAAACTAGTAGGTTT 1,46 0,19 
SI00301546 ACCTGCGTCCTTTTTCGTTTT -2,95 0,16 
RAB15 376267 
SI04159890 TAGCTCGTAGGAGGCCCTTTA -0,68 0,54 
SI04271330 TGCAGCTACGCTCACCCTAAA -3,71 0,02 
SI04308346 CACTGCGTGGCTGCAGCCAAA -0,83 0,13 
RAB32 10981 
SI00092232 TTGCCATCATATGGAAGATAA 1,75 0,47 
SI02662198 CTCTGCAAAGGATAACATAAA 8,04 0,04 
SI02662765 CACCAAAGCTTTCCTAATGAA 2,60 0,03 
RAB8A 4218 
SI00076090 CACGTTGTATATTCAGAGAGA -3,63 0,13 
SI00076104 ATGCTCTGTTTACATCGATAA -2,18 0,32 
SI02662254 TCGCCAGAGATATCAAAGCAA -2,5 0,03 
SCAMP1 9522 
SI03227175 TAGATCGTCGGGAACGAGAAA -0,56 0,81 
SI04232487 TACATGGACTATATCGCACAA -1,65 0,04 
SI00711424 CACCATTAACTTATATCCCAA -2,54 0,34 
SEC23A 10484 
SI03019464 CAGACTCATAATAATATGTAT 1,43 0,31 
SI04144238 CAGAGCCGGTTCTTCTTGATA 0,42 0,005 
SI04238815 CACTACAACCTTAGCCATATA -0,97 0,23 
SEC24D 9871 
SI04145197 AACGACCTCAGAAATGATATT -1,82 0,19 
SI04228938 CCCATTTATGCAGTTCATCGA 0,69 0,82 




SI00714154 TCGCGTTGATCTGCCCATTAA 0,62 0,16 
SI04131960 CCGAGATACCTCTATGGTTCA 2,40 0,02 
SI04203962 ATGATCATTACCATTGGGCAA 1,61 0,18 
SNX16 64089 
SI04288627 AAGATAGACCATCTACACCTA -2,78 0,11 
SI04304300 CCAGTCGGTATGCTTTCTAAA -0,52 0,35 
SI04318482 TCCACGTAATCTTTATCTCTA -0,29 0,58 
TBC1D5 9779 SI04285099 AAACGAGCAGTTGCTTTATAA -0,17 0,70 
SI04285848 CTTCGTAGCCATGTTACTTTA 3,83 0,26 
 
Genes are listed by NCBI gene symbol and the corresponding Entrez Gene ID. All siRNAs listed are 
purchased from Qiagen. Target sequence, normalized z-score and p-value are also given. 
a Cat. No. for siRNAs from Qiagen 
b
 The transport rate of VSVG was estimated by the ratio of PM VSVG intensity and total VSVG 
intensity. Median of the ratio was taken to summarize the effect of the siRNA. Z-score was computed 
by normalizing the median of ratio of the siRNA against the median of ratio of all siRNAs. Red 
indicates z-score<-1.5 . 
c



















Appendix Table 6.6. List of retroposed pseudogenes for each RAB GTPases  with 
transcriptional evidence indicated in red. 
 
  Retroposed transcript 
 Parent 
gene 








1 RAB1A 191857368 191858270 88,40% 2 yes yes 
2 RAB43 46660319 46660903 99,00% 11 yes no 
3 RAB5C 76183191 76183777 88,80% 6 yes no 
4 RAB6C 132120532 132121293 98,90% 9 yes yes 
5 RAB13 56374212 56374817 98,10% 270 yes yes 
6 RAB28 135929681 135930187 87,60% 23 yes no 
7 RAB42 90358471 90358785 96,20% 0  yes 
8 RAB8A 63481824 63548793 95,00% 0  no 
9 RAB1B 37636688 37637290 95,60% 2  no 
10 RAB9A 28064476 28065039 71,20% 0  no 
11 RAB9B 104435181 104435444 78,50% 0  no 
12 RAB11A 95641046 95641740 78,60% 0  no 
13 RAB11B 95641082 95641695 73,90% 0  no 
14 RAB22A 46605448 46605660 74,70% 0  no 




0  yes 
